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ABSTRACT 
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) is an FAD-dependent 
enzyme that catalyzes the oxidative deamination of D-arginine to generate the corresponding α-
keto acid and ammonia. The enzyme is similar to D-amino acid oxidase, except that PaDADH is 
a strict dehydrogenase with no oxygen reactivity. The enzyme exhibits broad substrate 
specificity and can oxidize 17 of the 20 common amino acids. The best substrates for the enzyme 
are D-arginine and D-lysine based on the second order rate constant kcat/Km values.  
The 3D structure of the DADH-iminoarginine complex suggests that E87 engages in an 
electrostatic interaction with the positively charged guanidinium group of D-arginine. The 3D 
structure also displays a hydrogen bonding network of water molecules that connects H48 to the 
substrate α-amine, suggesting it may serve as catalytic base. E87 and H48 were mutated to 
produce E87L and H48F variants, and pH effect kinetic approaches with zwitterionic and 
cationic substrates were employed. The data, in combination with previous results on Y53 and 
Y249 variants, suggests that there is no catalytic base, since the catalytic pKa is present in all 
variants. The results are also consistent with E87 required to be deprotonated to bind cationic 
substrates.  
 In the second part of this dissertation, a presumed nitronate monooxygenase from P. 
aeruginosa, PA1024, is characterized. PA1024 is determined to not possess NMO activity and 
instead catalyze the two-electron reduction of quinones via the oxidation of NADH. The enzyme 
has a strict preference for NADH over NADPH. The functional annotation and bioinformatics 
identifies a novel class of FMN-dependent NADH:quinone oxidoreductases (NQO) with a TIM-
barrel fold. The pH effects reveal that PA1024 has two regimes of activity at low and high pH 
dictated by the deprotonation of an enzymatic residue with pKa ~7. In addition, the 3D X-ray 
structure of PA1024 in complex with the reaction product NAD+ is solved. The structure reveals 
the structural basis for the strict NADH specificity, which relies on a steric constraint imposed by 
a nearby P78 and Q80. The structure also reveals a conformational gating mechanism of Q80 and 
an unusual interrupted helix structural pattern to bind the pyrophosphate of NAD+. 
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1 INTRODUCTION  
1.1 Substrate specificity of flavoenzymes that oxidize D-amino acids  
1.1.1 Abstract 
The oxidation of D-amino acids is relevant to neurodegenerative diseases, detoxification, 
and nutrition in microorganisms and mammals. It is also important for the resolution of racemic 
amino acid mixtures and the preparation of chiral building blocks for the pharmaceutical and 
food industry. Considerable biochemical and structural knowledge has been accrued in recent 
years on the enzymes that carry out the oxidation of the Cα-N bond of D-amino acids. These 
enzymes contain FAD as a required cofactor, share similar overall three-dimensional folds and 
highly conserved active sites, but differ in their specificity for substrates with neutral, anionic, or 
cationic side-chains. Here, we summarize the current biochemical and structural knowledge 
regarding substrate specificity on D-amino acid oxidase, D-aspartate oxidase, and D-arginine 
dehydrogenase, for which a wealth of biochemical and structural studies is available. 
1.1.2 Introduction 
The oxidation of D-amino acids is important from both fundamental and applied 
standpoints.1 The reaction is relevant to neurodegenerative diseases, detoxification, nutrition, and 
other biological processes in microorganisms and mammals. It is also important for the 
resolution of racemic amino acid mixtures, the preparation of chiral building blocks for the 
pharmaceutical industry, and the food industry. In this review article, we present a brief 
overview of the importance of D-amino acids regarding biochemical processes and industrial 
applications, and summarize the current biochemical as well as structural knowledge on the 
flavoenzymes that oxidize α-D-amino acids with emphasis on substrate specificity. The enzymes 
covered within the scope of this review include D-amino acid oxidase (DAAO), D-arginine 
2 
dehydrogenase (DADH), and D-aspartate oxidase (DASPO), for which a wealth of biochemical 
and structural studies is available. These enzymes are divided into three categories, depending on 
their preference for D-amino acid substrates with neutral, cationic, or anionic side-chains. 
Mutant variants of the enzymes that had an impact on substrate specificity are also discussed. We 
conclude with some general principles about structure and specificity for the oxidation of α-D-
amino acids by flavoenzymes. The mechanistic aspects of the enzymes that oxidize the Cα-N 
bond of D-amino acids have been recently reviewed by Fitzpatrick and are not covered here.2 
1.1.3 Importance of D-amino acids 
Due to a lack of detection methods for D-amino acids for most of the 20th century, with 
only isolated cases of detection mostly in invertebrates3-5, studies investigating L-amino acids 
have eclipsed those of D-amino acids. Analysis of D-amino acids changed with the advent of 
improved analytical techniques in the 1990s, such as gas chromatography, high performance 
liquid chromatography, and the use of chiral columns, which allow separation of D/L-racemic 
mixtures and the detection of trace amounts of D-amino acids.4, 6 In bacteria, D-Ala and D-Glu 
have been detected as important components of the bacterial peptidoglycan and contribute to the 
overall strength of the cell wall.5 In humans, D-Ser has been detected at high concentrations in 
the brain and serves as the endogenous agonist of N-methyl-D-Asp (NMDA) receptors.7 D-Asp 
has been detected in the β-amyloid peptides of patients with Alzheimer’s disease 8, the crystallin 
peptides of patients with cataracts 9, and the αA-crystallin peptides of the elastic fibers in sun-
damaged skin.10 Thus, the emergence of knowledge on D-amino acids is fairly recent and 
remains underappreciated in many fields of biochemistry.  
D-amino acid derivatives are increasingly attractive chiral building blocks for drug 
discovery.11 Many natural and synthetic antibiotics contain D-amino acid groups, such as 
3 
penicillins and cephalosporins.12 The inherent resistance to protease cleavage demonstrated by 
antibiotic peptides containing D-amino acids greatly reduces the rate of their inactivation. 
Several drugs containing D-amino acids have surfaced in recent years including Nafarelin, which 
is used in the treatment of estrogen-dependent conditions such as endometriosis.13 D-cycloserine 
has been reported to have antibacterial properties through its inhibition of bacterial DAAOs.13 
Furthermore, recent findings suggest that human DAAO may play a significant role in the 
pathogenesis of schizophrenia due to its metabolic action on the neuromodulator D-Ser.14 
Because many routine commercial methods to synthesize amino acids result in a racemic 
mixture, L-amino acids must often be purified from D-amino acids. Several enzymatic systems 
that use D-amino acid oxidizing enzymes have been designed to resolve racemic amino acid 
mixtures.12 D-amino acid detection is of paramount importance in the food industry, where 
spontaneous racemization due to heat and processing conditions can generate D-amino acids that 
contaminate food preparations.15, 16 Enzymes that oxidize D-amino acids have been shown to 
accomplish rapid D-amino acid detection in mixtures, with a low cost and accuracy comparable 
to classical analytical techniques, such as high-performance liquid chromatography that are more 
expensive and time-consuming.17 
1.1.4 Flavoenzymes and Cα-N bond oxidation 
Enzymes that are known to oxidize the Cα-N bond of D-amino acids with high 
stereospecificity for the D-isomer are flavoenzymes. Flavoenzymes are versatile catalysts that 
utilize a covalently, or more often, non-covalently bound FMN or FAD as a cofactor (Figure 
1.1).18 The reactive portion of FMN or FAD is the 7,8-dimethylisoalloxazine ring (Figure 1.1), 
which is a fusion of xylene, pyrazine and pyrimidine rings, allowing for multifunctional 
capabilities.19 The general reaction of D-amino acid oxidation by flavoenzymes entails the 
oxidation of the bond between the C
imino acid (Scheme 1.1). Non-enzymatic hydrolysis of the imino acid product yields the 
acid and ammonia. The reduced flavin cofactor donates electrons to an acceptor to regenerate the 
oxidized flavin. As illustrated in 
whereas dehydrogenases utilize electron acceptors other than oxygen. Althoug
reaction occurs non-enzymatically in solution, recent studies have reported an imine deiminase 
enzyme from the Rid protein family that can accelerate the breakdown of the imino acid to the 
corresponding α-keto acid.20, 21  
Figure 1.1 Structure of FMN, FAD, and 7,8 
 
α atom and the amine N atom to generate the corresponding 
Scheme 1.1, oxidases utilize oxygen as electron acceptor, 
-dimethylisoalloxazine. 
4 
α-keto 
h the hydrolysis 
 
5 
 
Scheme 1.1 General scheme of the reaction catalyzed by A) D-amino acid oxidases and B) D-arginine dehydrogenase.  EAox: oxidized electron acceptor; EAred: reduced electron acceptor. The D-amino acid substrate in the DAAO reaction loses the amino group proton prior to forming the ES complex.2  
The oxidation of D-amino acids is found in key life processes, such as regulatory 
processes, neurotransmission,22-24 cell-signaling,25 and metabolism.26 As a result, imbalance in 
the regulation or function of these enzymes is proposed to cause neurodegenerative diseases and 
even cell death.22, 25 The oxidation of the Cα-N bond of D-amino acids by flavoenzymes can be 
harnessed for the preparation of α-keto acids and chirally-active pharmaceutical precursors.27 
Among the several flavoenzymes reported that oxidize the Cα-N bond of D-amino acids, a wealth 
of biochemical information is available for D-amino acid oxidase from pig kidney (pDAAO), 
Rhodoturula gracilis (RgDAAO), and human (hDAAO), as well as Pseudomonas aeruginosa D-
arginine dehydrogenase (PaDADH), and DASPO (Table 1.1). X-Ray crystallographic data are 
available for all the enzymes except DASPO, for which we have built here a 3D model of the 
6 
enzyme from beef kidney (bDASPO) using SWISS-MODEL and the coordinates of pDAAO 
(PDB code: 1KIF), which share 43% identity in the amino acid sequence. These enzymes show 
similar overall three-dimensional structures (Figure 1.2), highly conserved active sites (Figure 
1.3), contain a non-covalently bound FAD, adopt a Rossmann fold to bind the cofactor,28 but 
show different substrate specificity (Table 1.2). 
 
Table 1.1 Select flavoenzymes that oxidize the Cα-N group of D-amino acids.  Enzyme Source Cofactor Electron acceptor EC number PDB 
D-amino acid oxidase Pig kidney FAD Oxygen 1.4.3.3 1KIF 
D-amino acid oxidase Rhodoturula gracilis FAD Oxygen 1.4.3.3 1C0I 
D-amino acid oxidase Human FAD Oxygen 1.4.3.3 2DU8 
D-arginine dehydrogenase Pseudomonas aeruginosa FAD Unknown (PMS in vitro) 1.4.99.6 3NYC 
D-aspartate oxidase Various FAD Oxygen 1.4.3.1 Unavailable 
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Table 1.2 Preferred and select biologically relevant D-amino acid substrates for pDAAO, RgDAAO, hDAAO PaDADH, and bDASPO. Substrate kcat/Km, M-1 s-1 kcat, s-1 Km, mM                 pDAAOa   D-Pro 9,200 87.2 9.5 D-Ala 5,500 12.7 2.3 D-Met 4,800 143 30  D-Phe 4,500 55.9 12.3                      RgDAAOb   D-Trp 530,000 160 0.3 D-Phe 358,000 105 0.3 D-Met 265,000 106 0.4 D-Ala 129,000 103 0.8 CephC 18,000 91 5.0                   hDAAOc   D-Cys 14,600 8.6 0.6 D-Tyr 13,500 14.8 1.1 D-DOPA 6,750 40.5 6.0 D-Ala 4,000 5.2 1.3 D-Ser 400 3 7.5                   PaDADHd   D-Arg 3,400,000 204 0.06 D-Lys 530,000 141 0.26 D-Tyr 27600 23 0.8 D-Met 14800 154 10 D-Phe 6900 75 11                   bDASPOe   NMDA 20600 30.9 1.5  D-Asp 6090 22.5 3.7 D-Glu 213 1.2 5.6 Enzyme activity was measured varying concentrations of the desired amino acid and 21% O2 (oxidase) or 1 mM PMS (dehydrogenase) at 25 oC and apH 8.5, bpH 8.5, cpH 8.5 (except D-Tyr - pH 8.3), dpH 8.7 and epH 7.2 astandard errors were not reported.29 bstandard errors reported to be <33%.17 cstandard errors reported to be <22%.30-32 dstandard errors reported to be <15%.33 estandard errors were not reported.34 CephC – Cephalosporin C; D-DOPA – D-3,4-dihydroxyphenylalanine   
Figure 1.2 Three-dimensional structure of: (A) 1C0I); (C) hDAAO (PDB 2DU8); (D) of bDASPO (model template: 1KIF).Each panel is shown with the same orientation of the subunit for ease of comparison.
pDAAO (PDB 1KIF); (B) RgDAAO (PDB PaDADH (PDB 3NYC); and (E) three-dimensional model  
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Figure 1.3 Active site of: (A) pDAAO in complex with benzoate (BEZ); (B) RgDAAO in complex with 2-amino benzoate (2-ABEZ); (C) hDAAO in complex with benzoate (BEZ); (D) PaDADH in complex with iminoarginine (IAR); and (E) model of the active site of bDASPO. The FAD carbons are shown in yellow. Some residues and/or water molecules have been omitted for clarity. FAD is shown with the same orientation in each panel for ease of comparison. The residues circled in red indicate the residue that chiefly defines the substrate specificity. 
 
1.1.5 D-amino acid oxidase: an enzyme with preference for neutral substrates 
Pioneering studies by the groups of Massey and Yagi established DAAO as the archetype 
of the flavin-dependent oxidase/dehydrogenase enzymes.35-48 DAAO is found in various animals 
and microorganisms. The enzyme catalyzes the oxidative deamination of D-amino acids to imino 
acids with concomitant flavin reduction. Subsequent reoxidation of the flavin by molecular 
oxygen produces hydrogen peroxide (Scheme 1.1A). Two protons are released during the 
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reaction; the first proton is released from the amino acid amino group prior to binding to the ES 
complex and the second proton is released from the amino acid α-hydrogen.49 Apart from being 
one of the initial discoveries in the flavin field by Krebs,50 DAAO has spurred a myriad of 
studies on several topics, including the versatility of the flavin cofactor, substrate specificity, 
biotechnological applications, and physiological role of the enzyme. Interest in this enzyme has 
never dwindled in part because of the controversy surrounding the accepted catalytic mechanism 
of amino acid oxidation, i.e., hydride transfer versus carbanion, along with the discovery of the 
enzyme in humans.2, 4, 51-53 DAAO serves a regulatory role in humans via the degradation of the 
neurotransmitter D-Ser, a co-agonist of the NMDA receptor, as hypofunction of the NMDA 
receptor is hypothesized to contribute to schizophrenia.54 In bacteria and fungi DAAO functions 
in a catabolic role to convert D-amino acids into carbon and nitrogen sources.54 
 
Pig kidney D-amino acid oxidase 
The pDAAO contains one FAD cofactor for each 40 kDa-subunit (Figure 1.2A).51, 55 The 
enzyme has been detected in multiple oligomeric states in solution depending on the protein 
concentration.4 The different oligomeric states can alter certain aspects of the kinetics, such as 
product release and inhibitor binding.36 pDAAO is most active with hydrophobic substrates, such 
as D-Pro, D-Ala, D-Met, and D-Phe (Table 1.2). 56 The bulky D-Tyr and D-Trp are slowly 
oxidized as well.56 The enzyme does not react with the anionic amino acids D-Asp and D-Glu 
and displays marginal activity against the cationic amino acids D-Arg and D-Lys.56 (Figure 
1.3A).51 Thiazolidine-2-carboxylic acid is also a substrate for the enzyme with catalytic turnover 
numbers similar to D-Pro.57 A hydrophobic cage comprised of L51, I215, Y224, and Y228 that 
surrounds the substrate side-chain explains why charged substrates display poor reactivity with 
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pDAAO (Figure 1.3A).51 The volume of the active site cavity is 160 Å3, permitting substrates 
with side-chains of 4-6 C atoms to bind optimally.51, 56 However, the structure of the 
iminotryptophan complex revealed some degree of plasticity of the active site in pDAAO, 
enabling it to expand the volume for bulky amino acids.52 Stabilization of the substrate α-
carboxylate is provided by interactions with Y228 and R283, whereas the α-amino group is 
within hydrogen bond distance to the hydroxyl group of Y224 and a buried water molecule 
(Wat352) (Figure 1.3A).  
Mutagenesis of Y224 to phenylalanine indicated that the hydroxyl group does not play a 
role in the substrate specificity of pDAAO since the kcat/Km values with D-Ala, D-Pro, D-Met, 
and D-Phe were largely unchanged as compared to the wild-type enzyme.29 In contrast, the 
kcat/Km value for the Y228F variant was roughly 20-fold lower for D-Ala and D-Phe, 10-fold 
lower for D-Pro, and 6-fold lower for D-Met than in the wild-type enzyme, suggesting the 
hydroxyl of Y228 affects the substrate specificity of pDAAO.29 A recent study that investigated 
Y224A and Y228A variants reported a significant reduction in specific activity against all 
substrates, demonstrating the importance of the phenyl ring of Y224 and Y228 in pDAAO for 
substrate specificity and catalytic function.58 Replacement of H307 with leucine provided 
evidence that this residue is involved in proper orientation of FAD for binding to the enzyme as 
the dissociation constant for FAD was 28-fold greater in the H307L variant as compared to the 
wild-type enzyme.59 Conversion of pDAAO into an R-stereoselective amine oxidase was 
recently accomplished by a double variant of I230A/R283G.60 
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Rhodotorula gracilis D-amino acid oxidase 
The RgDAAO is a homodimer of 80 kDa with one molecule of FAD bound per subunit 
(Figure 1.2B). The enzyme is most active with D-Trp, but can also process small neutral amino 
acids, such as D-Ala, as shown in Table 1.2.61, 62 RgDAAO exhibits 14,800- and 370-fold lower 
kcat/Km values with D-Asp and D-Arg as compared to D-Trp, respectively.63 The amino acid 
sequence identity between pDAAO and RgDAAO is 30% and their overall topology is highly 
similar (Figure 1.2A-B), yet RgDAAO possesses a more open active site architecture than 
pDAAO (Figure 1.3A-B). An active site volume of ~230 Å3 is estimated with Caver Analyst 1.0 
(J. Ball and G. Gadda; unpublished results), providing a rationale for RgDAAO exhibiting a 
preference for bulky substrates like D-Phe and D-Trp. (Figure 1.3B). The α-carboxylate of the 
amino acid substrate forms an electrostatic interaction with R285 and a hydrogen bond with the 
side-chains of Y223 and Y238 (Figure 1.3B). The α-amino group of the ligand establishes a 
hydrogen bond with the side chain of S335 and a water molecule (Wat72), which is fixated in 
space through hydrogen bond interactions with N54 and Q339.64 RgDAAO is highly sought after 
for biotechnological applications due to its overall higher catalytic efficiency than pDAAO, high 
thermal and operational stability65, and its ability to oxidize Cephalosporin C as part of a two-
step process to produce the antibiotic precursor 7-aminocephalosporic acid.66  
Considerable efforts have been undertaken to produce RgDAAO variants with altered 
substrate specificities due to its biotechnological potential. M213 is especially important because 
it resides ~3 Å from the β-carbon of D-F3-Ala bound to the enzyme and presumably interacts 
with the side-chain of the substrate.67 M213 of RgDAAO was mutated to arginine and the 
resulting M213R variant acquired activity with D-Asp as substrate,68 with a kcat/Km value for D-
Asp similar to the value reported with bDASPO (Table 1.2); however, the kcat/Km of M213R for 
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D-Ala was 220-fold lower in comparison to the wild-type enzyme.68 The M213G variant was 
shown to oxidize unnatural aromatic amino acids such as D-2-naphthylglycine, which is a 
component of Nafarelin.17. Mutations at R285 severely depleted the enzymatic activity of the 
enzyme, consistent with this residue being essential to the general reactivity with amino acids as 
it binds the α-amino group of the substrate.63, 69 Y238 was later mutated to generate the Y238F 
and Y238S variants, which demonstrated enhanced catalytic efficiency with D-Phe and D-Tyr 
without compromising D-Ala activity.17 A directed evolution study that employed an error-prone 
PCR approach identified three RgDAAO variants, i.e., L118H, T60A/Q144R/K152E, and 
Q144R/G199D/Y223C/H329R, which were active on all D-amino acids with significantly 
improved catalytic efficiency with D-Ala, D-Arg, and D-Asp than past mutagenic efforts. 
Intriguingly, most of the mutations identified by error-prone PCR that increased the catalytic 
activity of RgDAAO were not in the active site but they were clustered on the surface of the 
enzyme, but not far away from the substrate entrance.70 It was concluded that these surface 
residues synergistically enhance the catalytic turnover and substrate affinity by modulating the 
protein dynamics and/or stability.70 
 
Human D-amino acid oxidase 
The hDAAO is a homodimer of 80 kDa that binds one FAD per subunit (Figure 1.2C).32, 
71 hDAAO shares 85% amino acid sequence identity with pDAAO. The activation of hDAAO by 
pLG72, which elevates the biodegradation of the D-Ser, a potent activator of the NMDA 
receptor, has been associated with the pathophysiology of schizophrenia.72 A distinctive feature 
of hDAAO is that it demonstrates the weakest binding affinity of the FAD cofactor, with a Kd 
value of 8 M, among known DAAOs.32 A hydrophobic stretch (V47AAGL51) in hDAAO, which 
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is fully conserved in pDAAO, was shown to be in a different conformation than the pig enzyme, 
and this difference was proposed to be responsible for the weaker binding of FAD in the human 
enzyme.31 D-Cys is the best substrate for the enzyme as indicated by a kcat/Km value of 14,600 M-
1s-1 (Table 1.2), 30 and it was proposed that D-Cys might be the physiological substrate of the 
enzyme in some tissues.30 Due to the high levels of D-Ser in the brain it was also proposed that 
D-Ser might be the physiological substrate for hDAAO in the brain, although the enzyme has a 
low kcat/Km value of 400 M-1s-1, which would suggest otherwise.73 D-Glu and NMDA are not 
substrates for hDAAO, whereas D-Asp exhibits a low kcat/Km value of 4 M-1s-1.30 As shown in 
Figure 1.3C, the side-chain of the D-amino acid extends into a fairly hydrophobic pocket, which 
explains the specificity for neutral substrates.74, 75 The active site volume is ~220 Å3, making it 
larger than pDAAO and explaining the higher kinetic efficiency with D-Tyr than pDAAO.75 The 
α-carboxylate group of the ligand interacts with the guanidino group of R283 and the hydroxyl 
group of Y228, while the α-amino group participates in hydrogen bond interactions to the flavin 
O4 atom and the main-chain amide oxygen atom of G313 (Figure 1.3C).74-76  
Most of the mutations of hDAAO have focused on variants related to disease states. The 
R199W variant has been associated with familial amyotrophic lateral sclerosis, and biochemical 
investigations have shown that this mutation promotes protein instability and decreases kinetic 
efficiency with D-Ser.77 A W209R variant of the enzyme, which is also deposited in the single 
nucleotide polymorphisms database, exhibited greater D-Ser activity and higher affinity for 
FAD.77 It was proposed that the increased production of hydrogen peroxide by the W209R 
variant as a result of increased D-Ser oxidation might be the feature affecting cell viability.77 
Two variants associated with an increased risk of schizophrenia, D31H and R279A, showed an 
increased kinetic efficiency for D-Ser and tighter binding of the FAD cofactor.78 A recent study 
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reported that a Y55A variant, which is located on a loop on the border between the active site 
and the hydrophobic substrate binding pocket, increased the specific activity of hDAAO and 
pDAAO towards D-His, D-Met, D-Phe, D-Tyr, and D-Trp by facilitating solvent and substrate 
access.58 
 
1.1.6 D-arginine dehydrogenase: an enzyme with preference for cationic substrates 
PaDADH is a 42 kDa monomer that binds one FAD molecule (Figure 1.2D).33 PaDADH 
catalyzes the same chemical reaction as DAAO, except it employs an electron acceptor other 
than molecular oxygen to reoxidize the flavin (Scheme 1.1B). Phenazine methosulfate is used in 
vitro as the physiological electron acceptor remains unknown.79 The enzyme functions as the 
first step in a novel two-enzyme coupled system in P. aeruginosa that racemizes D-Arg to L-
Arg.26 The second enzyme is an NAD(P)H-dependent L-arginine dehydrogenase that combines 
ammonia and the α-keto acid to produce L-Arg. The three-dimensional structures of PaDADH in 
both a ligand-free and product-bound conformation, and that of the enzyme with an N5-
iminoleucine adduct, are available.33, 80  
PaDADH has a broad substrate specificity with the ability to oxidize all of the 19 common 
D-amino acids except D-Asp and D-Glu.33 The cationic amino acids, D-Arg and D-Lys, are the 
best substrates for the enzyme as judged by the high kcat/Km values shown in Table 1.2 (105-106 
M-1s-1).33  The position of iminoarginine bound to PaDADH suggests that the side-chain of the 
D-Arg substrate forms an electrostatic interaction with E87. The presence of E87 rationalizes the 
lack of reactivity with D-Asp and D-Glu. Similar to pDAAO, a hydrophobic cage formed by the 
side-chains of Y53, M240, V242 and Y249 (Figure 1.3D) engages in favorable van der Waals 
and π-π interactions with aliphatic and aromatic side-chains of the substrate, consequently D-Met 
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and D-Tyr are oxidized in the 104 M-1s-1 range. The active site volume of PaDADH, which is 
calculated to be ~320 Å with Caver Analyst 1.0 (unpublished results; J. Ball and G. Gadda), is 
large enough to provide the necessary space to accommodate bulky substrates, such as D-Arg, D-
Tyr and D-Trp. Contrary to the single arginine used to bind the α-carboxylate of the substrate in 
DAAOs, PaDADH employs two arginine residues, R222 and R305, to bind the substrate α-
carboxylate (Figure 1.3D).  
Mutagenic work on PaDADH established the importance of E87 to be unprotonated for 
optimal binding of cationic substrates.81 Although the E87L variant did not lose the ability to 
oxidize D-Arg, the kcat/Km value was down 20-fold compared to the wild-type enzyme.81 An 
H48F variant decreased the kcat/Km value with D-Arg only by 2-fold, indicating this residue does 
not significantly affect substrate specificity.81 Overall, the mutagenic work suggests there is no 
catalytic base operative in the mechanism, and the catalytic pKa seen, irrespective of the 
substrate or variant, belongs to the substrate α-amino group.81, 82 A base not being required for 
the chemical step of catalysis was also proposed for DAAO.63, 67 A recent and extensive review 
on PaDADH can be found here.83  
 
1.1.7 D-aspartate oxidase: an enzyme with preference for anionic substrates 
DASPO is a specialized enzyme of 39 kDa that oxidizes the anionic amino acids D-Asp 
and D-Glu.84, 85 The enzyme catalyzes the oxidative deamination of D-Asp to generate 2-
ketoglutarate, ammonia, and hydrogen peroxide. In the brain, D-Asp functions as a 
neurotransmitter.86 DASPO has been biochemically and kinetically characterized from various 
mammalian sources, including human brain, beef kidney, pig kidney, mouse, and octopus.85, 87-90 
DASPO has also been characterized from the yeast Cryptococcus humicola.91 Purified bDASPO 
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forms a homotetramer while purified pig kidney DASPO is monomeric.85, 88 The enzyme from 
all sources has a higher catalytic efficiency with D-Asp as compared to D-Glu. The major 
difference between human brain, beef kidney, pig kidney, and mouse DASPO to octopus 
DASPO is that the latter exhibits a lower activity against NMDA than the former enzymes.88, 90 
Increasing evidence has linked DASPO to schizophrenia in mammals, where enhanced activity 
of DASPO in the post-mortem dorsolateral prefrontal cortex of patients with schizophrenia 
contributes to dysfunctional NMDA transmission.92-94 DASPO is proposed to play a role in the 
assimilation and detoxification of D-Asp in yeast.95 
The three-dimensional structure of DASPO has yet to be solved, but a structural model of 
bDASPO using SWISS-MODEL with the pDAAO (PDB: 1KIF; 43% sequence identity) as 
template is shown in Figure 1.2E and Figure 1.3E. The position of R216 in the model suggests 
it might form an electrostatic interaction with the side-chain of D-Asp (Figure 1.3E). It appears 
the α-amino group may interact with S308 or Y223 (Figure 1.3E). Biochemical studies on R237 
from mouse DASPO, which corresponds to R278 of bDASPO, suggests it serves to bind the α-
carboxylate group of D-Asp, and does not significantly affect the strict specificity for anionic 
amino acids.96 Lower levels of turnover and higher Km values were detected with D-Glu, 
indicating an active site framework that is finely tuned for the one-carbon shorter D-Asp.34  
Mutations on DASPO have focused on R216 and S308, which are conserved between 
bDASPO and mouse DASPO. An R216L variant of mouse DASPO acquired the ability to 
oxidize D-Phe and D-His, but at the cost of appreciably lower activity against D-Asp and NMDA 
than the wild-type enzyme.96 Replacement of S308 with glycine doubled the specific activity 
(U/mg) of mouse DASPO against D-Asp and nearly tripled the specific activity against 
NMDA.97 H56 of yeast DASPO has been shown to be important for the substrate specificity of 
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the enzyme as the H56A and H56N variants of the enzyme lost the ability to oxidize D-Asp, but 
gained the ability to oxidize neutral substrates, such as D-Met, D-Phe, and D-Gln.98  
1.1.8 Active site lid 
pDAAO (I215-225N), hDAAO (T216-228Y), and PaDADH (R33-56P) contain a flexible 
loop region which acts as an “active site lid” (Figure 1.4).33, 51, 55, 99 The iminotryptophan 
complex of pDAAO demonstrated the flexibly of active site loop in pDAAO (Figure 1.4A). It 
has been proposed by Mattevi and coworkers that when in the closed conformation this loop 
primes pDAAO for the hydride transfer by desolvation of the active site.52 The active site lid is 
also thought to regulate substrate entry and exit.51 Specific inhibitors of hDAAO have been 
shown to stabilize the open conformation of the lid (Figure 1.4B).99 A similar active site lid is 
absent in RgDAAO, which may contribute to differences in substrate specificity and the reason 
FAD reduction is rate-limiting for RgDAAO instead of product release, contrary to pDAAO and 
hDAAO.64 Nonetheless, RgDAAO does have a residue Y238 that corresponds to Y224 of 
pDAAO and is proposed to exert a similar role in capping the active site.100 Structural models of 
a newly characterized DAAO from Rubrobacter xylanophilus (RxDAAO), which shows a strict 
specificity for D-Val, indicate there is a L215 in the corresponding spatial position of Y224 in 
pDAAO, and it was proposed this residue might contribute to the unique substrate specificity of 
RxDAAO.101 The flexible loop region comprised in PaDADH has been observed in both an open 
and closed conformations, representing the ligand-free enzyme and product-bound 
conformations, respectively.33 Y53 of PaDADH, which corresponds to Y224 of pDAAO, in the 
ligand-free enzyme points away from the active site, but in the product-bound conformation it 
swings inward to shield the active site from bulk solvent (Figure 1.4C).33  
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Deletion of the active site lid loop in both pDAAO and hDAAO results in variants 
deficient in activity or inactive towards most substrates.58 Mutagenesis of the I215-N225 loop 
region of pDAAO to the corresponding region of human brain DASPO (R216-G220) granted 
pDAAO the ability to oxidize D-Asp.102 Molecular dynamics studies on PaDADH indicated the 
loop is highly flexible and the loop variants S45A and A46G, which are two residues that reside 
on the “hinge” region of the loop (Figure 1.4C), suggested these mutations modulate the 
dynamics of the gate to a more open conformation and this negatively affects the ability of 
PaDADH to capture and oxidize D-amino acid substrates.103 The functional character of this 
loop and its flexibility are major determinants for the substrate specificity of flavoenzymes 
oxidizing the Cα-N bond of D-amino acids.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Active site loops of: (A) and 4QFD) and (C) PaDADH (PDB 3NYE).ITRP – iminotryptophan; IAR –Each closed conformation is shown in green. FAD carbons shown in yellow. ITRP and Icarbons are shown in cyan. Benzoate was removed from panel A and 3phenyl-2H-chromen-6-yl)propanoic acid and benzoate were removed from panel B for clarity.   
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carbon of the amino acid substrate must be within striking distance (<5 Å) of the N5 of the flavin 
in order to transfer a hydride equivalent. The ideal hydride transfer distance is achieved by 
tethering both the N and C terminus of the amino acid to the protein through a combination of 
electrostatic interactions and hydrogen bonds. Salt-bridge stabilization of the carboxylate group 
is made possible by an arginine residue(s). A tyrosine, serine, or water molecule is typically 
positioned to form hydrogen bond interactions with the α-amino group of the substrate. The 
cationic substrates are captured by E87 in PaDADH; the anionic substrates are captured by R216 
in bDASPO; pDAAO, hDAAO, and RgDAAO capture neutral substrates with I215, L215, and 
M213, respectively. M213 of RgDAAO could possibly be engaging in favorable sulfur-π 
interactions with the aromatic rings of D-Trp and D-Phe. An alanine is behind the N5 atom of the 
FAD in all the enzymes and may modulate the flavin redox potential. Another major factor is the 
active site cavity volume, which physically limits the size of substrates that can fit into the active 
site. A flexible loop that functions as an active site lid is present in most of the enzymes and 
plays a role to allow these enzymes to adjust the active site for a diverse range of amino acids. 
Lastly, the absence of a strong base in the proximity of the substrate α-C prevents reactions with 
α-hydroxy acids, which typically have much higher pKa values than the α-amino group on amino 
acids.2 
 
1.1.10 Closing thoughts and future directions 
 A single enzyme is not sufficient to oxidize at equal rates all the various D-amino acids, 
which differ in charge, size, and shape. Nature has designed different architectures for substrate-
binding sites. The opposite charge of anionic and cationic D-amino acids requires distinctive 
binding pockets for the side-chain. The varying size and shape of D-amino acids necessitates 
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characteristic active site volumes. Movements of flexible loops contribute to the active site 
plasticity, which broadens the substrate scope of the enzymes. Many of the factors governing the 
substrate specificity of enzymes that oxidize D-amino acids have been elucidated, yet most of the 
focus has been on active site residues and utilized a rational design approach. Mutagenesis of 
distal surface residues offers intriguing possibilities in altering the substrate specificity and 
would open new paradigms in the relationship between enzyme structure and substrate 
specificity. Future directions could focus on how the dynamic behavior and molecular motions of 
enzymes that oxidize D-amino acid influence the kinetics in order to develop a more complete 
understanding of their structure-function relationships. This information will help elaborate how 
a relatively rigid protein structure is fine-tuned by its internal motions to optimize catalysis for 
neutral, charged, as well as hydrophobic D-amino acid substrates. Another important aspect 
centers on engineering oxidases from dehydrogenases, i.e., DADH, to aid the industrial 
utilization of the enzymes that oxidize D-amino acids. A question that deserves attention is the 
physiological fate of the other product of reaction formed in the oxidation of D-amino acids, i.e., 
hydrogen peroxide or other reduced electron acceptors. Do these molecules play an active role in 
regulatory processes and neurotransmission, cell-signaling, and metabolism? The recent decades 
have witnessed incredible advances in our understanding of the structure-function of the 
enzymes that oxidize D-amino acids. The future offers intriguing questions whose answers will 
take synthetic biology a step closer to the de novo design of targeted catalytic activities for the 
oxidation of specific D-amino acids for industrial and biotechnological use. 
  
23 
1.1.11 References 
[1]  Genchi, G. (2017) An overview on D-amino acids, Amino Acids 49, 1521-1533. 
[2]  Fitzpatrick, P. F. (2010) Oxidation of amines by flavoproteins, Arch Biochem Biophys 
493, 13-25. 
[3]  Corrigan, J. J. (1969) D-amino acids in animals, Science (New York, N.Y.) 164, 142-149. 
[4]  Pilone, M. S. (2000) D-Amino acid oxidase: new findings, Cell Mol Life Sci 57, 1732-
1747. 
[5]  Cava, F., Lam, H., de Pedro, M. A., and Waldor, M. K. (2011) Emerging knowledge of 
regulatory roles of D-amino acids in bacteria, Cell Mol Life Sci 68, 817-831. 
[6]  Ohide, H., Miyoshi, Y., Maruyama, R., Hamase, K., and Konno, R. (2011) D-Amino acid 
metabolism in mammals: biosynthesis, degradation and analytical aspects of the 
metabolic study, J Chromatogr B Analyt Technol Biomed Life Sci 879, 3162-3168. 
[7]  Martineau, M., Baux, G., and Mothet, J. P. (2006) D-serine signalling in the brain: friend 
and foe, Trends Neurosci 29, 481-491. 
[8]  Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, 
I. M., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J., and et al. (1993) Structural 
alterations in the peptide backbone of beta-amyloid core protein may account for its 
deposition and stability in Alzheimer's disease, J Biol Chem 268, 3072-3083. 
[9]  Fujii, N., Takata, T., Fujii, N., and Aki, K. (2016) Isomerization of aspartyl residues in 
crystallins and its influence upon cataract, Biochim Biophys Acta 1860, 183-191. 
[10]  Fujii, N., Tajima, S., Tanaka, N., Fujimoto, N., Takata, T., and Shimo-Oka, T. (2002) 
The presence of D-beta-aspartic acid-containing peptides in elastic fibers of sun-damaged 
24 
skin: a potent marker for ultraviolet-induced skin aging, Biochem Biophys Res Commun 
294, 1047-1051. 
[11]  Feng, Z., and Xu, B. (2016) Inspiration from the mirror: D-amino acid containing 
peptides in biomedical approaches, Biomol Concepts 7, 179-187. 
[12]  Gao, X., Ma, Q., and Zhu, H. (2015) Distribution, industrial applications, and enzymatic 
synthesis of D-amino acids, Appl Microbiol Biotechnol 99, 3341-3349. 
[13]  Martinez-Rodriguez, S., Martinez-Gomez, A. I., Rodriguez-Vico, F., Clemente-Jimenez, 
J. M., and Las Heras-Vazquez, F. J. (2010) Natural occurrence and industrial applications 
of D-amino acids: an overview, Chem Biodivers 7, 1531-1548. 
[14]  Sacchi, S., Rosini, E., Pollegioni, L., and Molla, G. (2013) D-amino acid oxidase 
inhibitors as a novel class of drugs for schizophrenia therapy, Curr Pharm Des 19, 2499-
2511. 
[15]  Friedman, M. (2010) Origin, microbiology, nutrition, and pharmacology of D-amino 
acids, Chem Biodivers 7, 1491-1530. 
[16]  Friedman, M. (1999) Chemistry, nutrition, and microbiology of D-amino acids, J Agric 
Food Chem 47, 3457-3479. 
[17]  Frattini, L., Rosini, E., Pollegioni, L., and Pilone, M. S. (2011) Analyzing the D-amino 
acid content in biological samples by engineered enzymes, J Chromatogr B Analyt 
Technol Biomed Life Sci 879, 3235-3239. 
[18]  Ghisla, S., and Edmondson, D. E. (2001) Flavin Coenzymes, In eLS, John Wiley & Sons, 
Ltd. 
[19]  Massey, V. (2000) The chemical and biological versatility of riboflavin, Biochem Soc 
Trans 28, 283-296. 
25 
[20]  Hodge-Hanson, K. M., and Downs, D. M. (2017) Members of the Rid protein family 
have broad imine deaminase activity and can accelerate the Pseudomonas aeruginosa D-
arginine dehydrogenase (DauA) reaction in vitro, PLoS One 12, e0185544. 
[21]  Degani, G., Barbiroli, A., Regazzoni, L., Popolo, L., and Vanoni, M. A. (2018) Imine 
Deaminase Activity and Conformational Stability of UK114, the Mammalian Member of 
the Rid Protein Family Active in Amino Acid Metabolism, Int J Mol Sci 19. 
[22]  Wolosker, H., D'Aniello, A., and Snyder, S. H. (2000) D-aspartate disposition in neuronal 
and endocrine tissues: ontogeny, biosynthesis and release, Neuroscience 100, 183-189. 
[23]  Zaar, K., Kost, H. P., Schad, A., Volkl, A., Baumgart, E., and Fahimi, H. D. (2002) 
Cellular and subcellular distribution of D-aspartate oxidase in human and rat brain, J 
Comp Neurol 450, 272-282. 
[24]  Billard, J. M. (2012) D-Amino acids in brain neurotransmission and synaptic plasticity, 
Amino Acids 43, 1851-1860. 
[25]  Sasabe, J., Miyoshi, Y., Suzuki, M., Mita, M., Konno, R., Matsuoka, M., Hamase, K., 
and Aiso, S. (2012) d-Amino acid oxidase controls motoneuron degeneration through d-
serine, Proc Natl Acad Sci U S A 109, 627-632. 
[26]  Li, C., and Lu, C.-D. (2009) Arginine racemization by coupled catabolic and anabolic 
dehydrogenases, Proc Natl Acad Sci U S A 106, 906-911. 
[27]  Brodelius, P., Nilsson, K., and Mosbach, K. (1981) Production of alpha-keto acids Part I. 
Immobilized cells ofTrigonopsis variabilis containing D-amino acid oxidase, Appl 
Biochem Biotechnol 6, 293-307. 
[28]  Rossmann, M. G., Moras, D., and Olsen, K. W. (1974) Chemical and biological evolution 
of nucleotide-binding protein, Nature 250, 194-199. 
26 
[29]  Pollegioni, L., Fukui, K., and Massey, V. (1994) Studies on the Kinetic Mechanism of 
Pig-Kidney D-Amino-Acid Oxidase by Site-Directed Mutagenesis of Tyrosine-224 and 
Tyrosine-228, J Biol Chem 269, 31666-31673. 
[30]  Murtas, G., Sacchi, S., Valentino, M., and Pollegioni, L. (2017) Biochemical Properties 
of Human D-Amino Acid Oxidase, Front Mol Biosci 4, 88. 
[31]  Kawazoe, T., Tsuge, H., Imagawa, T., Aki, K., Kuramitsu, S., and Fukui, K. (2007) 
Structural basis of D-DOPA oxidation by D-amino acid oxidase: Alternative pathway for 
dopamine biosynthesis, Biochem Biophys Res Commun 355, 385-391. 
[32]  Molla, G., Sacchi, S., Bernasconi, M., Pilone, M. S., Fukui, K., and Polegioni, L. (2006) 
Characterization of human D-amino acid oxidase, FEBS lett 580, 2358-2364. 
[33]  Fu, G., Yuan, H., Li, C., Lu, C. D., Gadda, G., and Weber, I. T. (2010) Conformational 
changes and substrate recognition in Pseudomonas aeruginosa D-arginine dehydrogenase, 
Biochemistry 49, 8535-8545. 
[34]  Negri, A., Tedeschi, G., Ceciliani, F., and Ronchi, S. (1999) Purification of beef kidney 
D-aspartate oxidase overexpressed in Escherichia coli and characterization of its redox 
potentials and oxidative activity towards agonists and antagonists of excitatory amino 
acid receptors, Biochim Biophys Acta 1431, 212-222. 
[35]  Fitzpatrick, P. F., Ghisla, S., and Massey, V. (1985) 8-Azidoflavins as photoaffinity 
labels for flavoproteins, J Biol Chem 260, 8483-8491. 
[36]  Fitzpatrick, P. F., and Massey, V. (1982) The kinetic mechanism of D-amino acid 
oxidase with D-alpha-aminobutyrate as substrate. Effect of enzyme concentration on the 
kinetics, J Biol Chem 257, 12916-12923. 
27 
[37]  Ghisla, S., Entsch, B., Massey, V., and Husein, M. (1977) On the structure of flavin-
oxygen intermediates involved in enzymatic reactions, Eur J Biochem 76, 139-148. 
[38]  Ghisla, S., and Massey, V. (1989) Mechanisms of flavoprotein-catalyzed reactions, Eur J 
Biochem 181, 1-17. 
[39]  Ghisla, S., and Massey, V. (1986) New flavins for old: artificial flavins as active site 
probes of flavoproteins, Biochem J 239, 1-12. 
[40]  Massey, V., Palmer, G., and Bennett, R. (1961) The purification and some properties of 
D-amino acid oxidase, Biochim Biophys Acta 48, 1-9. 
[41]  Ronchi, S., Minchiotti, L., Galliano, M., Curti, B., Swenson, R. P., Williams, C. H., Jr., 
and Massey, V. (1982) The primary structure of D-amino acid oxidase from pig kidney. 
II. Isolation and sequence of overlap peptides and the complete sequence, J Biol Chem 
257, 8824-8834. 
[42]  Swenson, R. P., Williams, C. H., Jr., Massey, V., Ronchi, S., Minchiotti, L., Galliano, M., 
and Curti, B. (1982) The primary structure of D-amino acid oxidase from pig kidney. I. 
Isolation and sequence of the tryptic peptides, J Biol Chem 257, 8817-8823. 
[43]  Kotaki, A., Harada, M., and Yagi, K. (1967) Structure and function of D-amino acid 
oxidase. II. Terminal structure and amino acid composition of hog kidney D-amino acid 
oxidase, J Biochem 61, 598-605. 
[44]  Yagi, K., Nishikimi, M., Takai, A., and Oishi, N. (1974) Additional evidence for the 
liberation of substrate alpha-hydrogen prior to reduction of the coenzyme in D-amino 
acid oxidase reaction, J Biochem 76, 451-454. 
[45]  Yagi, K., Okamura, K., Naoi, M., and Kotaki, A. (1966) A characterization of a purple 
intermediate of D-amino acid oxidase, J Biochem 59, 527-530. 
28 
[46]  Yagi, K., and Ozawa, T. (1989) Crystallization of Michaelis complex of D-amino acid 
oxidase. 1962, Biochim Biophys Acta 1000, 207-208. 
[47]  Yagi, K., and Ozawa, T. (1962) Crystallization of Michaelis complex of D-amino acid 
oxidase, Biochim Biophys Acta 60, 200-201. 
[48]  Yagi, K., Ozawa, T., and Okada, K. (1959) Mechanism of inhibition of D-amino acid 
oxidase. II. Inhibitory actions of benzene derivatives, Biochim Biophys Acta 35, 102-
110. 
[49]  Fitzpatrick, P. F., and Massey, V. (1982) Proton release during the reductive half-reaction 
of D-amino acid oxidase, J Biol Chem 257, 9958-9962. 
[50]  Krebs, H. A. (1935) Metabolism of amino-acids: Deamination of amino-acids, Biochem J 
29, 1620-1644. 
[51]  Mattevi, A., Vanoni, M. A., Todone, F., Rizzi, M., Teplyakov, A., Coda, A., Bolognesi, 
M., and Curti, B. (1996) Crystal structure of D-amino acid oxidase: a case of active site 
mirror-image convergent evolution with flavocytochrome b2, Proc Natl Acad Sci U S A 
93, 7496-7501. 
[52]  Todone, F., Vanoni, M. A., Mozzarelli, A., Bolognesi, M., Coda, A., Curti, B., and 
Mattevi, A. (1997) Active site plasticity in D-amino acid oxidase: a crystallographic 
analysis, Biochemistry 36, 5853-5860. 
[53]  Fitzpatrick, P. F. (2001) Substrate dehydrogenation by flavoproteins, Acc Chem Res 34, 
299-307. 
[54]  Pollegioni, L., Piubelli, L., Sacchi, S., Pilone, M. S., and Molla, G. (2007) Physiological 
functions of D-amino acid oxidases: from yeast to humans, Cell Mol Life Sci 64, 1373-
1394. 
29 
[55]  Mizutani, H., Miyahara, I., Hirotsu, K., Nishina, Y., Shiga, K., Setoyama, C., and Miura, 
R. (1996) Three-dimensional structure of porcine kidney D-amino acid oxidase at 3.0 A 
resolution, J Biochem 120, 14-17. 
[56]  Dixon, M., and Kleppe, K. (1964) II. Specificity, competitive inhibition and reaction 
sequence, Biochim Biophys Acta 96, 368-382. 
[57]  Fitzpatrick, P. F., and Massey, V. (1982) Thiazolidine-2-carboxylic acid, an adduct of 
cysteamine and glyoxylate, as a substrate for D-amino acid oxidase, J Biol Chem 257, 
1166-1171. 
[58]  Subramanian, K., Gora, A., Spruijt, R., Mitusinska, K., Suarez-Diez, M., Martins Dos 
Santos, V., and Schaap, P. J. (2018) Modulating D-amino acid oxidase (DAAO) substrate 
specificity through facilitated solvent access, PLoS One 13, e0198990. 
[59]  Miyano, M., Fukui, K., Watanabe, F., Takahashi, S., Tada, M., Kanashiro, M., and 
Miyake, Y. (1991) Studies on Phe-228 and Leu-307 recombinant mutants of porcine 
kidney D-amino acid oxidase: expression, purification, and characterization, J Biochem 
109, 171-177. 
[60]  Yasukawa, K., Nakano, S., and Asano, Y. (2014) Tailoring D-amino acid oxidase from 
the pig kidney to R-stereoselective amine oxidase and its use in the deracemization of 
alpha-methylbenzylamine, Angew Chem Int Ed Engl 53, 4428-4431. 
[61]  Pollegioni, L., Harris, C. M., Molla, G., Pilone, M. S., and Ghisla, S. (2001) 
Identification and role of ionizing functional groups at the active center of Rhodotorula 
gracilis D-amino acids oxidase, FEBS Lett 507, 323-326. 
[62]  Pollegioni, L., Falbo, A., and Pilone, M. S. (1992) Specificity and kinetics of 
Rhodotorula gracilis D-amino acid oxidase, Biochim Biophys Acta 1120, 11-16. 
30 
[63]  Boselli, A., Piubelli, L., Molla, G., Pilone, M. S., Pollegioni, L., and Sacchi, S. (2007) 
Investigating the role of active site residues of Rhodotorula gracilis D-amino acid oxidase 
on its substrate specificity, Biochimie 89, 360-368. 
[64]  Pollegioni, L., Diederichs, K., Molla, G., Umhau, S., Welte, W., Ghisla, S., and Pilone, 
M. S. (2002) Yeast D-amino acid oxidase: structural basis of its catalytic properties, J 
Mol Biol 324, 535-546. 
[65]  Pollegioni, L., Iametti, S., Fessas, D., Caldinelli, L., Piubelli, L., Barbiroli, A., Pilone, M. 
S., and Bonomi, F. (2003) Contribution of the dimeric state to the thermal stability of the 
flavoprotein D-amino acid oxidase, Prot Sci 12, 1018-1029. 
[66]  Pollegioni, L., Caldinelli, L., Molla, G., Sacchi, S., and Pilone, M. S. (2004) Catalytic 
properties of D-amino acid oxidase in cephalosporin C bioconversion: a comparison 
between proteins from different sources, Biotechnol Prog 20, 467-473. 
[67]  Umhau, S., Pollegioni, L., Molla, G., Diederichs, K., Welte, W., Pilone, M. S., and 
Ghisla, S. (2000) The x-ray structure of D-amino acid oxidase at very high resolution 
identifies the chemical mechanism of flavin-dependent substrate dehydrogenation, Proc 
Natl Acad Sci U S A 97, 12463-12468. 
[68]  Sacchi, S., Lorenzi, S., Molla, G., Pilone, M. S., Rossetti, C., and Pollegioni, L. (2002) 
Engineering the substrate specificity of D-amino-acid oxidase, J Biol Chem 277, 27510-
27516. 
[69]  Gadda, G., Negri, A., and Pilone, M. S. (1994) Reaction of Phenylglyoxal with Arginine 
Groups in D-Amino-Acid Oxidase from Rhodotorula-Gracilis, J Biol Chem 269, 17809-
17814. 
31 
[70]  Sacchi, S., Rosini, E., Molla, G., Pilone, M. S., and Pollegioni, L. (2004) Modulating D-
amino acid oxidase substrate specificity: production of an enzyme for analytical 
determination of all D-amino acids by directed evolution, Protein Eng Des Sel 17, 517-
525. 
[71]  Kawazoe, T., Tsuge, H., Pilone, M. S., and Fukui, K. (2006) Crystal structure of human 
D-amino acid oxidase: context-dependent variability of the backbone conformation of the 
VAAGL hydrophobic stretch located at the si-face of the flavin ring, Prot Sci 15, 2708-
2717. 
[72]  Sacchi, S., Bernasconi, M., Martineau, M., Mothet, J. P., Ruzzene, M., Pilone, M. S., 
Pollegioni, L., and Molla, G. (2008) pLG72 modulates intracellular D-serine levels 
through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility, 
J Biol Chem 283, 22244-22256. 
[73]  Park, H. K., Shishido, Y., Ichise-Shishido, S., Kawazoe, T., Ono, K., Iwana, S., Tomita, 
Y., Yorita, K., Sakai, T., and Fukui, K. (2006) Potential role for astroglial D-amino acid 
oxidase in extracellular D-serine metabolism and cytotoxicity, J Biochem 139, 295-304. 
[74]  Duplantier, A. J., Becker, S. L., Bohanon, M. J., Borzilleri, K. A., Chrunyk, B. A., 
Downs, J. T., Hu, L. Y., El-Kattan, A., James, L. C., Liu, S., Lu, J., Maklad, N., Mansour, 
M. N., Mente, S., Piotrowski, M. A., Sakya, S. M., Sheehan, S., Steyn, S. J., Strick, C. 
A., Williams, V. A., and Zhang, L. (2009) Discovery, SAR, and pharmacokinetics of a 
novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) 
inhibitors, J Med Chem 52, 3576-3585. 
[75]  Sacchi, S., Caldinelli, L., Cappelletti, P., Pollegioni, L., and Molla, G. (2012) Structure-
function relationships in human D-amino acid oxidase, Amino Acids 43, 1833-1850. 
32 
[76]  Sparey, T., Abeywickrema, P., Almond, S., Brandon, N., Byrne, N., Campbell, A., 
Hutson, P. H., Jacobson, M., Jones, B., Munshi, S., Pascarella, D., Pike, A., Prasad, G. S., 
Sachs, N., Sakatis, M., Sardana, V., Venkatraman, S., and Young, M. B. (2008) The 
discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) 
inhibitors, Bioorg Med Chem Lett 18, 3386-3391. 
[77]  Cappelletti, P., Piubelli, L., Murtas, G., Caldinelli, L., Valentino, M., Molla, G., 
Pollegioni, L., and Sacchi, S. (2015) Structure-function relationships in human d-amino 
acid oxidase variants corresponding to known SNPs, Biochim Biophys Acta 1854, 1150-
1159. 
[78]  Caldinelli, L., Sacchi, S., Molla, G., Nardini, M., and Pollegioni, L. (2013) 
Characterization of human DAAO variants potentially related to an increased risk of 
schizophrenia, Biochim Biophys Acta 1832, 400-410. 
[79]  Yuan, H., Fu, G., Brooks, P. T., Weber, I., and Gadda, G. (2010) Steady-state kinetic 
mechanism and reductive half-reaction of D-arginine dehydrogenase from Pseudomonas 
aeruginosa, Biochemistry 49, 9542-9550. 
[80]  Fu, G., Yuan, H., Wang, S., Gadda, G., and Weber, I. T. (2011) Atomic-resolution 
structure of an N5 flavin adduct in D-arginine dehydrogenase, Biochemistry 50, 6292-
6294. 
[81]  Ball, J., Bui, Q. V., Gannavaram, S., and Gadda, G. (2015) Importance of glutamate 87 
and the substrate alpha-amine for the reaction catalyzed by D-arginine dehydrogenase, 
Arch Biochem Biophys 568, 56-63. 
33 
[82]  Gannavaram, S., Sirin, S., Sherman, W., and Gadda, G. (2014) Mechanistic and 
computational studies of the reductive half-reaction of tyrosine to phenylalanine active 
site variants of D-arginine dehydrogenase, Biochemistry 53, 6574-6583. 
[83]  Ouedraogo, D., Ball, J., Iyer, A., Reis, R. A. G., Vodovoz, M., and Gadda, G. (2017) 
Amine oxidation by d-arginine dehydrogenase in Pseudomonas aeruginosa, Arch 
Biochem Biophys 632, 192-201. 
[84]  D'Aniello, A., Vetere, A., and Petrucelli, L. (1993) Further study on the specificity of D-
amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-
amino acids, Comp Biochem Physiol B 105, 731-734. 
[85]  Negri, A., Massey, V., and Williams, C. H., Jr. (1987) D-aspartate oxidase from beef 
kidney. Purification and properties, J Biol Chem 262, 10026-10034. 
[86]  D'Aniello, S., Somorjai, I., Garcia-Fernandez, J., Topo, E., and D'Aniello, A. (2011) D-
Aspartic acid is a novel endogenous neurotransmitter, FASEB J 25, 1014-1027. 
[87]  Setoyama, C., and Miura, R. (1997) Structural and functional characterization of the 
human brain D-aspartate oxidase, J Biochem 121, 798-803. 
[88]  Yamamoto, A., Tanaka, H., Ishida, T., and Horiike, K. (2007) Functional and structural 
characterization of D-aspartate oxidase from porcine kidney: non-Michaelis kinetics due 
to substrate activation, J Biochem 141, 363-376. 
[89]  Katane, M., Furuchi, T., Sekine, M., and Homma, H. (2007) Molecular cloning of a 
cDNA encoding mouse D-aspartate oxidase and functional characterization of its 
recombinant proteins by site-directed mutagenesis, Amino Acids 32, 69-78. 
34 
[90]  Tedeschi, G., Negri, A., Ceciliani, F., Ronchi, S., Vetere, A., D'Aniello, G., and 
D'Aniello, A. (1994) Properties of the flavoenzyme D-aspartate oxidase from Octopus 
vulgaris, Biochim Biophys Acta 1207, 217-222. 
[91]  Takahashi, S., Takahashi, T., Kera, Y., Matsunaga, R., Shibuya, H., and Yamada, R. H. 
(2004) Cloning and expression in Escherichia coli of the D-aspartate oxidase gene from 
the yeast Cryptococcus humicola and characterization of the recombinant enzyme, J 
Biochem 135, 533-540. 
[92]  Errico, F., D'Argenio, V., Sforazzini, F., Iasevoli, F., Squillace, M., Guerri, G., 
Napolitano, F., Angrisano, T., Di Maio, A., Keller, S., Vitucci, D., Galbusera, A., 
Chiariotti, L., Bertolino, A., de Bartolomeis, A., Salvatore, F., Gozzi, A., and Usiello, A. 
(2015) A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related 
symptoms induced by phencyclidine in mice, Transl Psychiatry 5, e512. 
[93]  Nuzzo, T., Sacchi, S., Errico, F., Keller, S., Palumbo, O., Florio, E., Punzo, D., 
Napolitano, F., Copetti, M., Carella, M., Chiariotti, L., Bertolino, A., Pollegioni, L., and 
Usiello, A. (2017) Decreased free d-aspartate levels are linked to enhanced d-aspartate 
oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients, NPJ 
Schizophr 3, 16. 
[94]  Sacchi, S., Novellis, V., Paolone, G., Nuzzo, T., Iannotta, M., Belardo, C., Squillace, M., 
Bolognesi, P., Rosini, E., Motta, Z., Frassineti, M., Bertolino, A., Pollegioni, L., Morari, 
M., Maione, S., Errico, F., and Usiello, A. (2017) Olanzapine, but not clozapine, 
increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting 
D-aspartate oxidase activity, Sci Rep 7, 46288. 
35 
[95]  Takahashi, S., Kakuichi, T., Fujii, K., Kera, Y., and Yamada, R. H. (2005) Physiological 
role of D-aspartate oxidase in the assimilation and detoxification of D-aspartate in the 
yeast Cryptococcus humicola, Yeast 22, 1203-1212. 
[96]  Katane, M., Saitoh, Y., Maeda, K., Hanai, T., Sekine, M., Furuchi, T., and Homma, H. 
(2011) Role of the active site residues arginine-216 and arginine-237 in the substrate 
specificity of mammalian D-aspartate oxidase, Amino Acids 40, 467-476. 
[97]  Katane, M., Hanai, T., Furuchi, T., Sekine, M., and Homma, H. (2008) Hyperactive 
mutants of mouse D-aspartate oxidase: mutagenesis of the active site residue serine 308, 
Amino Acids 35, 75-82. 
[98]  Takahashi, S., Shimada, K., Nozawa, S., Goto, M., Abe, K., and Kera, Y. (2016) Possible 
role of a histidine residue in the substrate specificity of yeast d-aspartate oxidase, J 
Biochem 159, 371-378. 
[99]  Terry-Lorenzo, R. T., Chun, L. E., Brown, S. P., Heffernan, M. L., Fang, Q. K., Orsini, 
M. A., Pollegioni, L., Hardy, L. W., Spear, K. L., and Large, T. H. (2014) Novel human 
D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation, Biosci 
Rep 34. 
[100]  Boselli, A., Sacchi, S., Job, V., Pilone, M. S., and Pollegioni, L. (2002) Role of tyrosine 
238 in the active site of Rhodotorula gracilis D-amino acid oxidase. A site-directed 
mutagenesis study, Eur J Biochem 269, 4762-4771. 
[101]  Takahashi, S., Furukawara, M., Omae, K., Tadokoro, N., Saito, Y., Abe, K., and Kera, Y. 
(2014) A Highly Stable D-Amino Acid Oxidase of the Thermophilic Bacterium 
Rubrobacter xylanophilus, Appl Environ Microbiol 80, 7219-7229. 
36 
[102]  Setoyama, C., Nishina, Y., Mizutani, H., Miyahara, I., Hirotsu, K., Kamiya, N., Shiga, 
K., and Miura, R. (2006) Engineering the substrate specificity of porcine kidney D-amino 
acid oxidase by mutagenesis of the "active-site lid", J Biochem 139, 873-879. 
[103]  Ouedraogo, D., Souffrant, M., Vasquez, S., Hamelberg, D., and Gadda, G. (2017) 
Importance of Loop L1 Dynamics for Substrate Capture and Catalysis in Pseudomonas 
aeruginosa d-Arginine Dehydrogenase, Biochemistry 56, 2477-2487. 
  
37 
1.2 Quinone detoxification by flavoenzymes 
1.2.1 Quinones 
Quinones are six-membered cyclic, unsaturated compounds that contain two carbonyl 
groups, resulting in a fully conjugated cyclic dione. The carbonyl groups can be adjacent or 
separated by a vinylene group. The simplest single ring form of a quinone, 1,4-benzoquinone, is 
shown in Figure 1.5. The simplest double ring form of a quinone, 1,4-naphthoquinone, is also 
shown in Figure 1.5. These two classes of 1,4-quinones will be studied as substrates in this 
dissertation. 
 
Figure 1.5 1,4-benzoquinone and 1,4-naphthoquinone  
Quinones are pervasive in nature and participate in a wide variety of reactions, most 
notably in the electron transport chain in the form of Coenzyme Q10. As shown in Scheme 1.2, 
quinones can accept one or two electrons to generate the semiquinone or hydroquinone, 
respectively. 
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Scheme 1.2 One- and two- electron enzymatic reduction of quinones. Modified from Piper and Millson.1  
1.2.2 Two-electron reduction of quinones 
The two-electron reduction of quinones is interpreted as a detoxification mechanism 
employed by organisms to reduce potential oxidative stress.2, 3 Quinones can be reduced by a 
single electron by enzymes such as cytochrome p450 reductase to yield a semiquinone radical; 
however, the semiquinone radical can initiate chain reactions to produce reactive oxygenated 
species (ROS). Therefore, the prevention of the deleterious one-electron reduction is 
accomplished by directly reducing by two-electrons to the hydroquinone form. The 
hydroquinone can be further detoxified through conjugation mechanisms by the organism.  
Flavoenzymes can accomplish the two-electron reduction by first receiving two electrons 
from NADH to form the reduced flavin, and then transferring those two electrons to the quinone. 
The most well studied flavin-dependent two-electron NADH:quinone oxidoreductase (NQO) is 
NQO1. This enzyme is found in various sources, including humans, where they have proposed 
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roles in quinone detoxification and alleviation of oxidative stress.4 All of the flavin-dependent 
two-electron NQOs characterized to date are a flavodoxin-like fold.4 This dissertation will detail 
the characterization of a novel FMN-dependent two-electron NADH:quinone oxidoreductase 
from Pseudomonas aeruginosa with a TIM-barrel fold.  
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1.3 Specific Goals 
The first specific goal of this dissertation is to investigate ionizable groups in the active site 
of PaDADH through site directed mutagenesis in combination with kinetic approaches. H48 is 
hypothesized to serve as a catalytic base with the aid of two water molecules connected by the 
hydrogen-bonding network. E87 is hypothesized to be important for binding cationic substrates, 
a.k.a. amino acid substrates bearing positively-charged side chains. Methods to be employed 
include a) site-directed mutagenesis of E87 and H48, which are implicated to play roles in 
catalysis and/or substrate binding and b) pH effects on the kinetic parameters of the variant 
enzymes with multiple substrates of zwitterionic and cationic nature. The broader impact of this 
study will determine the identity of the catalytic base, or determine that there is no base 
functioning in the mechanism. This study will also establish the importance or insignificance of 
E87 and H48 for binding substrates through kinetic approaches. The factors controlling substrate 
specificity in PaDADH can provide valuable information to investigators interested in protein 
engineering efforts, particularly those focused on a single biosensor capable of detecting all types 
of amino acids.  
The second specific goal of this dissertation is to characterize the gene product of pa1024 
to improve the gene prediction of thousands of misannotated genes. Many of the genes annotated 
as Nitronate monooxygenases (NMOs) are likely not NMOs, specifically pa1024. Based on the 
genomic context of PA1024, the enzyme most likely is involved in β-oxidation, not nitronate 
detoxification. PA1024 may serve as a mechanism to regenerate NAD+ for use by a 3-hydroxy-
acyl Coa dehydrogenase present in the operon. Methods to be employed include testing of the 
potential substrates/non-substrates for the enzyme. A comprehensive spectral and kinetic 
characterization of PA1024 will be pursued. Refinement of the bioinformatic analysis of PA1024 
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will be carried out to more accurately assess the patterns or motifs in the amino acid sequence 
critical to the specific reaction catalyzed by the enzyme. This study will characterize the enzyme 
through pH and kinetic solvent viscosity approaches and X-ray crystallography, which will 
provide valuable insights on the function of ionizable groups in the mechanism, rate-limiting 
steps operative in the mechanism, and substrate binding modes. Finally, this study will aim to 
establish a new class of enzymes and remedy the annotations of more than one thousand 
hypothetical proteins in the database. 
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2 AMINE OXIDATION BY D-ARGININE DEHYDROGENASE IN Pseudomonas 
aeruginosa 
(This chapter has been published verbatim in Ouedraogo D., Ball J., Iyer A., Reis R.A.G., 
Vodovoz M., and Gadda G. (2017) Arch Biochem Biophys, 632, 192-201; the author contributed 
the substrate specificity and steady-state kinetic mechanism sections in addition to help with 
editing the final manuscript.) 
2.1 Abstract 
PaDADH is a flavin-dependent oxidoreductase with a noncovalently linked FAD that 
exhibits broad substrate specificity towards D-amino acids. Various biochemical studies have 
established the structure and the mechanistic properties of the enzyme. The enzyme effectively 
catalyzes the oxidation of positively charged and hydrophobic D-amino acids to their respective 
imino acids. It is a true dehydrogenase, since it displays no reactivity towards oxygen. As 
established through solvent and multiple kinetic isotope studies, PaDADH catalyzes the 
asynchronous CH and NH bond cleavage via a hydride transfer mechanism. The Steady-state 
kinetic studies with D-arginine and D-histidine are consistent with the enzyme following a ping-
pong bi-bi mechanism. As shown by a combination of crystallography, kinetic and 
computational data the shape and flexibility of the active site, in particular loop L1 in PaDADH, 
plays a significant role in its ability to oxidize a diverse range of D-amino acids. 
2.2 Introduction 
In 1848 Louis Pasteur made the groundbreaking discovery of molecular chirality1. 
Pasteur was also one of the first to observe enantioselectivity in a biochemical process, which is 
now a well-established concept1-3. Numerous investigations were launched concerning D-amino 
acids and their roles in nature4, 5.  Later in 1935, Hans Krebs discovered D-amino acid oxidase 
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(DAAO) through the observation that D-amino acids undergo selective deamination by 
homogenates derived from pig kidney6. 
D-amino acid oxidase is a ubiquitous flavin-dependent enzyme found in various species 
of bacteria, fungi, and mammals and remains the most extensively studied enzyme that oxidizes 
D-amino acids, with more than 30 structures deposited in the Protein Data Bank7. D-amino acid 
oxidase from pig kidney (pDAAO) remains the most studied orthologue of the D-amino acid 
oxidase structural family, which also contains D-amino acid oxidases from other organisms, 
sarcosine oxidases, glycine oxidase and dimethylglycine oxidase8-11.The enzyme has become a 
model for stereospecific flavin-dependent oxidoreductases that oxidize D-amino acids into their 
corresponding imino acids. Flavin-dependent enzymes that also oxidize D-amino acids include 
D-glutamate oxidase, D-amino acid dehydrogenase, and D-arginine dehydrogenase, among 
others12-16. 
The function of DAAO in microorganisms is to utilize D-amino acids as a nutrient 
source, although the functions of the enzyme in eukaryotes are still under investigation8, 17. 
DAAO has been reported to function in maintaining critical concentrations of D-serine that acts 
as a neuromodulator in mammals18-20. To gain an in-depth understanding of D-amino acid 
oxidizing enzymes, the readers are referred to recent reviews on DAAO and D-aspartate 
oxidase7, 19, 21, 22. 
The present review highlights the mechanistic and structural findings on D-arginine 
dehydrogenase from Pseudomonas aeruginosa which is a member of the DAAO structural 
family. D-arginine dehydrogenase is an FAD-dependent enzyme that catalyzes the oxidative 
deamination of D-amino acids to their respective imino acids, which nonenzymatically hydrolyze 
to α-keto acids and ammonia23, 24. The enzyme plays a pivotal role in utilizing D-arginine as a 
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primary source of carbon and nitrogen16. PaDADH oxidizes the CN bond between the αC and 
the amine group of the D-amino acid converting it to an imino acid25. The enzyme does not 
display any reactivity towards molecular oxygen, which could potentially be a preventative 
mechanism to avoid production of harmful reactive oxygen species in host cells. 
2.3 D-amino acids and their metabolism 
D-amino acids occur in free-form naturally in soil, plants, and are utilized by 
microorganisms commonly found in soil i.e., P. aeruginosa26. Racemization of amino acids 
depends on various abiotic factors like temperature, ionizing radiation, metal ions and pH, 
including several biotic factors like enzymes4. Environmental pressures and increased D-amino 
acid content in soil and waterways have forced bacteria to evolve in order to not only metabolize, 
but utilize and synthesize D-amino acids4. 
Higher organisms lack extensive machinery in place to degrade D-amino acids. Indeed, 
high levels of D-isomers are not tolerated and have a toxic effect on plants and fungi growth27, 28. 
In humans, D-amino acids have specialized roles such as D-Serine and D-aspartate which are 
agonists for N-methyl-D-aspartate receptors and D-aspartate is also associated with ageing in 
tissues18, 29-32. D-amino acids in most eukaryotes are racemized via a one-enzyme racemase, most 
of which are PLP-dependent19, 32, 33.  
In bacteria, however, several cases of the utilization of D-amino acids in peptidoglycan 
layers have been reported34. Bacteria, in most cases, have the required machinery in place to 
metabolize and utilize D-amino acids34. D-alanine and D-glutamate are among the D-amino 
acids that are most prevalent in bacteria, making alanine and glutamate racemases essential in 
microorganisms35. Tsukada in 1966 demonstrated that Pseudomonas fluorescens had two distinct 
D-amino acid dehydrogenases expressed in D-tryptophan treated cells. Both enzymes use FAD 
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as a cofactor and do not use molecular oxygen as an electron acceptor. One of the D-amino acid 
dehydrogenases specifically reacted with Dichlorophenolindophenol as an electron acceptor, 
while the other with methylene blue and were named D-amino acid:2,6-dichloroindophenol 
oxidoreductase and D-amino acid :methylene blue oxidoreductase, respectively15.  
Li & Lu in 2009 discovered a novel two-enzyme system that functions to convert D-
arginine to L-arginine in P. aeruginosa. Further analysis of the two gene products revealed that 
the two-enzyme system is composed of an FAD-dependent D-arginine dehydrogenase and an 
NAD(P)H-dependent L-arginine dehydrogenase as described in Scheme 2.123. Although Haas & 
associates in 1988 did provide evidence for an arginine racemase in P. aeruginosa by 
demonstrating utilization of D-arginine by Arginine auxotrophs, they were not able to 
demonstrate arginine racemase activity in vitro24. The two enzymes are products of the dauBAR 
operon, which can be induced by D-arginine and D-Lysine. The gene products DauA and DauB 
provide a unique coupled anabolic and catabolic system that enables PAO1 to utilize D-arginine 
as the only source of carbon and nitrogen. Li & Lu also reported that the DauBAR operon is 
conserved among several other bacterial species16, 23, 36. 
 
Scheme 2.1 D-Arginine racemization with the two-enzyme racemic system in Pseudomonas aeruginosa.  
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2.4 Structural features of PaDADH 
2.4.1 Overall fold of PaDADH 
The three-dimensional structure of PaDADH was determined by X-ray crystallography at 
high resolution without added D-amino acids (~ 1.06 Å, PDB ID: 3NYC)36. However, extra 
density for a low occupancy iminoarginine was found in the active site. Ligand-free and bound 
forms were obtained, the latter of which was probably due to the product of the enzymatic 
reaction being trapped during the expression of the enzyme by E. coli.36 The PaDADH crystal 
structures were also determined for crystals grown in presence of D-arginine and D-histidine 
thereby yielding a PaDADH/iminoarginine (PDB ID 3NYE)36 and PaDADH/iminohistidine 
(PDB ID 3NYF)36 complexes. Additionally, a covalent N5 flavin adduct was obtained at atomic-
resolution in the enzyme co-crystallized with D-leucine instead of the expected iminoleucine 
(PDB ID 3SM8)37. Table 2.1 summarizes the crystal structures of PaDADH available in the 
PDB. The four structures of hexahistidine-tagged PaDADH are highly similar, with RMS 
deviations of less than 0.14 Å for 381 αC atoms, and display a non-covalently bound FAD as the 
cofactor36. All 375 residues of PaDADH were well defined in the electron density map and 
organized in two domains. The FAD-binding domain is formed by a central six-stranded β-sheet 
surrounded by three-stranded antiparallel β-sheets with two α-helices on one side and five α-
helices on the other side (Figure 1A). The substrate binding domain is composed of eight-
stranded β-sheets and two short antiparallel β-strands that constitute a sandwich surrounded by 
four α-helices and four loops (L1 to L4)36 (Figure 2.1A). 
  
Table 2.1 Crystal structures of PaDADH deposited in PDB PDB ID Resolution (Å)3NYC 1.06 3NYE 1.30 3NYF 1.30 3SM8 1.07  *Ligand-free and product-bound conformations for PaDADH exhibit all the same space group   
Figure 2.1 Overall structure and active site of (A) The PaDADH structure is shown in cartoon diagram and surface representation. Carbon atoms are colored blue for the FADIminoarginine and FAD stick representations are illustrated in green and yellow, respectively. Loops that contribute to the active site are highlighted in magenta.active site showing the substrate interactions of the active site iminoarginine product. Protein side chains are displayed in sticks. 
2.4.2 FAD-binding domain 
The crystal structures of 
The flavin adopts an elongated conformation with the isoalloxaz
interface of the substrate-binding domain and the FAD
of the FAD moiety is buried deep within the FAD
 
 Redox state of flavin LigandMixed* IminoarginineReduced IminoarginineReduced IminohistidineReduced D-leucine N5 flavin adduct
PaDADH. The crystal structures of P212121.  
PaDADH in complex with iminoarginine.
-binding domain and gray for the substrate-
  (B) Close up view of the residues and FAD with the   
PaDADH show a noncovalently bound FAD as the cofactor
ine moiety located at the 
-binding domain. The adenosine portion 
-binding domain36 (Figure 2.
47 
     
  
binding domain. 
36. 
1A). The major 
interactions involved in the flavin
moiety has hydrogen bond interactions with the main
and the side chain of E32. The pyrimidine portion of the isoalloxazine moiety interacts through 
hydrogen bonds with backbone a
benzene portion forms van der Waals contacts with R44, R222, W301, G303 and R305 (
2.1B)36. Crystallographic data of 
FAD is in a non-planar conformation with a ring puckering angle of 15° along the N5 
axis, defining two planes containing the benzene and pyrimidine moieties
conformation is in agreement with other flavin
in the reduced state38, 39. 
Figure 2.2 Interactions of FAD with apoprotein.Apoprotein carbons in PaDADH are in grey and FAD moiety carbons are in yellow. The red spheres represent water molecules.
-apoprotein complex are shown in Figure 2. The ribose ring 
-chain of R33 and A171, water molecules 
toms of the I335, Q336, His48 and a water molecule while the 
PaDADH demonstrate that the isoalloxazine moiety of the 
-dependent enzymes structures containing flavin 
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49 
2.4.3 Substrate binding-domain 
The substrate-binding domain of PaDADH is formed by a small entrance that extends at 
the bottom near the isoalloxazine moiety of the FAD, adopting a triangular cross section shape 
with ~10 Å deep from the αC of G54 to the FAD O2 atom36. The carboxylate group of the 
iminoarginine product occupies the same plane as the isoalloxazine moiety of the FAD, while its 
side chain is almost perpendicular to the FAD (Figure 2.1B)36. The side chain atoms of Y53, 
R222, Y249, R305 and main-chain of G332 form polar interactions with the iminoproduct 
carboxylate group (Figure 2.1B)36. The side chain of the iminoarginine product has hydrophobic 
interactions with V242 and Y53 side chain, hydrogen bond interaction with T50 and ionic 
interaction with E87 side chain36(Figure 2.1B). Two water molecules are located near the imino 
group of the product and form a hydrogen bond network extending to the side chain of H4836. 
The entrance of the active site is controlled by a flexible loop L1, which is formed by residues 
33-56. The loop L1 has two different peptidyl regions including residues 45-47 and residues 50-
56 adopting two conformations depending on whether the substrate is present or not in the active 
site36. 
2.4.4 Structural Comparison of PaDADH with D-amino Acid Oxidase (DAAO) 
Previous crystallographic analysis showed that PaDADH has a high three-dimensional 
structural similarity compared to DAAO36. The crystal structure of PaDADH (PDB ID 3NYE) 
and pDAAO (PDB ID 1DDO) were used for an in-depth comparison of the overall structure and 
the active site36, 40, 41. pDAAO and PaDADH share 17.2 % sequence identity with a RMS 
deviation value of 2.4 Å for 270 αC atoms 36. PaDADH and DAAO were chosen since both 
enzymes catalyze the same chemical reaction except that DAAO utilizes molecular oxygen as its 
electron acceptor. As shown in Figure 3A, the overall structure of PaDADH is similar to 
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pDAAO. The isoalloxazine moiety of the FAD is located at the interface between the FAD-
binding domain and the substrate-binding domain in both enzymes36. The main difference 
between the two structures is observed in the FAD-binding domain as indicated in Figure 3A 
where three antiparallel β-sheets in PaDADH are replaced by an α-helix in DAAO36. The 
substrate binding-domain in both  PaDADH and pDAAO is characterized by the presence of a 
large β-sheets36 (Figure 2.3A). 
 
Figure 2.3 Comparison of the three-dimensional structure of pDAAO (light-blue, PDB ID 1DDO) with PaDADH (gray, PDB ID 3NYE). (A) represents the overall structure of the two enzymes and (B) represents the active sites of the enzymes. For clarity, Y53 from PaDADH was omitted. Iminoacid carbons in PaDADH are in green, iminotryptophan carbons in pDAAO are in magenta and FAD moiety carbons are in yellow and orange in PaDADH and pDAAO, respectively.  The active site of PaDADH in complex with iminoarginine and pDAAO in complex with 
imonotryptophan showed that the ligands in both enzymes bind at the re face of the isoalloxazine 
ring of the FAD moiety36, 40 (Figure 2.3B). The carboxylate groups of the iminoproducts in both 
enzymes lie almost on the same plane and parallel to the isoalloxazine moiety (Figure 2.3B). On 
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the contrary, the side chains of the iminoproducts are quasi-perpendicular to the isoalloxazine 
moiety of the FAD (Figure 2.3B). In pDAAO only one arginine side chain residue, R283, 
interacts with the iminoproduct carboxylate group whereas in PaDADH two arginine residues, 
R222 and R305, participate in the interaction (Figure 2.3B)36. pDAAO has polar interactions 
with the iminotryptophan product formed by the side chain residues of Y224, Y228, and the 
main chain oxygen atom of G313, which are similar to the interaction in PaDADH formed by 
the side chains of Y53,Y249 and main chain oxygen of G332 (Figure 2.3B). The side chains of 
the A49, L51, I215, I230 and Y224 in pDAAO form a hydrophobic cage interacts with the 
iminotryptophan product. PaDADH has a similar hydrophobic cage, but a key difference being 
the presence of E87 and T50 in PaDADH in place of I230 and L51 in pDAAO, respectively36, 40 
(Figure 2.3B). 
2.5 Substrate specificity of PaDADH 
PaDADH exhibits broad substrate scope, being most active with large basic and 
hydrophobic substrates, and demonstrates the highest activity with D-arginine and D-lysine42 
(Table 2.2). PaDADH is strictly stereospecific and L-amino acids are not substrates36. PaDADH 
cannot oxidize the anionic amino acids aspartate and glutamate. The anionic amino acids are 
oxidized by specific D-aspartate and D-glutamate oxidases12, 21. The portion of the PaDADH 
active site that binds the main chain follows intuition for the most part by providing a protein 
positive charge(s) from R222 and R305 to bind the carboxylate of the substrate, and hydrogen-
bonds from Y53 and the main chain O atom of G332 to bind the amino group. The portion of the 
active site that binds the side chain of the substrate is fine-tuned to bind arginine with E87 
positioned to form an electrostatic interaction at a distance of 2.5 Å with the guanidinium head-
group of arginine (Figure 1B)36. The relatively large active site volume and the presence of a 
52 
hydrophobic cage comprised of residues Y53, Y254, M240, and V242 grants PaDADH the 
ability to oxidize large hydrophobic amino acids as well43. The large active site of PaDADH and 
lack of a handle on glycine is likely the reason glycine cannot find an optimal configuration to be 
oxidized and smaller hydrophobic substrates are oxidized slowly by PaDADH36. Based on 
crystallographic and computational evidence PaDADH is proposed to be further modulated by a 
flexible loop to enhance the substrate scope by providing active site plasticity36.   
Table 2.2 Steady-state kinetic parameters for PaDADH with various D-amino acids.  Substrate kcat/Km, M-1 s-1 kcat, s-1 Km, mM D-arginine (3.4 ± 0.3) x 106 204 ± 3 0.06 ± 0.01 D-lysine (5.3 ± 0.2) x 105 141 ± 3 0.26 ± 0.01 D-tyrosine 27600 ± 3800 23 ± 1 0.8 ± 0.1  D-methionine 14800 ± 600 154 ± 3 10 ± 1 D-phenylalanine 6900 ± 300 75 ± 3  11 ± 1 D-histidine 3140 ± 30 35 ± 1 11 ± 1 D-leucine 515 ± 60 6.4 ± 0.3 12 ± 1 D-proline 420 ± 10 -a - D-tryptophan 245 ± 3 - - D-isoleucine 195 ± 3 - - D-glutamine 186 ± 3 - - D-valine 47 ± 1 - - D-alanine 41 ± 1 - - D-asparagine 16 ± 1 - - D-serine 3.8 ± 0.1 - - D-threonine 0.75 ± 0.01 - - D-glutamate - - - D-aspartate - - - L-arginine - - - glycine - - - D-cysteine ndb nd nd Enzyme activity was measured varying concentrations of the desired amino acid and 1 Mm PMS in 20 mM Tris-HCl, pH 8.7, at 25 oC. bCannot be saturated with substrate thereby kcat and Km values are not reported. cNot determined. PMS was reduced nonenzymatically by cysteine.  
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2.5.1 E87 dictates substrate specificity 
D-Arginine and D-lysine are the best substrates for PaDADH as gauged by their large 
kcat/Km values in the 106 M-1 s-1 range36. The kinetic parameter kcat/Km defines the ability of the 
enzyme for capturing the substrate to form the enzyme-substrate complex that proceeds to 
catalysis. D-Arginine exhibits the largest kcat/Km value at pH 8.7 of 3.4 x 106 M-1 s-1, about 7-fold 
higher than the next closest kcat/Km value belonging to D-lysine36. The bi-dentate electrostatic 
interaction that arginine engages with E87 is likely more energetically favorable than the mono-
dentate interaction involved with D-lysine and may account for the differences in kinetic 
parameters. Replacement of E87 with leucine resulted in a 20-fold decrease in the kcat/Km value 
with D-arginine, yet the value is still in the 105 M-1 s-1 range, hence the contributions of the 
hydrophobic cage and other H-bonds to bind the D-arginine side-chain, such as T50 shown in 
Figure 4, may be underestimated42. 
The kcat/Km value with D-histidine as a substrate may suffer simply because it cannot 
interact with E87 due to distance requirements42. In the crystal structure of the iminohistidine 
complex as shown in Figure 4, the iminohistidine product is present in two distinct 
conformations, one of which does not point towards E87 and may partially explain the 1000-fold 
lower kcat/Km values with D-histidine as compared to D-arginine36. Further evidence of a distinct 
binding behavior for D-histidine comes from the inverse solvent viscosity effect on the kcat/Km 
value, Such a solvent effect is not seen with D-arginine as a substrate36. 
Figure 2.4 Overlay of the crystal structures of iminohistidine. PaDADH residues line the interior of the substrate binding pocket. (Some residues were omitted for clarity). Iminoarginine and iminohistidine bind in two distinct conformations. The surface of the substrate binding pocket is in blue and the surface of the FAD binding domain is in white. Iminoacid carbons are in green, FAD carbons are in yellow, and side chain carbons are in grey. The arrow indicates the entrance to the active site. 
2.5.2 A hydrophobic cage and a flexible loop extends substrate scope
In addition to exceptional kinetic parameters for amino acids bearing positively charged 
side chains, PaDADH can efficiently oxidize the bu
phenylalanine, and the sulfur-containing methionine (
accommodate hydrophobic amino acid substrates is rooted in the presence of a hydrophobic cage 
as mentioned above (Figure 2.3B
form π-π stacking interactions with either or both of Y53 and Y249
potentially form hydrogen bonds with one or both of the Y53 and Y249 residues. D
is also a good substrate, making it likely that the sulfur of methionine engages in favorable 
PaDADH in complex with iminoarginine and 
 
 
lky aromatic substrates tyrosine and 
Table 2.2)36. The ability of 
). The D-phenylalanine and D-tyrosine substrates most likely 
36. D-Tyrosine can also 
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PaDADH to 
-Methionine 
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sulfur-π interactions with the aromatic rings of Y53 and Y24942, 44. The flexible loop L1 of 
PaDADH is present in two alternate conformations and is proposed to act as a gate to control 
substrate entry/exit and substrate accommodation36. A similar loop is found in pDAAO 
composed of residues 216-22840. Loop L1 in PaDADH may help lock small substrates in place 
by closing tightly, whereas in the case of large substrates like D-tyrosine and D-tryptophan the 
loop may protrude outward36. 
2.5.3 Substrate specificity comparison to D-amino acid Oxidases 
The specificity of PaDADH for large and basic substrates is in contrast to the pDAAO 
and human DAAO enzymes which show a preference for smaller hydrophobic substrates i.e., D-
alanine,  and likewise possess small active site volumes of 160 and 220 Å3, respectively7. The 
substrate specificity of the yeast enzymes, RgDAAO and TvDAAO, demonstrate a preference for 
amino acids bearing large and bulky hydrophobic side-chains such as valine, phenylalanine and 
tryptophan45. Naturally, the key factors that determine the specificity of each of the enzymes 
seem to lie within the interactions of the substrate side-chain with the active site residues and the 
relative sizes of the active site pockets.   
2.6 Steady-state kinetic mechanism of PaDADH 
The steady-state kinetic mechanism of PaDADH is consistent with the minimal ping-
pong bi-bi kinetic mechanism depicted in Scheme 246. Evidence for a ping-pong mechanism 
stems from the occurrence of parallel lines in the double reciprocal plots of the enzymatic rates 
versus varied concentrations of D-arginine or D-histidine at different fixed concentrations of 
PMS as electron acceptor. The artificial electron acceptor PMS was utilized because the 
physiological oxidizing substrate is unknown. As shown in Scheme 2, the irreversible release of 
the iminoacid product (k5) must occur before the second substrate, PMS, binds to enzyme (k7)46. 
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In agreement with a ping-pong mechanism, the binding of PMS was not significantly altered 
when either D-arginine or D-histidine was used as the reducing substrate, yielding a Km of 
around 10 µM in both cases. Flavin reduction (k3) was demonstrated to be irreversible with D-
histidine as substrate using rapid kinetics approaches46. This conclusion can be extended to the 
faster substrate D-arginine, since it was shown that 85% of the reduction of the flavin occurs 
within the dead time of the instrument (2.2 ms)46. The reoxidation of the flavin (k9) is also 
presumed to be irreversible after examination of the reduction potentials of PMS/PMSH2 > 
FAD/FADH2, with values of +80 and -200 mV respectively47. However, it is worth noting that 
the reduction potentials could potentially be far different when buried within the enzyme 
environment.  
 
Scheme 2.2 Steady-state kinetic mechanism of PaDADH. PaDADHox, oxidized D-arginine dehydrogenase; S, amino acid substrate; PaDADHred, reduced D-arginine dehydrogenase; P, iminoacid product; PMS, phenazine methosulfate. k5 and k11 are shown as irreversible because products are assumed to be close to zero during the determination of the initial rates of reaction; k4 is shown although it is close to zero based on stopped-flow data46.  
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2.6.1 Product release 
The release of the iminoacid product (k5) is partially rate determining for overall turnover 
with D-arginine as substrate. Evidence for this conclusion comes from the effect of increasing 
solvent viscosity on the normalized rate constant for overall turnover when the enzyme is 
saturated with substrates21. Product release is the only diffusion-controlled step present in the 
proposed steady-state kinetic mechanism of PaDADH46. The kcat value for D-arginine exhibits a 
linear dependence on increasing viscosity yielding a positive slope of 0.14, consistent with 
product release being partially rate-determining, or about 14% responsible for the rate46. 
Furthermore, the kred value for D-arginine is not measurable using stopped-flow reaction 
techniques due to the reduction occurring within the dead-time of the instrument, consistent with 
an estimated value for flavin reduction > 800 s-1 48. Thus, another step other than product release 
may also be contributing to the overall rate of turnover with D-arginine but has yet to be 
elucidated.  In the case of D-histidine, increasing solvent viscosity elicited no effect on kcat, 
indicating product release was not limiting for turnover48. Comparison of the kred value of 60 s-1 
with D-histidine and its corresponding kcat of 35 s-1 implies that flavin reduction is at least 
partially rate-limiting with D-histidine as substrate46. Yet this also implies there is another step 
that occurs prior to product release and after substrate binding, such as an internal isomerization 
of the enzyme, that contributes to the overall turnover with D-histidine as well.  
2.6.2 Substrate inhibition via a dead-end complex   
At sufficiently high concentrations of D-arginine ( > 0.5 mM) during steady-state 
turnover, substrate inhibition of PaDADH occurs46. The excess D-arginine  binds to the free 
reduced enzyme to form a dead-end complex PaDADHred-D-Arg as shown in Scheme 2. The 
accumulation of the dead-end complex leads to a lower overall rate of turnover. Substrate 
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inhibition due to the formation of dead-end complexes between the reduced enzyme and 
substrate has been observed in other flavoproteins such as nitroalkane oxidase, flavocytochrome 
b2, thymidylate synthase, aldehyde oxidase, and cellobiose dehydrogenase49-53.  
2.7 Catalytic mechanism 
2.7.1 Mechanism CN bond cleavage 
The reductive-half reaction of PaDADH was investigated to gain insight on the 
mechanism of CN bond cleavage.  During flavin reduction with either D-leucine or D-
histidine, C4a or flavin N5 adducts were not observed, which is consistent with a hydride 
transfer mechanism (Scheme 3). pH-profile and computational studies showed that the hydride 
transfer in PaDADH is triggered by the abstraction of the substrate -NH3+ group proton 
(Scheme 2.3).   Moreover, substrate, solvent and multiple kinetic isotope effects studies on wild-
type PaDADH were consistent with the NH and CH bond cleavage of the substrate occurring 
asynchronously with irreversible flavin reduction (refs).  In order to investigate on the status of 
the base that abstracts the substrate -NH3+ group proton (Scheme 2.3), Y53F and Y249F 
variant enzymes were generated through site-directed mutagenesis. Indeed, the crystal structure 
of PaDADH showed that the hydroxyl groups of Y53 and Y249 residues are at a distance ≤ 4 Å 
from the substrate amino group consistent with the Y53 and Y249 residues to act as a base25, 36. 
The pH-profile studies on the reductive-half reaction of the Y53F and Y249F variant enzymes, 
and subsequent steady-state kinetic studies on E87L and H48F enzymes, established that Y53, 
Y249, E87 or H48 residues were not the base25, 42. Thus, it was proposed that the -NH3+ group 
of the substrate loses its proton to the solvent to trigger amine oxidation in PaDADH25, 42, 48. 
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Scheme 2.3 Hydride transfer mechanism in PaDADH. B- is a catalytic base, currently assumed to be a solvent molecule. 
 
Similar to the wild-type PaDADH, no flavin intermediates were observed in the Y53F 
and Y249F variants, consistent with a hydride transfer mechanism. On the contrary, flavin 
reduction was reversible in both the Y53F and Y249F variants. Moreover, the solvent and 
multiple kinetic isotope effect studies on the Y53F and Y249F variants demonstrate a 
synchronous CH and NH bond cleavage, consistent with a hydride transfer, and an alteration in 
the relative timing of the two bond cleavages as compared to the wild-type enzyme25. Based on 
this observation, it was concluded that the two tyrosine residues are involved in the stabilization 
of the transition state in PaDADH to facilitate the hydride transfer from the substrate αC to the 
N5 atom of the isoalloxazine moiety of the FAD25. 
2.7.2 Restricted proton transfer 
The pH-profile studies on the substrate affinity value, Kd, and computational studies 
indicate that PaDADH prefers to bind the protonated form of the substrate (i.e., -NH3+)48. As 
shown in Scheme 4, after formation of the ESH+ complex the substrate then loses a proton to 
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form the ES complex that proceeds to catalysis. A prominent hollow observed in the kcat pH-
profiles with D-lysine as a substrate with the wild-type PaDADH provides evidence that the 
equilibration of the proton within the enzyme-substrate complex (i.e., k16/k15) is slower than other 
relevant kinetic steps42 (Scheme 2.4). Moreover, a requirement for the hollow is usually 
observed with sticky substrates, which have a very high capacity to proceed to catalysis (i.e., k3) 
after the formation of the enzyme-substrate complex in comparison to its dissociation (i.e., k2) to 
free enzyme and substrate54-56.  
 
Scheme 2.4 Reductive half-reaction of PaDADH accounting for a slow proton equilibrium in the Michaelis complex. S is the D-amino acid substrate. P is the iminoacid product. 
The pH-profiles on the variant enzymes H48F and E87L provide further evidence that the 
hollow is related to a sub-optimal binding of the substrate in the active site of the enzyme42. The 
E87 residue stabilizes D-arginine by engaging in an ionic interaction with the substrate guanido 
group, thereby replacement of the E87 side chain to leucine impaired the optimal binding of the 
substrate, resulting in a slow proton release to the solvent42. It was shown that the hollowed pH-
profile of the H48F variant, which is not in direct contact with the substrate, is likely due to the 
disruption of the H-bond network between the water molecules, H48 residue and the amino 
group of the substrate (Figure 2.5)36, 42. The H-bond network is important to optimize substrate 
binding and to prevent a slow proton release from the enzyme-substrate complex42 (Figure 2.5). 
As shown in the crystal structure, E87 residue has an ionic interaction with the substrate guanido 
group, while H48 residue interacts indirectly with the substrate via two water molecules (
2.5)36. Thus, it was concluded that both H48 and E87 residues pa
orientation of the substrate to prevent a slow proton exchange between the ESH
the solvent42 (Figure 2.5).  
Figure 2.5 PaDADH loop L1 with S45, A46 and H48 residues.The isoalloxazine moiety of the FAD is in yellow, and the iminoarginine product is in green. Loop L1 is in magenta with H48 interacting with the iminoarginine product through two water molecules.  
2.8 Role of loop L1 dynamics in 
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Figure 2.6 Open-closed conformations of loop L1.The open conformation is shown in blue and the closed conformation in magenta. The carbons in the isoalloxazine ring of the FAD are shown in yellow.  
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Figure 2.6)36. 
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2.8.1 S45/A46 switch and the Y53 gate 
In the open conformation, as shown by the crystal structure, both the side chains of S45 
and A46 located at the FAD-binding domain point away from the isoalloxazine moiety, while the 
side chain of Y53 points away from the active site pocket toward the bulk solvent (Figure 2.6)36. 
In the closed conformation, S45 and A46 side chains move closer to the isoalloxazine moiety and 
the side chain of Y53 gate swings back into the active site pocket to interact with the carboxylate 
group of the iminoarginine product 36.  S45 and A46 residues were mutated individually to 
alanine and glycine, respectively, to investigate the dynamics of loop L1 57. The molecular 
dynamics data indicate that in both S45A and A46G variants the Y53 gate has a higher 
probability to be in the open conformation as compared to the wild-type, where the gate has 
almost equal probability to be in the open and closed conformations during the simulation time57. 
Thus, it was concluded that the conformations of the S45/A46 switch and the Y53 gate are 
coupled57. Moreover, the intensity of the fluorescence spectroscopy showed an increase of ~ 2-
fold in the S45A and A46G variant enzymes compared to the wild-type when the flavin was 
excited at its lower energy peak in the enzyme bound-flavin57. The emission peak of the flavin 
fluorescence of the enzyme-bound flavin was red-shifted from 513 nm in the wild-type to 522 
nm in both the variant enzymes (Figure 2.7). It was concluded that the active site in the S45A 
and the A46G variant is more exposed to the solvent due to the higher probability of Y53 gate to 
stay in the open conformation with respect to wild-type PaDADH57.  
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Figure 2.7 Probability distribution of the S45A, A46G variant enzymes and the wild-type. S45A variant is colored in blue, A46G variant in read and the wild-type in black. The inset represents the flavin fluorescence of the variants and the wild-type enzyme.  
2.8.2 Dynamics of loop L1 in substrate capture and catalysis  
The  dynamics of loop L1 participate in the optimal orientation of the enzyme-substrate 
complex, as evidenced by molecular dynamics simulations and steady-state kinetic approaches57. 
The pH-independent kcat/Km values were lowered by 11- to 13-fold in the S45A and A46G 
variants compared to the wild-type42, 57. Based on the decreased kcat/Km values observed in the 
S45A and A46G variants, it was proposed that the likelihood of substrate capture in the variants 
is impaired due to the higher probability of the Y53 gate to be in the open conformation as 
compared to the wild-type enzyme57. A hollow was observed in the kcat pH-profiles for both the 
S45A and A46G variants, consistent with a restricted proton transfer from the enzyme-substrate 
complex to the solvent57. To gain insight on the effect of loop L1 dynamics on the rate of flavin 
reduction, the reductive half-reaction of both variants was investigated. No conclusions could be 
gained on the status of flavin reduction since both variants could not be saturated with the slow 
substrate D-leucine57.  
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The movement of side chain residues in mobile loops has been shown to participate in the 
catalytic function of several enzymes58. In RgDAAO, Y238 was proposed to act as a gate that 
may control substrate entrance and product exit from the active site, and the corresponding 
residue in pDAAO, Y224, was proposed to contribute to the active site plasticity responsible for 
the binding of various substrates40, 59. Y215 in lactate oxidase and E89 in phosphoenolpyruvate 
carboxykinase, which are not in direct contact with the substrate, help to optimize substrate 
binding60, 61. Residues on flexible loop portions located at the entrance of enzymes not only act 
as gates but have been shown to shield the active site from the solvent upon binding of the 
substrate58, 62-64.  
 
2.9 Open questions 
Although the mechanistic and structural features of PaDADH have been established, the 
physiological electron acceptor of the enzyme has yet to be identified. In vitro, PMS has been 
used as an artificial electron acceptor. Based on the abundance of quinones in nature and their 
participation in many electron transport systems, quinones could possibly act as potential 
physiological electron acceptors. Oxygen reactivity could be useful in exploiting the enzyme 
function in industrial use to separate racemic mixtures. Engineering flavoprotein dehydrogenases 
to react with molecular oxygen to this day remains a challenging endeavor. Previous studies have 
established that there is no catalytic base in PaDADH and the proton is simply transferred from 
the substrate amino group to the solvent in the active site of the enzyme. Investigation into 
identifying if there is a catalytic base functioning in PaDADH is still under work. PaDADH is 
part of a novel two-enzyme racemic system involved in D- to L-arginine racemization, since 
most of the racemization is catalyzed by a single enzyme. The presence of two enzymes instead 
of one could potentially serve as a regulatory mechanism. Further investigation of PaDADH and 
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engineering variants that display oxygen reactivity can be utilized for enzymatic synthesis of 
various α-keto acids and the separation of racemic amino acid mixtures which are of potential 
interest to the industry. 
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3 IMPORTANCE OF GLUTAMATE 87 AND THE SUBSTRATE α-AMINE IN THE 
REACTION CATALYZED BY D-ARGININE DEHYDROGENASE 
(This chapter has been published verbatim in Ball J., Bui Q.V., Gannavaram S., and Gadda G. 
(2015), Arch Biochem Biophys, 568, 56-63; the author contributed the pH effects with D-
arginine and D-Lys, and the pH effects with the H48F variant.) 
3.1 Abstract 
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) catalyzes the oxidation 
of D-arginine to iminoarginine, which is non-enzymatically hydrolyzed to 2-ketoarginine and 
ammonia. Here, site-directed mutagenesis and pH effects were used to investigate binding and 
catalysis of zwitterionic and cationic substrates for the enzyme. An unprotonated group with 
apparent pKa value ≥7.9 is required for binding D-arginine or D-lysine, but not D-methionine or 
D-leucine. This group is E87, as suggested by its replacement with leucine. An unprotonated 
group with pKa of 9.5, which persists in the H48F and E87L variants, is required for amine 
oxidation with all substrates. Since Y53 and Y249 were previously ruled out, the pKa is assigned 
to the substrate α-NH3+ group, which previous QM/MM and Kd pH-profile demonstrated to be 
protonated for preferred binding to the enzyme. Lack of pH effects on the Dkred with D-leucine 
established 9.5 as the intrinsic pKa, and D-leucine as a non-sticky substrate. D-Arginine, D-lysine 
and D-methionine and their corresponding iminoproducts were significantly stickier than D-
leucine, as indicated by apparent pKa values <9.5 in both kcat/Km and kcat. Restricted proton 
movements in catalysis were established from hollowed kcat pH profiles in wild-type PaDADH 
with D-lysine and in the H48F and E87L enzymes with D-arginine. 
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3.2 Introduction 
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) catalyzes the flavin-
mediated, oxidative deamination of D-arginine to iminoarginine, followed by the non-enzymatic 
hydrolysis in solution of the imino product to give 2-ketoarginine and ammonia (Scheme 3.1).[1]  
 
Scheme 3.1 Oxidation of D-Arginine by PaDADH.  
All the standard D-amino acids except D-glutamate, D-aspartate, and glycine are 
oxidized by the enzyme,[1, 2] with D-arginine and D-lysine displaying the highest rate constants 
for substrate capture, kcat/Km, of 105-106 M-1s-1.[2] PaDADH is one of the few known enzymes 
that can oxidize cationic D-amino acids with great efficiency, sharing strikingly similar substrate 
specificity to D-amino acid oxidase (DAAO) from Arthrobacter protophormiae.[3] Acidic D-
amino acids are oxidized by the highly selective D-aspartate oxidases.[4, 5] L-Amino acids are 
not substrates for PaDADH.[2] PaDADH is a strict dehydrogenase because during turnover it 
reacts with an electron acceptor other than molecular oxygen, presumably ubiquinone in vivo.[6] 
The enzyme follows a Ping-Pong Bi-Bi steady-state kinetic mechanism, as demonstrated with D-
arginine or D-histidine as substrate and phenazine methosulfate (PMS) as electron acceptor.[6] 
In the reductive half-reaction the enzyme-bound flavin (PaDADHox) is reduced to hydroquinone 
with concomitant oxidation of the amino acid to the imino acid (PaDADHox-P), as shown in 
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Scheme 3.2. In the oxidative half-reaction, the reduced flavin is oxidized (in vitro) by PMS 
(Scheme 3.3). 
 
 
Scheme 3.2 Reductive half-reaction of PaDADH. 
 
Scheme 3.3 Oxidative half-reaction of PaDADH.  
Flavin reduction is irreversible with D-histidine or D-leucine as substrate, as established by a 
zero intercept value in a plot of the observed rate constant for flavin reduction as a function of 
substrate concentration.[6] With D-arginine, however, the reaction is too fast and cannot be 
studied in a stopped-flow spectrophotometer due to >80% of the flavin being completely reduced 
within the mixing time of the instrument (i.e., 2.2 ms), as previously reported.[6] Amine 
oxidation has been studied with D-leucine, which is amenable to mechanistic investigation using 
a stopped-flow spectrophotometer, with pH, substrate and solvent kinetic isotope effects, as well 
as computational studies.[7] Free energy calculations and the pH profile for Kd are consistent 
with the enzyme binding preferentially the zwitterionic form of D-leucine.[7] After isomerization 
of the enzyme-substrate complex, amine deprotonation triggers the oxidation reaction, with 
cleavages of the NH and CH bonds of D-leucine occurring asynchronously, as suggested by 
multiple deuterium kinetic isotope effects on the rate constant for flavin reduction.[7] In this 
respect PaDADH is similar to proline dehydrogenase,[8] but different from other flavin-
dependent amine oxidases, such as DAAO or monomeric sarcosine oxidase, for which amine 
oxidation occurs from the anionic substrate.[9] 
77 
The three-dimensional structures of PaDADH in complex with iminoarginine or 
iminohistidine, or in the unliganded form, have been previously solved at high resolution (1.06-
1.3 Å), along with an atomic-resolution structure of a 4-methyl-2-pentanone-FAD adduct in the 
enzyme co-crystallized with D-leucine.[2, 10] The structure of the enzyme in complex with 
iminoarginine underlines the importance of the side chain carboxylate of E87 for binding the 
cation of the iminoarginine side chain, as shown in Figure 3.1.[10]  
  
 Figure 3.1 Interactions of iminoarginine with active site residues of Carbon atoms are colored green for each of the iminoarginine. FAD is represented by its isoalloxazine ring with the C atoms colored yellow. Hbond and ionic interactions are shown as dashed lines. Two water molecules in the binding site are shown as red spheres. For clarity, panels A and B focus on different interactions. Note that the side chain of M240 is present in two alternate conformations.  
 
PaDADH. PaDADH active site residues and magenta for 
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Two tyrosine residues, i.e., Y53 and Y249, with the aid of M240 and V242 arrange into a 
hydrophobic pocket that surrounds the central part of the iminoarginine side chain. The imine of 
the imino-product is connected to H48 through two intervening water molecules (Figure 3.1B). 
The imino-product Cα atom is close to the flavin N(5) atom, presumably indicating where the Cα 
atom of the amino acid substrate resides during catalysis. The structure of the enzyme in 
complex with iminohistidine demonstrates that the imidazole of the ligand is present in two 
alternate conformations, with H-bonding interactions with the side chains of H48, T50, and 
either E87 or Q336. A mobile loop, composed of residues 50-56, is present in two alternate 
conformations in the unliganded and product-bound enzyme structures.[2] This flexible loop 
forms an active site lid and is proposed to play an important role for substrate specificity and 
recognition, allowing the enzyme to accommodate bulky substrates like phenylalanine or 
tryptophan.[2] 
In this study, we have used mechanistic approaches to investigate further the reaction of 
amine oxidation catalyzed by PaDADH. Effects of pH were determined on the steady-state 
kinetic parameters with selected substrates and on the kinetic isotope effects associated with 
flavin reduction using D-leucine. Mutagenesis of specific residues hypothesized to be important 
for catalysis or binding has been carried out to facilitate in the assignment of the observed pKa 
values. The results shed light on the ionization states of groups that are relevant to amine 
oxidation and provide further mechanistic insight on the catalytic mechanism for amine 
oxidation by PaDADH. 
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3.3 Experimental Procedures 
3.3.1 Materials 
D-Methionine and D-leucine were purchased from Sigma-Aldrich (St. Louis, MO). D-
Arginine and D-lysine were obtained from Alfa-Aesar (Ward Hill, MA). D-Leucined10 was 
obtained from CDN Isotopes (Pointe-Claire, Canada). PaDADH-wt was prepared as described 
previously.[2, 6] All other reagents used were of the highest purity commercially available. 
3.3.2 Steady-state kinetics 
The steady-state kinetic parameters for D-arginine, D-lysine, or D-methionine were 
measured polarographically on a computer-interfaced O2 electrode by using the method of initial 
rates. The enzyme does not react with O2, hence as electron acceptor we used PMS, which 
spontaneously reacts in its reduced form with molecular oxygen.[11] The reaction was initiated 
by the addition of the enzyme, with final concentrations ranging from 5 nM to 2 μM depending 
on pH and the substrate used, yielding a reaction volume of 1 mL. Substrate concentrations 
ranged from 0.01-100 mM for D-arginine, 0.25-250 mM for D-lysine, 1-186 mM for D-
methionine, and 0.5-50 mM for D-leucine, ensuring that the Km values determined were within 
the range of substrate concentrations used at any given pH. The same concentrations of D-
arginine were used as substrate for the H48F and E87L enzyme variants. The assays were carried 
out at 25 o C in 20 mM sodium pyrophosphate (pH 8.5-10.0), 20 mM sodium phosphate (pH 6.0-
8.5) or 20 mM piperazine (pH 4.75-6.0). The same buffers, substrate concentrations, and enzyme 
concentrations were used for the assays performed at 6 oC.  Substrate solutions were prepared in 
buffer and the pH values were adjusted prior to addition to the reaction mixtures. The 
concentration of PMS was kept fixed at 1 mM to ensure full saturation of the enzyme. Data for 
D-leucine with the wild-type were taken from Yuan et al.[7] 
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3.3.3 Kinetic isotope effects 
The reductive half-reaction of PaDADH with D-leucine was monitored using an SF-
61DX2 Hi-Tech KinetAsyst high performance stopped-flow spectrophotometer thermostated at 
25 oC. The observed first-order rate constants for flavin reduction (kobs) were determined at 
varying concentrations of D-leucine or D-leucined10 between 0.5 and 50 mM under pseudo first-
order conditions using the buffer system described above at pH 7.0, 8.5, and 10.0. Multiple 
measurements typically differed by ≤5%. 
3.3.4 Mutagenesis 
Mutagenesis to prepare the H48F or E87L variants of the enzyme was performed 
following the QuikChange protocol using the cloned wild-type gene pET20b(+)/PA3863 as 
template. The forward primer for H48F was 5’-GCTCCGCCGCGTTCTACACGGTGGCCTA-
3’, while that for E87L was 5’-AGCCCGCGTCCGCTGATGGTGGTCGACTTC-3’ The 
underlined portions represent the mutated sites. Oligonucleotide primers were purchased from 
Sigma Genosys (The Woodlands, TX). Plasmids were purified using kits from Qiagen, Inc 
(Valencia, CA). Sequencing was performed by the GSU Biology Core Facility using an Applied 
Biosystems Big Dye Kit on an Applied Biosystems model ABI377 DNA sequencer. The 
expression and purification of H48F and E87L mutant enzymes followed the same protocol as 
the wild-type enzyme.[2, 6] 
3.3.5 Data analysis 
Kinetic data were analyzed with KaleidaGraph software (Synergy Software, Reading, 
PA) and the Kinetic Studio Software Suite (Hi-Tech Scientific, Bradford on Avon, U.K.). 
Stopped-flow traces were fit to eq 1, which describes a single exponential process where kobs 
represents the observed first-order rate constant for flavin reduction at any given concentration of 
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substrate, t is time, A is the absorbance at 446 nm at any given time, B is the amplitude of the 
absorbance change, and C is the absorbance at infinite time, which in this case is the non-zero 
absorbance of the fully reduced enzyme. Kinetic parameters for the reductive half-reactions were 
determined by using eq 2, where kobs is the observed first-order rate constant for the reduction of 
the enzyme-bound flavin at any given concentration of substrate (S), kred is the limiting first-
order rate constant for flavin reduction at saturating concentrations of substrate, and appKd is the 
apparent dissociation constant for binding of the substrate to the enzyme. 
The apparent steady-state kinetic parameters at varying substrate concentrations were 
determined by using the Michaelis-Menten equation for a single substrate. Previous results 
demonstrated a Ping Pong Bi–Bi steady-state kinetic mechanism for PaDADH for both the fast 
substrate arginine and the slow substrate histidine, with a Km value for PMS of ~10 µM.[6] 
Consequently, and after considering the results of the pH effect obtained in this study, when the 
steady-state kinetic parameters were determined at a fixed concentration of 1 mM PMS they 
approximate well the true kcat, Km, and kcat/Km values for the amino acid substrate. 
The pH profiles of the kcat values for D-arginine and kcat and kcat/Km values for D-
methionine were fit to eq 3, which describes a curve that increases at increasing pH with slope of 
+1 and a limiting value (C) at high pH. The pH profiles of the kcat/Km values for D-arginine and 
D-lysine were fit to eq 4, which describes a curve that increases at increasing pH with slope of 
+2, a limiting value (C) at high pH and two indistinguishable pKa values. The pH profiles of the 
kcat values for D-lysine with the wild-type enzyme and D-arginine with the H48F and E87L 
enzymes were fit to eq 5, which describes a curve that increases with increasing pH to a limiting 
value (C) to yield three pH dependent terms containing a hollow that is defined by β = 1 + k3/k2 
and Kα = (k1/k7 )(1+k8/k5)K1. Here, pKe is the intrinsic pKa value for kcat, β reflects the stickiness 
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of the substrate (k3/k2), and Kα describes the relative rates of the kinetic steps involved in the 
equilibration of ESH+ complex. [12]   
A = Beି௞౥ౘ౩୲  +  C (1) 
݇୭ୠୱ = ௞౨౛ౚୗ௄ౚାୗ౗౦౦  (2) 
log(݇ୡୟ୲, ݇ୡୟ୲/ܭ୫) = log ቀ େଵାଵ଴(౦಼౗ష౦ౄ)ቁ (3) 
           log(݇ୡୟ୲/ܭ୫) = log ቀ େଵାଵ଴(౦಼౗ష౦ౄ)మቁ (4) 
log(݇ୡୟ୲) = log ൬ େ∗൫ଵାଵ଴(౦಼ಉష౦ )൯൫ଵାଵ଴(౦಼౛ష౦ౄ)൯൫ଵାଵ଴(ಊ౦಼ಉష౦ౄ)൯൰ (5) 
Standard errors were obtained from KaleidaGraph's "General curve fit", which uses the 
Levenburg-Marquardt algorithm.[13] 
3.4 Results 
3.4.1 Steady-state kinetics with D-leucine at variable concentration of PMS 
The steady-state kinetic parameters for D-leucine as substrate for PaDADH were 
measured at two concentrations of PMS (0.1 and 1 mM) at pH 6.0 and 10.0, in order to ensure 
full saturation of PMS was achieved across the pH range used. As shown in Table 3.1, the 
kinetic parameters were indistinguishable at both pH values, consistent with the enzyme being 
fully saturated at 1 mM PMS. In agreement with these results, previous data with D-arginine and 
D-histidine at pH 8.7 established a Km < 10 µM for PMS.[6]  Since the enzyme follows a Ping 
Pong Bi–Bi steady-state kinetic mechanism,[6] it is concluded that 1 mM PMS saturates the 
enzyme irrespective of the substrate used within the pH range used in this study. 
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Table 3.1 Apparent steady-state kinetic parameters at saturating PMS  [PMS] (mM) pH kcat (s-1)  Km (mM)  kcat/Km (M
-1s-1)  (R
2)a 
0.1 6.0 0.061 (±0.002)  1.8 (±0.2) 33 (±3) 0.994  1.0 6.0 0.059 (±0.002) 1.6 (±0.1) 36 (±3) 0.995 0.1 10.0   55 (±1) 4.6 (±0.3) 12,000 (±1,000) 0.998 1.0 10.0   53 (±1) 4.4 (±0.3) 12,000 (±1,000) 0.997 
 Experimental conditions: 20 mM sodium pyrophosphate in H2O at 25 oC. Data were acquired at varying concentrations of D-leucine and fixed PMS concentrations of 0.1 and 1.0 mM yielding overlapping saturation curves. a Coefficient of determination, which in the algorithm used in KaleidaGraph is: 
Rଶ = 1 − ஧మ∑ ஢౟(୷౟ି୷ഥ)మ౟ , where χଶ is defined as Chi Square, σ୧ is the weight, y୧ is the actual value, and yത is the mean of actual values.  
3.4.2 kcat/Km and kcat pH-profiles with cationic substrates 
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were 
determined with D-arginine or D-lysine as substrate to establish relevant ionizations of groups 
involved in binding or catalysis with substrates carrying a positive charge on the side chain. As 
shown in Figure 3.2, the kcat pH-profile with D-arginine increased to a limiting value at high pH, 
defining the requirement for an unprotonated group for catalysis. With D-lysine as substrate a 
similar pattern was seen at low pH, with an unprotonated group required for catalysis having a 
pKa similar to that seen with D-arginine, although the enzyme could not be saturated with D-
lysine below pH 6.0 (Figure 3.2). Despite similar kcat values with the two substrates up to pH 
7.5, turnover with D-lysine was significantly faster than with D-arginine at high pH, and the 
curve demonstrated a hollow that yielded three pKa values. Both D-lysine and D-arginine had 
kcat/Km pH-profiles increasing to limiting values with increasing pH (Figure 3.2). However, the 
ascending limbs clearly showed the presence of two unprotonated groups rather than the single 
one seen in the kcat pH-profiles. The apparent pKa values and the pH-independent, limiting values 
of kcat/Km and kcat determined with D-arginine and D-lysine are summarized in Table 3.2.  
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Figure 3.2 pH-profiles of kcat (A) and kcat/Km (B) with D-arginine (▲), D-lysine (∇), and D-arginine (●) at 6 o C.  PaDADH activity was measured at varying concentrations of D-arginine or D-lysine and 1 mM PMS at 25 oC, unless otherwise stated. Curves represent fits of the data to eqs 3-5.   
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Table 3.2 pH Effects on kcat/Km and kcat of PaDADH  kcat/Km kcat  pKa1 pKa2 (kcat/Km)Ha(M-1s-1) pKa pKα pKe (kcat)Ha(s-1) cationic substrates D-arginine 7.2b,c 7.2b,c 2,600,000 (±500,000)   6.3b,d – – 160 (±20) D-lysine 7.9b,c 7.9b,c    580,000 (±150,000) ~6.2e,f,g,h 8.7f,g 9.2f,g ~550j D-arginine 6 oC  6.9b 6.9b,c    140,000 (±40,000)   6.0b,d – –  zwitterionic substrates D-methionine   7.7b,d –   36,000 (±6,000)   6.9b,d – – 190 (±20) D-leucinei ~9.5d,j –    ~11,000j ~9.5d,j – – ~100j a pH-independent limiting value at high pH. b (±0.1).  c Determined by using eq 4. d Determined by using eq 3. e Inferred by visual inspection of Figure 2A. f (±0.3). g Determined by using eq 5. h βpKα i From Yuan et al.[7] j Approximate value, due to plateau being not well defined.  
3.4.3 kcat/Km and kcat pH-profiles with D-arginine at 6 oC 
Previous studies on creatine kinase by Cook et al. demonstrated that altering temperature 
may induce hollowed pH profiles of steady-state kinetic parameters.[14] In an effort to evaluate 
if this could be the case for PaDADH with D-arginine, the pH profiles of the steady-state kinetic 
parameters were determined at 6 oC. As shown in Figure 2A, no hollow was detected for the pH 
profile of the kcat, which qualitatively looked similar to that obtained at 25 oC. Table 3.2 
summarizes the apparent pKa values and the pH-independent, limiting values of kcat/Km and kcat 
determined with D-arginine at 6 oC. 
3.4.4 kcat/Km and kcat pH-profiles with zwitterionic substrates 
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were 
determined with D-methionine or D-leucine as substrate to establish relevant ionizations of 
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groups involved in binding or catalysis with substrates not carrying a positive charge on the side 
chain. With both D-methionine and D-leucine, the pH-profiles of the kcat and kcat/Km values 
increased with increasing pH, reaching limiting values at high pH, and demonstrating the 
requirement for a single unprotonated group for catalysis (Figure 3.3). 
 
Figure 3.3 pH-profiles of kcat and kcat/Km with D-methionine (●) and D-leucine (○). PaDADH activity was measured at varying concentrations of d-methionine or d-leucine and 1 mM PMS at 25 °C. Curves represent fits of the data to Eq. 3. 
3.4.5 kcat/Km and kcat pH-profiles with H48F variant 
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were 
determined with D-arginine in the H48F variant to investigate if H48 acts as a catalytic base in 
amine oxidation. The kcat/Km pH profiles of the H48F enzyme resembled that obtained with the 
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wild-type enzyme; however, the kcat pH profile did not exhibit a pronounced hollow describing 
three pKa values (Figure 3.4), as for the case of D-lysine with wild-type PaDADH. Thus, H48 
was not responsible for the pKa values seen in the wild-type enzyme. Table 3.3 summarizes the 
apparent pKa values and the pH-independent, limiting values of kcat/Km and kcat. 
 
Table 3.3 pH Effects on kcat/Km and kcat of PaDADH Variants with D-Arginine as Substrate.  kcat/Km kcat  pKa1 pKa2 (kcat/Km)Ha(M-1s-1) βpKα pKα pKe (kcat)Ha(s-1) PaDADH Variant H48F 7.1b,c 7.1b,c 1,100,000 (±240,000)   6.1b,d 8.9b,d 9.4d,e ~150f E87L 8.2g,h –    150,000 (±50,000) ~5.5i 9.0b,d 9.7d,h ~150f a pH-independent limiting value at high pH. b (±0.1).  c Determined by using eq 4. d Determined by using eq 5. e (±0.3).  f Approximate value, due to plateau being not well defined. g Determined by using eq 3. h (±0.2). i Approximate value, not able to populate limb because of increasing Km at acidic pH.  
3.4.6 kcat/Km and kcat pH-profiles with E87L variant 
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were 
determined with D-arginine in the E87L variant to investigate the role of E87 in amine oxidation. 
The kcat pH profile of the E87L variant increased with increasing pH to reach a limiting value at 
high pH, exhibiting three pH dependent terms (Figure 3.4). In contrast to the wild-type kcat/Km, 
the E87L variant demonstrated the requirement for only a single unprotonated group for maximal 
activity. Table 3.3 summarizes the apparent pKa values and the pH-independent, limiting values 
of kcat/Km and kcat. 
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Figure 3.4 pH-profiles of kcat and kcat/Km with PaDADH variants H48F (●) and E87L (○). PaDADH activity was measured at varying concentrations of D-arginine and 1 mM PMS at 25 °C. Curves represent fits of the data to Eqs. (3)–(5).  
3.4.7 Dkred pH-profile with D-leucine 
The pH-dependence of the kinetic isotope effects on the rate constant for flavin reduction 
at saturating substrate (kred) was determined with D-leucine to establish if the latter is a slow 
substrate for PaDADH for which apparent and intrinsic pKa values are identical. Since the 
reaction is too fast with D-arginine, it could not be studied in a stopped-flow spectrophotometer, 
as previously reported.[6] Flavin reduction was followed at 446 nm upon mixing the enzyme 
with varying concentrations of D-leucine in a stopped-flow spectrophotometer, yielding 
monophasic traces (Figure 3.5 shows the case of pH 8.5, with pH 7.0 and 10.3 being similar). 
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The Dkred values were computed from the ratio of the kred values with D-leucine and D-leucined10 
determined by plotting the observed rate constants for flavin reduction as a function of substrate 
concentration. As illustrated in Table 3.4, the Dkred had similar values in the pH range from 7.0 to 
10.3. 
 
Figure 3.5 Kinetic isotope effects on kred at pH 8.5 with D-leucine (black) and D-leucined10 in (red).  Panel A shows representative time courses for the light and heavy substrate at 50 mM substrate concentration; the traces were fit to Eq. (1). Panel B shows the concentration dependences of the observed rate constants for flavin reduction at different substrate concentrations of protiated and deuterated leucine.   
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Table 3.4 pH effects on kinetic isotope effects with D-leucine.  pH Dkred 7.0a 4.6 (±0.9) 8.5b 5.2 (±0.4) 10.3c 5.1 (±0.1) Experimental conditions: 20 mM asodium phosphate and bsodium pyrophosphate in H2O at 25 oC with between 0.5 to 50 mM D-leucine and  D-leucine-d10. c From Yuan et al.[7]  
3.5 Discussion 
The substrates of PaDADH, which displays broad specificity being able to oxidize most 
of the D-amino acids except D-aspartate, D-glutamate, and glycine,[2] can be classified as 
cationic or zwitterionic, depending on the presence of a charge on the side chain. In this study, 
we have used D-arginine, D-lysine, D-methionine and D-leucine to investigate mechanistically 
how cationic and zwitterionic substrates bind to and are oxidized by PaDADH. Insights on the 
roles played by several functional groups in the active site of the enzyme have emerged from the 
investigation of wild-type and selected active site variants of the enzyme, as discussed below. 
The unprotonated side chain of E87 is important for binding cationic substrates through 
an electrostatic interaction with the substrate side chain. This conclusion is supported by pH 
profiles of the steady-state kinetic parameters, site-directed mutagenesis and previously 
published X-ray structures of the enzyme in complex with the iminoarginine product.[2] While a 
single unprotonated group is required to achieve maximal kcat/Km values at high pH with the 
zwitterionic substrates D-methionine and D-leucine, two groups are seen in the kcat/Km pH-
profiles with the cationic substrates D-arginine and D-lysine. The extra unprotonated group must 
be involved in substrate binding rather than catalysis, since it is not seen in the kcat pH-profiles, 
which show the requirement for a single unprotonated group for catalysis with both cationic and 
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zwitterionic substrates. The kcat/Km pH-profile of the E87L mutant indicates only a single group 
is required for maximal activity with D-arginine, providing unequivocal evidence that E87 is the 
unprotonated group on the enzyme that binds cationic substrates. Further support for E87 
interacting with the side chain of the cationic substrates comes from the X-ray structures of the 
enzyme in complex with iminoarginine and one of the two alternate conformations of 
iminohistidine,[2]  showing the carboxylate chain of E87 at ≤2.8 Å away from the guanido and 
ε-amino groups of the cationic products of the reaction. Interestingly, the pKa of E87 is perturbed 
to a value ≥7.9, as suggested by the kcat/Km pH-profiles with the cationic substrates D-arginine 
and D-lysine. This may be due to E87 being close to the hydrophobic side chains of M240 and 
V242. Large upward perturbations of pKa values for aspartate and glutamate attributed to a 
hydrophobic environment have been previously reported for bacteriorhodopsin and bacterial 
thioredoxin, respectively.[15-18] Upward shifts in pKa values of anionic residues have also been 
reported to occur when other negatively-charged residues are in close proximity to the group in 
question, such as E72 in Bacillus circulans xylanase.[19] In the case of PaDADH, while there is 
no other anionic group close to E87 a hydrogen bond interaction of the side chain of E87 with 
the O atom of T50 may also contribute to the elevation of the pKa value, similar to human 
thioredoxin, in which a hydrogen bond to a neighboring serine elevates the pKa of an aspartate 
residue.[20] An intrinsic value for the pKa for E87 in the active site of PaDADH, however, 
cannot be estimated because different pKa values were determined with D-arginine and D-lysine. 
pKa values determined from kcat/Km pH-profiles refer to ionizations of the free enzyme or 
substrate, but not of enzyme-substrate complexes.[21] Thus, the different values determined with 
D-arginine and D-lysine reflect the stickiness of these substrates, i.e., the propensity of the 
enzyme-substrate complex to catalyze amine oxidation rather than releasing the substrate to bulk 
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solvent (k3/k2 in Scheme 3.2). Due to substrate stickiness perturbing apparent pKa values outward 
in kcat/Km pH-profiles,[21] D-arginine, with a pKa value of 7.2, is stickier than D-lysine, with pKa 
value of 7.9. However, no conclusion on the stickiness of D-lysine can be drawn with the data 
available, preventing the determination of the intrinsic pKa value of E871. In the case of DAAO, 
Denu and Fitzpatrick observed outward perturbation of the pKa values with D-alanine, 
establishing it as a sticky substrate.[22] 
An unprotonated group with an intrinsic pKa value of ~9.5, which is assigned to the -
NH3+ group of the amino acid substrate, is required for catalysis with both cationic and 
zwitterionic substrates. Evidence for this conclusion comes from the pH profiles of the steady-
state kinetic parameters and site-directed mutagenesis. The kcat and kcat/Km values increased to 
limiting values with increasing pH with all substrates. This establishes the requirement for an 
unprotonated group acting in the chemical step of amine oxidation rather than in substrate 
binding, since kcat excludes binding steps because the enzyme is saturated with the substrate.[23] 
The linear decrease with decreasing pH in both kcat and kcat/Km with all tested substrates is 
consistent with the unprotonated group not acting as an electrostatic catalyst, in which case the 
kinetic parameters would approach a limiting, lower value at low pH. The apparent pKa values 
determined in the kcat and kcat/Km pH profiles with D-leucine approximate well the intrinsic pKa 
value, since D-leucine is a slow, non-sticky substrate for PaDADH. This conclusion comes from 
the pH-independence of the Dkred value for the reduction of the enzyme-bound flavin with D-
leucine between pH 7.0 and 10.3, where both kcat and kcat/Km depend on pH, which establishes 
that the enzyme-substrate complex is not committed to catalysis and that D-leucine is not a 
                                                 1 Since E87 does not interact with the side chain of D-leucine, the perturbations of the apparent pKa of E87 and of the unprotonated group participating in catalysis, which is instead common to all substrates oxidized by PaDADH, are not the same. For this reason, while the ΔpKa values attributed to the chemical step of catalysis allows the determination of the intrinsic pKa value on kcat (vide infra), the same cannot be done to establish the intrinsic pKa value of E87. 
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sticky substrate.[24] Independent support for D-leucine being a slow substrate is provided by the 
comparison of the pKa of ~9.5 determined for kcat/Km with the pKa of 9.6 recently reported for the 
kred pH-profile with D-leucine.[7] The active site of the enzyme has several side chains that could 
potentially act as catalytic base for the deprotonation of the -NH3+ group of the amino acid 
substrate, including H48, Y53, Y249 and, although less likely due to its location and 
participation in binding the side chain of cationic substrate, E87. The pH profiles of the kcat and 
kcat/Km values for the H48F variant with D-arginine still show the requirement for the 
unprotonated group in the catalytic step, thereby eliminating H48 as being responsible for the 
observed pKa value. A similar conclusion is drawn for E87, since the unprotonated group 
involved in catalysis is still present in the pH profiles for the E87L variant. Previous site-directed 
mutagenesis and rapid reaction studies established that neither Y53 nor Y249 is the catalytic 
group required for flavin reduction.[25] Instead, Y53 may exert a similar role to the analogous 
Y238 in DAAO from Rhodotorula gracilis by modulating the substrate entry and exit.[26] Thus, 
despite the presence of several candidates in the active site of PaDADH the unprotonated group 
required for catalysis cannot be attributed to any of the protein residues with potential to act as 
base in the active site of the enzyme. Consequently, the pKa value of 9.5 for the unprotonated 
group involved in catalysis is assigned to the -NH3+ group of the amino acid substrate.  
D-Arginine is considerably stickier than D-leucine, followed by D-methionine and D-
lysine, as suggested by the perturbations of the apparent pKa values in the kcat/Km pH-profiles 
from the intrinsic value of ~9.5 determined with D-leucine. Substrate stickiness can be computed 
by using eq 6, where ΔpKa is the difference between the apparent and intrinsic pKa values. As 
expected from the kcat/Km of 106 M-1s-1, D-arginine is the stickiest substrate, with k3/k2 of ~200, 
likely due to the optimization of the active site with key residues involved in binding, such as 
95 
Y53, Y249, R222, R305 and, most importantly, E87. Interestingly, k3/k2 ratios of similar 
magnitude are computed with D-methionine (~60) and D-lysine (~40), despite lack of interaction 
of the side chain of methionine with E87, which instead is present with D-lysine. The stickiness 
of D-methionine is possibly due to its S atom establishing S-π interactions[27] with the phenols 
of either Y53, Y249 or both. 
Δpܭୟ = log ቀ1 + ௞య௞మቁ  (6) 
The cationic side chains of the iminoarginine and iminolysine products contribute to their 
stickiness compared to products lacking a positive charge. This conclusion is supported by the 
pH-profiles of the kcat values, showing apparent pKa values with D-arginine and D-lysine ~3 pH 
units lower than the intrinsic value of 9.5 determined with D-leucine. Perturbations of pKa values 
in kcat pH-profiles are symptomatic of a kinetic step other than the chemical step of catalysis 
being at least partially rate-determining for the overall turnover of an enzyme saturated with 
substrates.[21] Since PaDADH operates through a Ping-Pong Bi-Bi kinetic mechanism in steady-
state and previous studies established that the oxidative half-reaction with PMS as electron 
acceptor is fast,[7] the only first-order kinetic step other than amine oxidation in the reductive 
half-reaction of the enzyme is product release (k5 in Scheme 3.2). Most likely product stickiness 
with cationic substrates is due to an interaction of the positive charge present on the side chain of 
the ligand with the carboxylate of E87, as suggested by the structures of the enzyme in complex 
with iminoarginine.[2] The similar pKa perturbations seen with D-arginine and D-lysine suggest 
that the interaction of the carboxylate of E87 with the side chain of the ligand has similar effects 
on the rate of turnover of PaDADH irrespective of the presence of an ε-amino or guanido group 
on the product side chain. The increase in kcat from ~150 s-1 to ~550 s-1 seen in the pH-profile 
with D-lysine above pH 9.2 is consistent with a difference in the rate-limiting kinetic step 
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between the two substrates, potentially product release. Interestingly, iminomethionine is also 
considerably stickier than iminoleucine, as suggested by the apparent pKa of 6.9 compared to the 
intrinsic pKa ~9.5. Since both lack a cationic side chain, the stickiness of iminomethionine 
cannot be due to electrostatic interactions with E87. Rather, potential S-π interactions of the 
ligand S atom with the aromatic rings of Y53 or Y249 are likely responsible for the stickiness of 
iminomethionine,[27] as also proposed for D-methionine.  
Previous QM/MM computations and the pH profile of the Kd value determined in the 
reductive half-reaction of wild-type PaDADH with D-leucine as substrate demonstrated that the 
enzyme preferentially binds the zwitterionic form of the substrate rather than the anionic 
form.[7] Solvent and substrate deuterium kinetic isotope effects on the rate constant for flavin 
reduction with D-leucine further indicated that flavin reduction occurs through the asynchronous 
cleavage of the substrate NH and CH bonds.[7] Thus, an accurate representation of the reductive 
half-reaction that accounts for the effects of pH on the ionization state of the substrate is given 
by Scheme 3.4, in which the substrate -amino group is either protonated or unprotonated before 
binding to form the enzyme-substrate complex.  
 
Scheme 3.4 Reductive half-reaction of PaDADH accounting for pH effects on substrate ionization.  
Cook et al. demonstrated earlier with creatine kinase that a “hollowed” pH profile is obtained 
with sticky substrates when the equilibration of a proton within an enzyme-substrate complex is 
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not rapid with respect to other relevant kinetic steps.[14] This yields three apparent pKa values, 
which corresponds to the intrinsic pKa value for the ionization of the relevant group involved in 
catalysis and two apparent pKa values from which the stickiness of both the substrate and the 
proton with restricted movement can be extracted.[14] Alternatively, the hollow will not be 
present when the proton rapidly equilibrates within the complex, as is the case for most 
enzymatic reactions, or when the substrate/product is non-sticky.[14] With wild-type PaDADH 
in turnover with cationic substrates the pH profile of the kcat value clearly demonstrates the 
presence of a hollow with D-lysine, but not with D-arginine irrespective of temperature. Thus, 
despite both substrates are sticky (see above) and share long, cationic side-chains that interact 
with E87, they must have (slightly) different arrangements within their respective enzyme 
complexes that result in different rates of proton release to the solvent. This may arise from a 
sub-optimal orientation of the -NH3+ group of D-lysine as compared to D-arginine, which 
would impair the unrestricted release of the proton to solvent within the active site of the 
enzyme. In the three dimensional structure of the enzyme in complex with iminoarginine two 
well-defined water molecules are present in the active site of the enzyme-product complex, 
which are arranged to connect the -NH3+ group of the ligand with the side chain of H48 and 
likely contribute to deprotonation of the substrate -NH3+ group in turnover. Such an optimal 
arrangement may be missing in the complex with D-lysine and is likely to be disrupted upon 
mutation of H48 or of the neighboring residue E87, as suggested by the appearance of hollowed 
kcat pH profiles in the H48F and E87L variants with D-arginine as substrate. Lack of an 
interaction between E87 and the side chain of D-methionine likely arranges the substrate -NH3+ 
group so that proton release to solvent is also unrestricted, resulting in a kcat pH profile not being 
hollowed. Similarly, the kcat pH profile with D-leucine is not hollowed due to the latter being a 
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non-sticky substrate (see above). In this context, previous results with tryptophan 2-
monooxygenase showed hollowed kcat/Km pH profiles with methionine or alanine, which were 
associated with proton related isomerizations of the enzyme-substrate complex.[28, 29] Although 
hollowed pH profiles were reported for the rate constant for anerobic flavin reduction of 
Rhodotorula gracislis DAAO with alanine or asparagine as substrate, a different interpretation 
was offered based on these substrates being nonsticky.[30] 
In summary, we have used pH profiles, kinetic isotope effects, and site-directed 
mutagenesis to investigate further the steady-state mechanism of amine oxidation in PaDADH 
with a number of amino acid substrates. From a structural-functional standpoint, the results 
presented herein have established the importance of E87 in the active site of the enzyme for 
binding cationic substrates that carry a positive charge on the side chain, i.e., D-arginine and D-
lysine. Despite the presence of several groups in the active site of the enzyme with the potential 
to act as base, substrate deprotonation occurs through the direct release of the substrate -amino 
proton to the solvent without involvement of protein residues. In this respect, PaDADH is similar 
to other well-characterized flavoproteins that catalyze the oxidation of amino acids, i.e., L-amino 
acid oxidase, DAAO, and monomeric sarcosine oxidase, which lack in their active sites catalytic 
bases.[9, 30-32] From a mechanistic standpoint, D-arginine, D-lysine and D-methionine, as well 
as their respective imino-products, are sticky, resulting in steady-state turnover being primarily 
populated of enzyme complexes with substrates and products rather than the free enzyme. 
Among the pool of sticky substrates, proton release from the substrate -amino group to solvent 
is restricted with D-lysine as substrate due, most likely, to a non-optimal configuration of the 
enzyme-substrate complex. The side chains of both H48 and E87 also contribute to optimal 
orientation of the D-arginine substrate and its -amino group and the solvent in the active site of 
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the enzyme. This study demonstrated restricted movements of protons that are relevant to 
catalysis have been observed in a flavoenzyme that oxidizes -amino acids, both in the wild-type 
species with a non-preferred substrate and in mutated variants with the physiological substrate. 
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4 FUNCTIONAL ANNOTATION OF A PRESUMED NITRONATE 
MONOOXYGENASE REVEALS A NEW CLASS OF NADH:QUINONE 
REDUCTASES 
(This chapter has been published verbatim in Ball J., Salvi F., and Gadda G., (2016), J Biol 
Chem, 291(40), 21160-21170) 
4.1 Abstract 
The protein PA1024 from Pseudomonas aeruginosa PAO1 is currently classified as 2-
nitropropane dioxygenase, the previous name for nitronate monooxygenase in the GenBankTM 
and PDB databases, but the enzyme was not kinetically characterized. In this study, PA1024 was 
purified to high levels and the enzymatic activity was investigated by spectroscopic and 
polarographic techniques. Purified PA1024 did not exhibit nitronate monooxygenase activity; 
however, it displayed NADH:quinone reductase and a small NADH:oxidase activity. The 
enzyme preferred NADH to NADPH as a reducing substrate. PA1024 could reduce a broad 
spectrum of quinone substrates via a Ping Pong Bi-Bi steady-state kinetic mechanism, generating 
the corresponding hydroquinones. The reductive half reaction with NADH showed a kred value of 
24 s-1 and an apparent Kd value estimated in the low µM range. The enzyme was not able to 
reduce the azo dye methyl red, routinely used in the kinetic characterization of azoreductases. 
Finally, we revisited and modified the existing six conserved motifs of PA1024, which define a 
new class of NADH:quinone reductases and are present in more than 490 hypothetical proteins 
in the GenBankTM, the vast majority of which are currently misannotated as nitronate 
monooxygenase. 
4.2 Introduction 
The discrepancy between the rapid increase in the number of sequenced genomes of 
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prokaryotes and the slower experimental determination of protein function has resulted in the 
presence of a large number of hypothetical proteins in the databases, with gene function 
prediction oftentimes unreliable (1,2). One case of an enzyme family consisting mainly of 
hypothetical proteins is represented by the nitronate monooxygenases (NMOs, E.C. 1.13.12.16), 
which includes >5000 genes in the GenBankTM. NMOs are FMN-dependent enzymes that 
catalyze the detoxification of propionate 3-nitronate (P3N), a metabolic poison produced by 
plants and fungi as a defense mechanism against herbivores (3). The kinetic mechanism of NMO 
has been investigated in previous studies on the fungal enzymes from Neurospora crassa (4)  
and Cyberlindnera saturnus (previously known as Williopsis saturnus) (5). The recent structural 
and kinetic characterization of the gene product PA4202 from Pseudomonas aeruginosa PAO1 
as PaNMO identified four motifs that establish Class I NMO, with 500 sequences from bacteria, 
fungi, one insect and one animal (6). Class I NMO oxidizes the anionic nitronate form of the 
substrate, whereas Class II NMO can oxidize both the neutral and anionic forms of P3N (6). P. 
aeruginosa PAO1 possesses two other genes coding for hypothetical NMOs, namely pa0660 and 
pa1024; however, these proteins do not carry the four motifs characteristic of Class I NMO nor 
any of the motifs signature of Class II NMO, raising the possibility that they code for enzymes 
with different function. While there is no experimental evidence at transcript or protein levels for 
the gene product PA0660, a crystal structure for the hypothetical protein PA1024 is available for 
the enzyme in free form and in complex with 2-nitropropane (PDB codes 2GJL and 2GJN) at 2.0 
and 2.3 Å resolution, respectively (7). The protein PA1024 is currently classified as 2-
nitropropane dioxygenase, a previous name for NMOs, based on the gene function prediction 
(~32% sequence identity) and a qualitative enzymatic assay performed with 20 mM 2-
nitropropane at pH 6.5 (7). Nonetheless, the kinetic parameters with 2-nitropropane were not 
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determined, and the physiological substrate P3N was not tested, because it was unknown at the 
time of the study. The structural characterization of PA1024 previously highlighted six motifs 
conserved in other hypothetical proteins similar to PA1024 (7), which are different from the four 
motifs described for Class 1 NMO (6). 
In the present study, we have cloned from genomic DNA the gene pa1024, purified the 
His-tagged recombinant PA1024, and characterized the spectral and kinetic properties of the 
enzyme. We demonstrated that purified PA1024 does not exhibit NMO activity. The enzyme 
belongs to an operon that contains two acyl-CoA dehydrogenases, an acyl-CoA 
hydratase/isomerase, a short chain dehydrogenase, and a porin (all hypothetical).  All of these 
enzymes together imply the operon plays a role in β-oxidation. Based on the genomic context of 
PA1024, we hypothesized the enzyme oxidizes NAD(P)H to NAD(P)+ to maintain a favorable 
[NADH]/[NAD+] ratio, since it has been observed that a low ratio stimulates β-oxidation (8,9). 
The connection between the [NADH]/[NAD+] ratio and β-oxidation is assumed to be due to the 
cofactor requirement of NAD+ for 3-hydroxyacyl-CoA dehydrogenases, which catalyze the third 
step in β-oxidation (10).  We also hypothesized the reduced enzyme is oxidized by quinones 
since they are prevalent redox agents in nature (11,12). To investigate this hypothesis, we 
experimentally tested NADH, NADPH, and various quinones for catalytic activity. Furthermore, 
we reanalyzed and modified the conserved motifs identified by Ha et al. in the protein sequence 
of PA1024 (7), and showed that they are present in more than 490 sequences in the non-
redundant protein database.  The results reinforce the need for accurate experimental data on 
select hypothetical proteins to work in concert with computational methods for improved gene 
function prediction. 
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4.3 Results 
4.3.1 Protein purification 
The gene pa1024 was cloned from the genomic DNA of P. aeruginosa PAO1 in the 
expression vector pET20b(+), with the addition of a His-tag at the C terminus of the recombinant 
protein. The recombinant protein PA1024 was expressed in Escherichia coli and purified to high 
yield by affinity chromatography. The presence of 200 mM NaCl in a storage buffer composed 
of 20 mM TRIS-Cl, pH 8.0, 10 % v/v glycerol, was necessary for the in vitro stability of purified 
PA1024. SDS-PAGE analysis of the purified protein estimated a high level of purity. 
4.3.2 Spectral properties 
The UV-visible absorption spectrum of purified PA1024 shows maxima at 370 and 461 
nm (Figure 4.1), which are consistent with the presence of FMN as a cofactor, as previously 
demonstrated in the crystal structure of PA1024 (PDB code 2GJL) (7) (Figure 4.2). The flavin 
cofactor extracted by heat denaturation was released to the bulk solvent, indicative of a non-
covalent attachment of FMN to the protein, which is also in agreement with the crystal structure 
of the enzyme. The molar ratio FMN/enzyme was ~0.9, consistent with a 1:1 stoichiometry per 
monomer of protein. The enzyme-bound flavin emitted light at 545 nm when excited at 461 nm, 
with an intensity equivalent to ~10% that of an equimolar concentration of FMN in solution 
(Figure 4.1). 
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Figure 4.1 UV-visible absorption spectrum of the gene product PA1024.  Inset, solid line, fluorescence emission spectrum when the low energy band of the FMN-bound to PA1024 is excited; dashed line, fluorescence emission spectrum when the low energy band of the free FMN is excited. Buffer conditions: 20 mm Tris-Cl, pH 8.0, 200 mm NaCl, 10% v/v glycerol, at 25 °C.  
 
Figure 4.2 Surface depiction and active site of PA1024. A, surface depiction of the three-dimensional structure of PA1024. FMN is shown as yellow sticks. Water molecules are represented by red circles. B, FMN locus of PA104 with select residues.  
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4.3.3 Lack of nitronate monooxygenase activity 
Nitronate monooxygenase activity was tested at pH 7.5 and atmospheric oxygen, i.e. 230 
µM, as previously described (5,6,13), to determine the validity of the previous classification of 
PA1024 as an NMO. No enzymatic activity was detected with 1 mM P3N or 3-NPA.  No 
enzymatic activity was detected with 20 mM nitroethane, 1-nitropropane, 2-nitropropane, nor the 
anionic forms ethylnitronate, propyl-1-nitronate, and propyl-2-nitronate. In the case of propyl-2-
nitronate and ethylnitronate, velocities of 16 and 5 µM oxygen consumed per minute were 
detected, which would correspond to enzymatic rates of 1 and 0.5 s-1 with 180 nM enzyme. 
However, the same velocities were detected by incubating propyl-2-nitronate or ethylnitronate in 
the reaction buffer without PA1024, and they therefore represent non-enzymatic reactions. The 
activity reported by Ha et al was thus likely due to the non-enzymatic reaction of propyl-2-
nitronate with oxygen.   
4.3.4 Reducing substrate 
The operon where PA1024 is found suggests that PA1024 could serve to regenerate 
NAD(P)+ for use by fatty acid oxidizing enzyme(s) also found in the operon. To evaluate the 
reduction of PA1024 by NAD(P)H, the reduction of the FMN cofactor was followed by 
monitoring the decrease in absorbance at 461 nm under anaerobic conditions at pH 7.0 and 25 
°C, with the use of a stopped-flow spectrophotometer. The enzyme was fully reduced with 
NADH in a biphasic pattern (Figure 4.3).  
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Figure 4.3 Reduction of PA1024 by NADH. A, anaerobic reduction with 500 μm NADH of PA1024 in 20 mm potassium phosphate, 200 mm NaCl, pH 7.0, at 25 °C. B, observed rate constants of the first phase as a function Note the log time scale on the x axis. The dead-time of the instrument was 2.2 ms. 
The fast phase, which accounts for more than 95% of the total change in absorbance at 461 nm, 
was assigned to flavin reduction. A slow phase accounting for less than 5% of the total change in 
absorbance at 461 nm was seen, with a substrate concentration-independent kobs value of 1 s-1. 
The latter phase, which was considerably slower than the kcat values determined with various 
quinone substrates (see below), could be due to a fraction of the enzyme being damaged. The fast 
phase of flavin reduction was analyzed with Eq. 2, demonstrating that the enzyme was fully 
saturated with NADH from 90 to 500 µM, with a kred value of 24 ± 1 s-1. An accurate Kd value 
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was not determined because it was not possible to lower NADH below 90 µM in order to 
maintain pseudo first-order conditions. However, the observation that the enzyme was fully 
saturated with 90 µM NADH suggests a Kd value in the 5 µM range or lower. When the enzyme 
was anaerobically mixed with 500 µM NADPH, there was slow reduction of the enzyme-bound 
flavin over 10 min, with an estimated rate constant of 0.0074 ± 0.0006 s-1. Thus, NADH is the 
preferred reducing substrate of PA1024. 
4.3.5 Oxidizing substrates 
Quinones were selected as potential oxidizing substrates based on their powerful 
oxidizing ability and pervasive nature in the cell. Turnover of PA1024 was monitored with a 
quinone as the oxidizing substrate and NADH as the reducing substrate at pH 7.0 and 25 °C. 
PA1024 turned over with a number of different quinones and the apparent steady-state kinetic 
parameters were determined at a fixed, saturating concentration of 100 µM NADH. As shown in 
Table 4.1, benzoquinone and 5,8-dihydroxy-1,4-naphthoquinone were the best substrates for the 
enzyme based on the kcat/Km value. Naphthoquinone substrates with hydroxyl groups on the 
aromatic ring of the naphthoquinone showed the highest kcat/Km values for the bi-cyclic series. 
The kcat/Km values plotted against the one-electron reduction potentials did not show a linear 
relationship (data not shown). 
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 Table 4.1 Apparent steady-state kinetic parameters of PA1024 with various electron acceptors.  
Electron acceptor appkcat/Km (M-1 s-1) appkcat (s-1) appKm (µM) 1,4-Naphthoquinones    5,8-dihydroxy- 1,500,000 ± 100,000 14 ± 1 10 ± 1 5-hydroxy- 1,200,000 ± 100,000 17 ± 1 14 ± 2 2-methyl-5-hydroxy-    920,000 ± 120,000 16 ± 1 18 ± 3 2-methyl-  270,000 ± 10,000 16 ± 1 60 ± 5 2-methoxy-  30,000 ± 3,000   6 ± 1 185 ± 40 2-hydroxy- nda  nda nda     1,4-Benzoquinones    benzoquinone 1,900,000 ± 130,000 27 ± 1             15 ± 1 2-methyl-5,6-dimethoxy- (Q0)  350,000 ± 30,000 24 ± 1   70 ± 10 2,6-dimethoxy-  100,000 ± 20,000  ndb                ndb 2,3,4,6-tetramethyl-    80,000 ± 10,000 28 ± 3           355 ± 75 The kinetic parameters were determined with 100 µM NADH in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. aEnzymatic activity not detected; bkcat or Km not determined because unable to saturate with substrate 
 
4.3.6 Steady-state kinetic mechanism with 5-Hydroxy-1,4-naphthoquinone 
The traditional approach to obtain the steady-state kinetic mechanism of varying both 
NADH and quinone concentrations yielded overlapping lines in a double reciprocal plot (data 
not shown), likely due to NADH being saturating at all concentrations used. Consequently, the 
product inhibition pattern using NAD+ and 5-hydroxy-1,4-naphthoquinone as a substrate was 
used to establish the steady-state kinetic mechanism of PA1024. 5-Hydroxy-1,4-naphthoquinone 
was chosen for its occurrence and importance in nature (14), and because of its high kcat/Km value 
(Table 1). A double reciprocal plot of the initial rate of reaction versus the substrate 
concentration yielded lines converging on the y-axis (Figure 4.4), consistent with 5-hydroxy-
1,4-naphthoquinone and NAD+ binding to the same form of enzyme.  This, in turn, is in line with 
a Ping-Pong Bi-Bi steady-state kinetic mechanism, as illustrated in Scheme 4.1. The Kis for 
NAD+ was determined to be 2.2 mM. 
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Figure 4.4 Lineweaver-Burk plots of product inhibition of PA1024 by NAD+. Buffer conditions: 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. NADH was kept at a fixed, saturating concentration of 100 μM, and 5-hydroxy-1,4-NQ varied from 2 to 17 μM. Each line represents a different concentration of NAD+: ●, 0 mM; ○, 0.4 mM; ▴, 1.2 mM; and 
▵, 3 mM.  
  Scheme 4.1 Steady-state kinetic mechanism of PA1024 with 5-hydroxy-1,4-napthoquinone as substrate.  
4.3.7 Quinone mode of reduction 
To assess if the reduction of the quinones catalyzed by PA1024 occurs through a single- 
or two-electron transfer from the enzyme-bound flavin, the obligatory one-electron transferring 
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protein Cyt c was employed as a reporter. A single-electron flux, as defined by Iyanagi (15), is 
the coupled Cyt c reduction rate (v) divided by the doubled NADH oxidation rate (2v). The 
single-electron flux can have a value of 1 or lower, depending upon whether the reaction of 
PA1024 with the quinone occurs via a single- or a two-electron transfer. As shown in Figure 4.5, 
all quinones tested had single-electron fluxes considerably lower than unity, ruling out a pure 
single-electron reduction of the quinone being catalyzed by PA1024. 
 
Figure 4.5 Single electron flux for quinone reduction by PA1024. Values are expressed as the ratio of coupled Cyt c reduction rate divided by the doubled NADH oxidation rate. The dashed line represents the theoretical limit for a one-electron quinone reductase. Experiments were performed in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. The concentration of each quinone was saturating (if possible), and NADH was held at a fixed, saturating concentration of 100 μM. BQ, benzoquinone; NQ, naphthoquinone.  
In an independent experiment, the initial rates of the coupled Cyt c reduction were 
measured in the absence and presence of SOD, since in the latter case a roughly 50% decrease in 
the rate of reaction would be expected if quinone reduction by PA1024 occurred through a 
single-electron reaction. As illustrated in Table 4.2, in all cases except 2,6-dimethoxy-1,4-
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benzoquinone2, the initial rates for the coupled Cyt c reduction catalyzed by PA1024 were equal 
or lower than 50% in the presence of SOD, further ruling out a single-electron reaction of 
PA1024 with the quinone substrates. 
Table 4.2 Rate constants for the coupled Cyt c reduction by PA1024 with various quinones in the presence or absence of SOD.  
Electron acceptor Coupled Cyt c reduction (s-1)  Coupled Cyt c reduction + SOD (s-1) 1,4-Naphthoquinones     2-methyl-5-hydroxy- 20.0 ± 1.5   7.5 ± 0.3 5-hydroxy- 22.1 ± 1.1 11.1 ± 1.2 2-methyl- 13.0 ± 0.3   4.6 ± 0.1 5,8-dihydroxy- 14.5 ± 0.3   7.0 ± 0.3 2-methoxy-   4.6 ± 0.2   2.1 ± 0.1    1,4-Benzoquinones   benzoquinone 0.9 ± 0.1   nd 2,6-dimethoxy- 9.3 ± 0.9    6.7 ± 0.2 2-methyl-5,6-dimethoxy- (Q0)  3.8 ± 0.2   1.4 ± 0.1   2,3,5,6-tetramethyl- 0.9 ± 0.2  nd nd: enzymatic activity not detected. The kinetic parameters were determined with 100 µM NADH in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, 25 °C, at a saturating (if possible) concentration of the quinone substrate with or without the addition of superoxide dismutase. 
 
4.3.8 NADH:oxidase activity 
PA1024 displayed an NADH oxidase activity of ~1.0 s-1 at atmospheric oxygen, pH 7.0 
and 25 °C. Addition of catalase to the reaction mixture decreased the rates of oxygen 
consumption by half (data not shown), providing evidence for the production of hydrogen 
peroxide, consistent with PA1024 displaying a small oxidase activity.  
                                                 2The product of this substrate may reduce Cyt c primarily through the hydroquinone form 
of the product and the autoxidation products are a minor reduction pathway, thus SOD exerts less 
of an inhibitory effect.   
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4.3.9 Lack of azoreductase activity 
In order to determine if PA1024 could perform azoreductase reactions, which is a 
common activity shared among most quinone reductases, turnover of PA1024 was monitored 
with the azo dye methyl red at saturating NADH concentration at pH 7.0, 25 °C. No significant 
enzymatic reduction of methyl red was observed over 10 min, indicating PA1024 is not an 
azoreductase. 
4.3.10 Bioinformatics 
In a previous study, Ha et al. identified six consensus motifs in the amino acid sequence 
of PA1024 (7) and annotated PA1024 as 2-nitropropane dioxygenase, the former official name of 
NMO. That study was carried out before the crystal structure of Pa-NMO (PA4202) was 
available (6), which established Class I NMO. A reanalysis of the conserved motifs of PA1024 
based on the comparison of the active site residues of the two enzymes, PA1024 and Pa-NMO, in 
addition to a comprehensive PHI-BLAST search was carried out here, identifying small changes 
in the six motifs originally reported (Table 4.3). A PHI-BLAST search of the six consensus 
motifs of PA1024 recognized ~500 (erroneously annotated) hypothetical proteins that share these 
motifs, the bulk of which come from bacterial sources and are currently annotated as NMOs. The 
complete list of the genes and the PHI-BLAST search parameters can be found in the 
supplemental data at http://www.jbc.org/content/291/40/21160/suppl/DC1. 
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Table 4.3 Conserved motifs in the protein sequence of PA1024.  
Motif Consensus sequence 
Ib 17P-[I/V]-h-Q-G-G-M-Q-W-[V/I]26 
IIa 66T-D-[K/R]-P-F-G-V-N-L-T-h-[L/F]-P78 
IIIb 121[V/I]-h-H-K-C-T-X-[V/I]-R-H-A131 
IVb 144I-D-G-F-E-C-[A/G]-G-H-P-G-E-X-D-X-[P/G/T]159 
Vb 177A-S-G-G-h-[A/G]-[D/E]-[A/G]-R-G-L-h-A-A-[L/F]-A-L-G-A-[D/E]-[G/A]-h-X-M-G-T-R-F204 
VIb 225E-X-X-[T/S]-X-L-h-X-R-X-[L/M/W]-[R/H/K]-N-T-[S/A/V]-R-V241 
VII 85Y-A-E-Y-R-X-[A/V]-I-[I/V]-E-X-G-h-X-[I/V]-V-E-T-A-G-X-X-P-X-[E/D]-H110 
The numbering of the residues refers to the protein sequence of PA1024; the brackets identify alternative residues that can be present in that position, h represents a position occupied by a hydrophobic residue, while X represents a position where any amino acid is accepted. aMotif was identified in a previous study by Ha et al. (7). bMotif was identified in a previous study by Ha et al. (7) and modified in this study. The modifications to the consensus sequence are underlined.  
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4.4 Discussion 
Recent advances in the efficiency and speed of gene sequencing coupled to a 
comparatively much slower pace of acquiring experimental evidence for protein function has 
given rise to a large number of hypothetical or erroneously annotated proteins in the databases 
(1,2). An example of a family of enzymes with a sizable amount of hypothetical proteins in the 
database is the nitronate monooxygenases (NMOs), with over 5000 genes in the GenBankTM 
currently annotated as NMO. The present study aimed to characterize PA1024, one of the three 
genes encoding a hypothetical NMO in Pseudomonas aeruginosa PAO1. The current 
classification of PA1024 is based on a 2006 study (7), but the enzyme does not carry the 
consensus motifs characteristic of the recently defined Class I and Class II NMOs (6). The 
biochemical and kinetic characterization of PA1024 presented herein show that the enzyme 
indeed is not an NMO, as indicated by the lack of oxygen consumption with propionate-3-
nitronate and other nitronates. The enzyme, instead, uses NADH and quinones as reducing and 
oxidizing substrates, respectively. Thus, PA1024 should be reclassified as an NADH:quinone 
Reductase (E.C. 1.6.99.5), along with ~500 genes that contain the consensus motifs identified in 
PA1024. 
PA1024 efficiently uses NADH as a reducing substrate; the enzyme was fully reduced by 
NADH with a kred value of 24 s-1 and a Kd value estimated in the low µM range (Figure 4.3). 
PA1024 displayed a marked preference for NADH over NADPH, as indicated by the fact that 
flavin reduction with 500 µM NADPH is ~3,500 times slower than with an equivalent 
concentration of NADH. Preference for NADH as a substrate was previously reported for some 
flavin-dependent monooxygenases (16), FMN-dependent quinone reductases in bacteria, such as 
tryptophan [W] repressor-binding protein (WrbA) (17), and the FMN-dependent azoreductases 
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AzoA (18), AcpD (19), and AzoR (20). In the case of PA1024, the structural determinants for 
NADH specificity are currently unknown, and future crystallographic studies of the enzyme in 
complex with the product NAD+ will be required for their elucidation.  
PA1024 catalyzes the reduction of various quinone substrates as shown in Table 4.1. The 
enzyme prefers benzoquinone, but naphthoquinones carrying hydroxyl groups in the 5 or 8 
positions are also good substrates, as indicated by the large kcat/Km values determined with these 
substrates. Addition of methyl groups on the benzoquinone ring or methoxy groups in the 2 
position results in a significant decrease in the kcat/Km value, possibly due to increased steric 
constraints for the formation of a catalytically competent enzyme-substrate complex. 
Interestingly, PA1024 does not react when the hydroxyl group is in the 2 position of the 
naphthoquinone substrate. Non-reactivity with 2-hydroxy-1,4-napthoquinone is in stark contrast 
to Enterococcus cloacae nitroreductase, which shows a marked preference for this substrate (21).  
PA1024 reduces quinones to the hydroquinone form through a two-electron mechanism. 
Two lines of evidence support this conclusion. First, single-electron fluxes considerably smaller 
than 1 were obtained with a number of quinone substrates when the obligatory one-electron 
acceptor Cyt c was used in a coupled enzymatic assay (Figure 4.5). In this context, a single-
electron flux is the ratio of the rate constant for Cyt c reduction to the doubled rate constant for 
NADH oxidation (15). The data rule out the alternative possibility of a single-electron reduction 
of the quinones by the enzyme-bound flavin of PA1024, since if this were the case single-
electron fluxes of 1 would have been observed. The different single-electron fluxes determined 
with the various quinone substrates tested can be reconciled with their autoxidation rates, which 
were previously shown for naphthohydroquinones to follow the order of 5-hydroxy > 2-methoxy 
> 2-methyl > unsubstituted hydroquinone (22). In essence, hydroquinones that are more prone to 
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non-enzymatic autoxidation can indirectly reduce Cyt c at faster rates through the products of 
autoxidation. The effect of SOD on the enzymatic activity of the enzyme in the Cyt c coupled 
assay provides independent evidence for quinone reduction to the hydroquinone rather than the 
semiquinone state. With all quinone substrates tested except 2,6-dimethoxy-1,4-benzoquinone, 
the presence of SOD decreased the initial rates for the coupled Cyt c reduction catalyzed by 
PA1024 by 50% or more (Table 4.2). In the presence of Cyt c, if a semiquinone radical were 
produced in the quinone reduction catalyzed by PA1024 it would redox cycle without reducing 
oxygen and bypass superoxide formation (23). This property explains the ability to significantly 
inhibit the coupled Cyt c reduction by a 2-electron reductase with SOD, but not a 1-electron 
reductase, and the latter phenomenon has been observed in studies with ferric reductase B from 
Paracoccus denitrificans (23). Additional evidence of a two-electron reduction comes from the 
kcat/Km values, which did not show a linear relationship with the one-electron reduction potentials 
and were sensitive to the structure of the substrate. The last two features are common amongst 
most two-electron quinone reductases (21,24).  
The two-electron reduction of quinones by PA1024 occurs through a Ping-Pong Bi-Bi 
steady-state kinetic mechanism, as demonstrated by the competitive inhibition pattern observed 
between NAD+ and the quinone substrate (Figure 4.4). NAD+ must first leave the reduced 
enzyme before the quinone can bind, and the napthoquinone and NAD+ compete for the reduced 
free enzyme (Scheme 4.1). All known two-electron flavin-dependent NAD(P)H:quinone 
reductases operate via a Ping-Pong Bi-Bi mechanism (25). This is likely due to the requirement 
for both reducing and oxidizing substrates to alternately position close to the flavin for the 
transfer of a hydride in the reductive and oxidative half-reactions catalyzed by NADH:quinone 
reductases (26). 
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With benzoquinones, flavin reduction is fully rate-limiting for the overall turnover of the 
enzyme. Evidence for this conclusion comes from the comparison of the limiting rate constant 
for flavin reduction (kred) and the kcat value that define turnover at saturating concentrations of 
both substrates, showing similar values of 24-28 s-1. In contrast, with all naphthoquinones used, 
flavin reduction is partially rate-limiting for the overall turnover of the enzyme, as indicated by 
the kred value being significantly larger than the kcat values. This may reflect a slower rate 
constant for the release of the product of the reaction for the bulkier naphthoquinones compared 
to the smaller benzoquinones.  
The Kis value for NAD+ of ~2 mM is at least 400 times larger than the Km value for 
NADH. This substantial difference is consistent with an unfavorable interaction of the positively 
charged NAD+ in the active site of the enzyme as compared to the neutral NADH. The 
crystallographic structure of PA1024 (PDB 2GJL) shows the presence of the side chain of K124 
at ~4 Å from the N1-C2 locus of the flavin (Figure 4.2B), allowing us to speculate that this 
residue may be responsible for NAD+ binding being weaker than NADH due to electrostatic 
repulsion.  
PA1024 has a small NADH oxidase activity, with a turnover rate of ~1 s-1 at saturating 
NADH concentration and atmospheric oxygen. This indicates that the NADH oxidase activity is 
likely not the primary function of PA1024. Slow oxidase activity has been observed in the case 
of NADH:quinone oxidoreductases (27), chromate reductase (28),  flavin-dependent 
monooxygenases (uncoupling) (16), and old yellow enzyme (OYE) (29,30). In contrast to 
PA1024, FAD-dependent NAD(P)H:quinone oxidoreductase 1 (NQO1) and the quinone 
reductase Lot6p are not oxidized by molecular oxygen (25). In PA1024, the presence of a 
positive charge near the N1-C2 locus of the flavin, i.e., on the side chain of K124, may 
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contribute to the small oxidase activity observed, as in the case of several other flavin-dependent 
oxidases (31). 
The UV-visible absorption spectrum of purified PA1024 in Figure 4.1 displays the 
characteristic flavin signature, but the low-energy band of the cofactor at 461 nm is significantly 
red shifted compared to free FMN (450 nm) and to Pa-NMO (443 nm) (6). A large red shift in 
the low-energy peak is a feature usually indicative of a more polar protein environment around a 
flavin cofactor (32,33). Accordingly, in the crystal structure of PA1024 (7) there is a polar T75 
located 3.8 Å from the N3 atom of FMN, while in the same position in Pa-NMO (PDB 4Q4K) 
there is the hydrophobic F71 at 3.6 Å from N3 atom of FMN (6). Furthermore, the flavin in 
PA1024 is exposed to the solvent (Figure 4.2B), which could contribute to additional hydrogen 
bond interactions with water. The fluorescence emission peak of PA1024 upon exciting the 
enzyme-bound flavin at 461 nm demonstrates a significant red shift to 543 nm and is only 10 
times less fluorescent than FMN free in solution (Figure 4.1 inset). 
Enzymes with NAD(P)H:quinone reductase activity were recently reported from bacteria 
with the ability to detoxify azo dyes from the environment (34-36). Convergent evolution of 
azoreductases and quinone reductases has been proposed based on similar reaction mechanisms 
involving the flavin-mediated reduction of an organic molecule with NAD(P)H and substrate 
scope (37,38). The lack of enzymatic activity with the azo dye methyl red indicates that PA1024 
is not an azoreductase. Although there are several azoreductases from P. aeruginosa capable of 
reducing quinones (38), WrbA is the only other two-electron NAD(P)H:quinone reductase 
identified to date that does not possess azoreductase activity (39) beside PA1024. 
PA1024 is a novel NADH:quinone reductase as illustrated below. The enzyme shares 
little overall sequence similarity to the well-characterized human NQO1 and FAD-dependent 
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NAD(P)H:quinone oxidoreductase 2 (NQO2), with only 20% and 19% identity in its amino acid 
sequence, respectively. As shown in Figure 4.6, which compares the active sites of the three 
enzymes, there are prominent differences in the active site frameworks of the three enzymes.  
 
Figure 4.6 Comparison of the active sites of PA1024, NQO1, and NQO2. FMN or FAD carbon atoms are in yellow sticks, and the side chain residue carbons are in cyan sticks. A, PA1024 (PDB 2GJL). B, NQO1 (PDB 1QBG) (66). C, NQO2 (PDB 1QR2) (67).  
A major difference is the presence of H152 above the flavin of PA1024 and S288 near the C7/C8 
methyls of the flavin, both of which are absent in the NQOs. Also, K124 is located near the N1 
of PA1024, as opposed to T148 residue in the NQOs. Notably a M23 is positioned behind the re 
face of the flavin in PA1024, whereas a hydrophilic residue is present in NQO1 and NQO2. 
Similarities include the presence of a tryptophan below the flavin, and hydrophilic residues near 
the N1-C2(O) locus of the flavin. Besides the active site, PA1024 displays several differences 
with respect to mammalian NQOs. First, PA1024 contains FMN while the mammalian NQOs 
use FAD (7,25). Second, PA1024 has a clear preference for NADH, whereas NQO1 can utilize 
both NADH and NADPH with similar efficacy, and NQO2 prefers modified derivatives of 
NADH such as dihydronicotinamide riboside (40). Third, PA1024 is unable to reduce azo dyes, 
which are substrates of NQO1 and NQO2 (41-44).   
Comparison of PA1024 with other known NADH:quinone reductases indicates that the 
123 
enzyme is distinct in sequence and structure from those enzymes as well. The overall fold of 
PA1024 is a TIM-barrel, distinguishing it from the flavodoxin-like fold of most 
NAD(P)H:quinone reductases characterized to date (25). As mentioned earlier, very few FMN-
dependent quinone reductases specific for NADH have been identified. Other FMN-dependent 
quinone reductases, which however utilize both NADH and NADPH, have also been identified 
in bacteria, fungi and plants, including Methanothermobacter marbergensis NQO (45), Lot6p 
from Saccharomyces cerevisiae (46), YhdA (47),  FQR1 (48) and NQR (49), among others. It is 
worth noting that other flavin-dependent enzymes with known functions have been shown to 
exhibit NAD(P)H:quinone reductase activity, for example bacterial nitroreductases and glucose 
oxidase (50). Thus, the possibility that the primary function of PA1024 may be different from the 
NADH:quinone reductase activity characterized in this study cannot be excluded.  
The six consensus motifs identified in PA1024 contain critical differences to PaNMO that 
discriminate the reactivity and substrate preference between the two enzymes.   Motif I and V 
may aid in binding the cofactor and possibly modulating the redox potential. Motif II is most 
likely related to the folding of the TIM barrel domain, yet a key difference being the presence of 
T75 in PA1024 as opposed to F71 in PaNMO. Motif III is also a part of the TIM barrel fold since 
all of the residues are not located near the active site, with the exception of the K124 which is 
unique to the PA1024-like class of quinone reductases. Motif IV is located on the surface above 
the active site cavity and may play a role in substrate preference. Motif VI is located in the 
putative substrate binding domain and is completely absent in PaNMO. Most importantly, the 
last part of motif II, motif III, and motif VI of PA1024 are the most helpful in identifying 
significant differences in the two classes of enzymes represented by PA1024 and Pa-NMO. 
NAD(P)H:quinone oxidoreductases have been implicated in the detoxification of 
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quinones within intracellular pools, thereby exerting an antioxidant protective role. This is due to 
the fact that upon a two-electron reduction of quinones to the hydroquinones, the highly reactive 
semiquinones are bypassed, which in turn lowers free radical formation and consequent lipid 
peroxidation, formation of protein adducts, and DNA modifications (51-53). This could be the 
case for PA1024. However, when one considers that the operon containing pa1024 includes 
hypothetical acyl-CoA dehydrogenases, a short chain dehydrogenase, an acyl-CoA 
hydratase/isomerase, and a porin, an alternative speculation is that PA1024 may be required to 
maintain an appropriate [NAD+]/[NADH] ratio for the catabolism of fatty acids in P. aeruginosa 
PAO1. A link between a low [NAD+]/[NADH] ratio and the stimulation of β-oxidation was 
observed previously (8,9). Furthermore, participation of an NADH:acceptor oxidoreductase as a 
physiological partner of a butyryl-CoA dehydrogenase was recently proposed in 
Syntrophomonas wolfei, although the enzyme was not identified (54).  
In summary, the results presented in this study remedy the annotations of close to five 
hundred, mostly bacterial, hypothetical proteins in the databases, and define a new class of 
FMN-dependent quinone reductases with a TIM-barrel fold. There appears to be a widening gap 
between the benchtop and desktop that if left unchecked could potentially cause confusion, 
raising the necessity for computational biochemists and experimentalists to cooperate more 
closely in order to enhance gene function prediction.  The results presented herein also highlight 
the structural diversity among quinone reductases and their deeply rooted evolutionary 
differences in nicotinamide preference and azoreductase activity. The biological significance of 
an NADH:quinone reductase activity is possibly more complex than previously considered, and 
the various effects of quinones and quinone reductases on the cellular setting have yet to be fully 
unraveled. 
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4.5 Experimental procedures 
4.5.1 Materials 
The enzymes XhoI, NdeI, DpnI, calf intestinal alkaline phosphatase (CIP), and T4 DNA 
ligase were from New England BioLabs (Ipswich, MA), Pfu DNA polymerase from Stratagene 
(La Jolla, CA), and oligonucleotides from Sigma Genosys (The Woodlands, TX). Escherichia 
coli strain DH5α was purchased from Invitrogen Life Technologies (Grand Island, NY). E. coli 
strain Rosetta(DE3)pLysS and the expression vector pET20b(+) were from Novagen (Madison, 
WI), QIAprep Spin Miniprep kit, QIAquick PCR purification kit and QIAquick gel extraction kit 
were from Qiagen (Valencia, CA). The genomic DNA of P. aeruginosa PAO1 was a kind gift 
from Dr. Jim Spain, Georgia Institute of Technology, Atlanta, GA. HiTrapTM Chelating HP 5 
mL affinity column was from GE Healthcare (Piscataway, NJ), and isopropyl-1-thio-β-D-
galactopyranoside (IPTG) was from Promega (Madison, WI). Cytochrome c from bovine heart, 
superoxide dismutase, nitroalkanes and quinones were from Sigma-Aldrich (St. Louis, MO). All 
other reagents used were of the highest purity commercially available. 
4.5.2 Cloning 
The gene pa1024 was amplified from the genomic DNA of P. aeruginosa PAO1 by PCR 
in presence of 5% DMSO. The PCR protocol included an initial denaturation step at 95 °C, 20 
cycles of denaturation for 45 s at 95 °C, annealing for 30 s at 56 °C (with the annealing 
temperature progressively decreasing by 0.2 °C at each cycle), extension for 3 min at 72 °C, and 
a final step for 10 min at 72 °C. 
The pa1024 gene amplified by PCR was purified by agarose gel extraction with the 
QIAquick gel extraction kit. The amplicon and the expression vector pET20b(+) were subjected 
to double digestion with NdeI and XhoI and purified with the QIAquick PCR purification kit. 
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After a dephosphorylation step with 0.5 units of calf intestinal alkaline phosphatase for 30 min at 
37 °C the dephosphorylated vector was purified with the QIAquick PCR purification kit and 
ligated to the insert with incubation for 15 h at 16 °C with T4 DNA ligase. A volume of 5 µL of 
the ligation mixtures was used to transform E. coli strain DH5α. The resulting colonies grown at 
37 °C on Luria-Bertani agar plates containing 50 μg/mL ampicillin were screened for the 
presence of the desired insert by DNA sequencing at the Cell, Protein and DNA Core Facility at 
Georgia State University. The DNA sequencing confirmed the correct insertion of the gene in the 
plasmid vector and the absence of undesired mutations. 
4.5.3 Recombinant expression and purification 
E. coli expression strain Rosetta(DE3)pLysS transformed with the construct 
pET20b(+)/pa1024 was used to inoculate 90 mL of Terrific Broth containing 50 µg/mL of 
ampicillin and 34 µg/mL of chloramphenicol, which was incubated at 37 °C for 15 h. One 
aliquot of 8 mL of this culture was used to inoculate 1 liter of Terrific Broth containing 50 
µg/mL of ampicillin and 34 µg/mL of chloramphenicol, which was incubated at 37 °C until it 
reached an optical density at 600 nm of 0.8. IPTG was then added to a final concentration of 200 
µM and the culture was incubated at 18 °C for 20 h. The wet cell paste of 8.5 g, recovered by 
centrifugation, was resuspended in 40 mL of lysis buffer containing 10 mM imidazole, 300 mM 
NaCl, 10% v/v glycerol, 1 mM phenylmethylsulfonyl fluoride, 5 mM MgCl2, 2 mg/mL 
lysozyme, 5 μg/mL DNase, 5 μg/mL RNase, and 20 mM sodium phosphate, pH 7.4. The 
resuspended cells were subjected to several cycles of sonication. The cell free extract obtained 
after centrifugation at 12000 g for 20 min was loaded onto a HiTrapTM Chelating HP 5 mL 
affinity column equilibrated with 10 mM imidazole, 300 mM NaCl, 10% v/v glycerol, and 20 
mM sodium phosphate, pH 7.4. After washing with 10 column volumes of equilibrating buffer, 
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the column was treated with four intermediate steps at 50, 100, 150 and 250 mM imidazole in 
equilibration buffer to remove possible contaminants. PA1024 was eluted with 500 mM 
imidazole in equilibration buffer. The purest fractions based on SDS-PAGE analysis were 
pooled, dialyzed against 20 mM Tris-Cl, pH 8.0, 200 mM NaCl, 10 % glycerol and stored at -20 
°C. 
4.5.4 Spectroscopic studies 
UV-visible absorbance was recorded with an Agilent Technologies diode-array 
spectrophotometer Model HP 8453 PC (Santa Clara, CA) equipped with a thermostated water 
bath in 20 mM TRIS-Cl, pH 8.0, 200 mM NaCl, plus 10 % glycerol at 25 °C. The extinction 
coefficient of purified PA1024 was determined by extracting the FMN cofactor by heat 
denaturation of the enzyme. After removing the denatured protein by centrifugation, the 
concentration of free FMN was determined spectroscopically by using ε450 = 12,500 M-1 cm-1 
(55). The concentration of flavin-bound active enzyme was determined by using the 
experimentally determined extinction coefficient ε461 of 12,400 M-1 cm-1 (this study). The total 
protein concentration was determined using the Bradford method with bovine serum albumin as 
standard (56). Initial rates of enzymatic reaction were normalized for the concentration of 
enzyme-bound flavin. 
Fluorescence emission spectra were recorded in 20 mM TRIS-Cl, pH 8.0, 200 mM NaCl, 
10 % glycerol, at 25 °C, with a Shimadzu model RF-5301 PC spectrofluorometer (Kyoto, Japan) 
using a 1 cm path length quartz cuvette. All fluorescence spectra were corrected with the 
corresponding blanks for Rayleigh and Raman scatterings. For flavin fluorescence, the sample at 
an FMN concentration of 3.2 μM was excited at 461 nm (447 nm for free FMN) and the 
emission scan was determined from 480 to 680 nm. Free FMN was obtained by boiling the 
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native enzyme followed by centrifugation.  
4.5.5 Enzymatic assays 
Reduction of the enzyme-bound flavin with NAD(P)H was carried out anaerobically with 
an SF-61DX2 Hi-Tech KinetAsyst high-performance stopped-flow spectrophotometer 
(Bradford-on-Avon, U.K.), thermostated at 25 ºC. Anaerobiosis of the instrument was obtained 
by overnight incubation with glucose (5 mM)/glucose oxidase (1 µM) in sodium pyrophosphate, 
pH 6.0. The enzyme was passed through a desalting PD-10 column equilibrated with 20 mM 
potassium phosphate, pH 7.0, 200 mM NaCl, transferred in a tonometer and subjected to 20 
cycles of degassing by applying vacuum and flushing with argon. The syringes containing 20 
mM potassium phosphate, pH 7.0, 200 mM NaCl, as buffer, or the substrate NAD(P)H dissolved 
in buffer were flushed for 30 min with ultrapure argon before mounting onto the stopped-flow 
spectrophotometer. To ensure complete removal of traces of oxygen, glucose (2 mM) and 
glucose oxidase (0.5 µM) were present in the buffer, enzyme and substrate solutions. The 
concentration of the substrate NAD(P)H was determined spectrophotometrically at 340 nm with 
the extinction coefficient 6,220 M-1 cm-1 (57). The concentration of the enzyme after mixing was 
15 µM and of NAD(P)H ranged from 90 to 500 µM to maintain pseudo first order conditions.  
Turnover of PA1024 with NADH was monitored with a suitable quinone in 20 mM 
potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. NADH was kept at a constant, saturating 
concentration of 100 µM. Stock solutions of quinones were prepared in 100% ethanol, except 
2,6-dimethoxy-1,4-benzoquinone, which was dissolved in DMSO. The final ethanol or DMSO 
concentration in all reaction mixtures was kept fixed at 1% to minimize possible effects on 
enzymatic activity. Reaction rates were measured by following NADH consumption at 340 nm, 
using ε340 = 6,220 M-1 cm-1 (58). In the case of 2-methyl-1,4-naphthoquinone, 343 nm was 
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followed instead, since its oxidized and reduced forms are isosbestic at this wavelength. The 
coupled Cyt c reduction was monitored by measuring the increase of absorbance at 550 nm using 
an ε550 = 29,500 M-1 cm-1 in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. The 
final concentrations of NADH and Cyt c were saturating at 100 µM and 8.4 µM, respectively.  
For the experiments that compared the NADH oxidation versus the coupled Cyt c reduction, 
assays were done in triplicate in the presence and absence of 330 units of superoxide dismutase 
(SOD). Control reactions were run in the absence of the enzyme for all experiments.  
NADH oxidase activity was monitored on an Oxy-32 oxygen-monitoring system at 
atmospheric oxygen in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0 and 25 oC, by 
following the initial rate of oxygen consumption. Final concentrations of NADH and the enzyme 
were 100 µM and 0.14 µM, respectively. To test whether hydrogen peroxide was produced 
during enzymatic turnover, the rate of oxygen consumption was measured at a fixed substrate 
concentration in the presence and absence of 170 units of catalase. 
The NMO activity assay was performed as previously described (5,6,13,59), following 
the initial rate of oxygen consumption with a Hansatech Instruments computer-interfaced Oxy-
32 oxygen-monitoring system at atmospheric oxygen, i.e., 230 µM oxygen, and 30 °C. Stock 
solutions of nitronates and nitroalkanes were prepared as previously described (5,13). Enzyme 
concentration was 180 nM and substrate concentration was 1 mM for P3N or 3-NPA, and 20 
mM for 2-nitropropane, propyl-2-nitronate, nitroethane, or ethylnitronate. A positive control for 
nitronate monooxygenase activity was performed in parallel with purified Pa-NMO to a final 
concentration of 1.4 nM and 1 mM P3N as previously described (6). 
The azoreductase activity of PA1024 was tested as previously described (19,60), by 
monitoring the reduction of methyl red at 430 nm, using ε430 = 23,360 M-1 cm-1, in 20 mM 
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potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. The final concentrations of NADH, 
methyl red and enzyme were 100 µM, 25 µM, and 0.20 µM. The control reaction run in the 
absence of the enzyme was negligible, consistent with the non-enzymatic reaction between 
NADH and methyl red occurring only at low pH (61). 
4.5.6 Product inhibition of PA1024 with NAD+ 
Product inhibition of PA1024 was carried out using NAD+ as the inhibitor with NADH 
and 5-hydroxy-1,4-naphthoquinone as substrates in 20 mM potassium phosphate, 200 mM NaCl, 
pH 7.0, at 25 °C. The final concentration of NADH was held fixed at 100 µM, whereas 5-
hydroxy-1,4-naphthoquinone concentrations ranged from 2 µM to 17 µM. The concentration of 
NAD+ was kept fixed at 0.4, 1.2, and 3 mM and a set in the absence of NAD+ was included. 
4.5.6.1 Data analysis 
The steady-state kinetic parameters for the enzymatic assays were obtained from the 
fitting of the experimental points to the Michaelis-Menten equation for one substrate using 
KaleidaGraph software (Synergy Software, Reading, PA). Double reciprocal plots were 
constructed for product inhibition patterns using KaleidaGraph, and global analysis was carried 
out using Enzfitter software (Biosoft, Cambridge, U.K.). Stopped-flow traces were fit with the 
software KinetAsyst 3 (TgK-Scientific, Bradford-on-Avon, U.K.) to Equation 1, which 
represents a double-exponential process. A represents the absorbance at 461 nm at time t, B1 and 
B2 are the amplitudes of the decrease in absorbance, kobs1 and kobs2 represent the observed rate 
constants for the change in absorbance, and C is an offset value accounting for the nonzero 
absorbance of the enzyme-bound reduced flavin at infinite time. 
 
A = B1– kobs1t + B2– kobs2t + C                               Eq. 1 
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Concentration dependence of the observed rate constants for flavin reduction was 
analyzed with Equation 2, where S represents the concentration of organic substrate, kred is the 
rate constant for flavin reduction at saturating substrate concentration, and Kd is the apparent 
dissociation constant for substrate binding. 
 
݇୭ୠୱ = ௞౨౛ౚௌ௄ౚାௌ                                  Eq. 2 
 
4.5.7 Bioinformatic analysis 
The analysis of the protein sequence of PA1024 was performed with BlastP  (62), 
selecting the non-redundant protein sequence database. Multiple sequence alignments were also 
created with Clustal Omega (63) and Jalview 2.8 (64). To find hypothetical proteins sharing the 
6 motifs of PA1024, the PHI-BLAST (65) feature was utilized. The modifications to the 
conserved motifs were designed manually based on the multiple sequence alignment generated 
by BlastP, analysis of potential critical residues, and multiple PHI-BLAST reiterations of varying 
patterns. 
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5 PH EFFECTS DEMONSTRATE TWO CATALYTIC REGIMES IN A FLAVIN-
DEPENDENT NADH:QUINONE OXIDOREDUCTASE 
5.1 Abstract 
NAD(P)H:quinone oxidoreductases (NQOs) catalyze the flavin-mediated two electron 
reduction of quinones to hydroquinones using NAD(P)H as an electron donor. NQOs are 
proposed to detoxify quinones by preventing one-electron reductases from reducing the quinone 
to the semiquinone, the latter of which wreaks cellular havoc though chain radical reactions 
resulting in superoxide generation. PA1024 is a recently discovered NQO from Pseudomonas 
aeruginosa with proposed roles in quinone detoxification and maintenance of the cellular 
[NAD+]/[NADH] balance. The present study utilizes pH and viscosity effects on the reductive 
half-reaction and steady-state kinetics of PA1024 to gain additional mechanistic clues on the 
general NQO reaction. The results revealed that PA1024 has two competent, catalytic regimes of 
activity at low and high pH modulated by a separate deprotonation event with pKa ~6. The slow 
and fast regimes of activity may have implications in the P. aeruginosa pH-influenced metabolic 
stress response.   
5.2 Introduction 
The NASA spacecraft STARDUST collected interstellar dust particles in 2004 and 
determined the main class of compounds present were quinone-type molecules, suggesting they 
are some of the most ancient organic molecules in the universe.1 Quinones are cyclic unsaturated 
compounds containing two carbonyl groups either adjacent or separated by a vinylene group in a 
six-membered ring.2 Found in all domains of life from Bacteria to Archaea to Eurkarya3, 
quinones are essential to biological processes such as electron transfer and oxidative 
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phosphorylation4, which utilize ubiquinone (Coenzyme Q10) or some variation of it to carry out 
redox reactions. Quinones can participate in a wide array of chemistry in addition to redox 
catalysis including cycloadditions, halogenations, and radical reactions.5 
NAD(P)H:quinone oxidoreductases (NQOs) catalyze the flavin-mediated two-electron 
reduction of quinones via the oxidation of NAD(P)H. The most well studied member of these 
enzymes is NAD(P)H:quinone oxidoreductase 1 (NQO1). The consensus among the majority of 
the scientific community is the enzyme serves to detoxify quinones through the two electron 
reduction to the hydroquinone, thereby preventing one electron reductases such as cytochrome 
p450 reductase that act on the quinone to produce toxic semiquinone radicals.6-9 On the other 
hand, several quinone-containing drugs are activated upon NQO1 action to become cytotoxic 
such as β-lapachome and mitomycin C.6, 8, 10 The bioactivation of specific quinones by NQO1 
has prompted the development of antitumor and chemotherapeutic compounds incorporating 
quinone moieties.  
An alternative role for these enzymes could entail maintenance of the [NADH]/[NAD+] 
ratio in the cell. The [NADH]/[NAD+] ratio has a significant impact on the ability to break down 
fatty acids, as a low ratio stimulates β-oxidation.11 This role was speculated for a newly 
discovered NQO in Pseudomonas aeruginosa, PA1024, based on the genomic context and 
kinetic specificity for NADH. The operon PA1024 belongs to consists of probable acyl-CoA 
dehydrogenases, a β-hydroxylacyl CoA dehydrogenase, an enoyl-CoA hydratase/isomerase, a 
short chain dehydrogenase, and a porin,12, 13 all of which are proteins typically involved in β-
oxidation. The requirement for NAD+ in β-oxidation stems from the enzyme β-hydroxylacyl 
CoA dehydrogenase.14  
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PA1024 was originally annotated in the GenBankTM and PDB databases as a nitronate 
monooxygenase (NMO), and the highest levels of sequence identity are shared with P. 
aeruginosa NMO and Streptococcus pneumoniae enoyl-acyl carrier protein reductase (FabK) at 
32% and 31%, respectively. Despite the considerable levels of sequence identity and structural 
overlap, subsequent kinetic studies demonstrated PA1024 does not possess NMO nor enoyl-acyl 
carrier protein reductase activity15, 16, but instead the enzyme catalyzes the FMN-dependent 
oxidation of NADH utilizing quinones as electron acceptors (Scheme 5.1)15. Closer inspection of 
PA1024 revealed the active sites of NMO and FabK contain key differences from PA1024 and 
that may explain the divergence in catalytic function.15, 17 
 
Scheme 5.1 Reaction catalyzed by PA1024  
PA1024 shares little sequence similarity (< 25 %) to known flavin-dependent NQOs such 
as eukaryotic NQO118, 19, eukaryotic N-ribosyldihydronicotinamide:quinone reductase 2 
(NQO2)20, lot6p from Saccharomyces cerevisiae7, tryptophan repressor binding protein from 
Escherichia coli (WrbA)9, 21, 22, or Pst2p (protoplasts-secreted 2).23 PA1024 demonstrates a strict 
specificity for NADH with virtually no reactivity with NADPH, and the best quinone substrates 
for the enzyme based on the second order rate constant kcat/Km are 1,4-benzoquinone, 5,8-
dihydroxy-1,4-naphthoquinone and 5-hydroxy-1,4-naphthoquinone.15 The TIM-barrel fold of the 
34 kDa monomer of PA102424 is in contrast to most NAD(P)H quinone oxidoreductases reported 
to date which are typically a dimer in a flavodoxin-like fold.25 
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In the present study we sought to gain insights on the catalytic mechanism through a 
detailed investigation into the effect of pH on the reductive half-reaction and pH and viscosity on 
the steady-state kinetics of PA1024. The pH effects reveal two regimes of catalytic activity for 
the enzyme dictated by a deprotonation event with pKa ~6. The two catalytic regimes are 
discussed in the context of the pH effect on P. aeruginosa virulence. 
5.3 Materials and Methods 
5.3.1 Materials 
Nicotinoamide adenine dinucleotide reduced (NADH) was from VWR (Randor, PA). 
1,4-benzoquinone, 5-hydroxy-1,4-naphthoquinone, sucrose, glucose, glucose oxidase, and 
piperazine were from Sigma-Aldrich (St. Louis, MO). Sodium chloride, sodium phosphate and 
sodium pyrophosphate were from Fischer Scientific (Fairlawn, NJ). PA1024 was prepared as 
described previously.15 All other reagents used were of the highest purity commercially 
available.  
5.3.2 Enzymatic Assays 
All assays were conducted in buffer consisting of 20 mM sodium phosphate, sodium 
pyrophosphate, or piperazine (depending on the pH) and 200 mM sodium chloride at 25 oC. The 
reduction of enzyme-bound FMN by NADH was monitored at 461 nm on a SF-61DX2 Hi-Tech 
KinetAsyst high-performance stopped-flow spectrophotometer (Bradford-on-Avon, U.K.), 
thermostatted at 25 ºC. Anaerobiosis of the instrument and all buffers, substrate, and enzyme 
solutions was achieved according to published procedures.15 The concentration of the substrate 
NADH was determined using the extinction coefficient at 340 nm of  6,220 M-1 cm-1.26 The 
concentration of the enzyme after mixing was 15 µM and of NADH ranged from 90 to 500 µM 
to maintain pseudo first order conditions.   
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The steady-state kinetic parameters of PA1024 were monitored on an Agilent 
Technologies UV-visible Spectrophotometer (Santa Clara, CA) thermostatted at 25 oC in 20 mM 
sodium phosphate, sodium pyrophosphate, or piperazine (depending on the pH) and 200 mM 
sodium chloride.  The reducing substrate was NADH and the electron acceptor was either 1,4-
benzoquinone or 5-hydroxy-1,4-naphthoquinone. Initially, a fixed concentration of 100 µM 
NADH was used across the pH range of 5-11 and variable quinone concentrations ranging from 
4 µM to 200 µM for 1,4-benzoquinone and 12.5 µM to 200 µM for 5-hydroxy-1,4-
naphthoquinone. Because of the requirement for steady-state kinetics where the [S] » [E], 
accurate Km values lower than roughly 10 µM concentration were not measureable. The Km of 
1,4-benzoquinone could only be measured at pHs 5-7.5, and 10-11. The Km for each of these pH 
values for 1,4-benzoquinone was less than 20 µM (data not shown). Because of these 
complications, very little emphasis is put on the Km and kcat/Km values of the quinone substrates. 
To ensure NADH was saturating at all pH values, the steady-state kinetic values were measured 
at varying concentrations of NADH and a saturating concentration for each quinone at the pH 
extremes of 5 and 11. The kinetics at pH 5 demonstrated no dependence on the concentration of 
NADH. Upon determining 100 µM was not sufficient to fully saturate at pH 11, which yielded a 
Km value for NADH of 80 µM, pHs 10.5, 10, 9.5 and 8.5 were assayed at variable NADH 
concentrations and a fixed, saturating quinone concentration of 200 µM  to obtain a Km value for 
NADH and an close estimate of the true kcat values. A limiting value of 30 µM was calculated for 
the Km of NADH at low pH. Consequently, when the apparent steady-state kinetic parameters 
were determined at a fixed concentration of 100 µM NADH and variable quinone concentration 
from pH 5 to 8.5, they approximate about 80% of the true kcat values. Since the values are plotted 
on a log scale, the overall pKa’s and limiting values would be similar if 100% saturation was 
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achieved. Stock solutions of quinones were prepared in 100% ethanol. The final ethanol 
concentration in all reaction mixtures was kept fixed at 1% to minimize possible effects on 
enzymatic activity. Reaction rates were measured by following the disappearance of NADH 
absorption at 340 nm, using ε340 = 6,220 M-1 cm-1.26 Final enzyme concentrations ranged from 
100-200 nM. All steady-state kinetic assays were initiated by the addition of NADH. 
Solvent viscosity effects on steady-state kinetic parameters were measured in 20 mM 
sodium pyrophosphate, 200 mM NaCl at pH 6.0 and 8.5. Glucose and sucrose were investigated 
independently as viscosigens at both pH 6.0 and 8.5. The relative viscosity values at 25 °C were 
calculated according to the reference values at 20 °C from Lide.27 For each set of viscosigen 
concentration, NADH was held constant at 100 µM and 5-hydroxy-1,4-naphthoquinone was 
varied from 10-140 µM. The final enzyme concentration was 140 nM.  
5.3.3 Data Analysis 
The steady-state kinetic parameters were obtained from the fitting of the experimental 
points of the enzymatic assays to the Michaelis-Menten equation for one substrate using 
KaleidaGraph software (Synergy Software, Reading, PA). The pH profiles of the kred values for 
NADH were fit to eq 1, which describes a curve that plateaus to a limiting value (CL) at low pH 
and increases with increasing pH with slope of +1 and plateaus to a limiting value (CH) at high 
pH. The pH profiles of the kcat values for 1,4-benzoquinone and kcat and kcat/Km values for 5-
hydroxy-1,4-naphthoquinone were fit to eq 2, which describes a curve that plateaus to a limiting 
value (CL) at low pH and increases with increasing pH with slope of +1 and plateaus to a limiting 
value (CH) at pH 8-9 to decrease at pH 10-12 with a slope of -1. Eq 2 is also known as a bell-
shaped dependence with an offset at low pH. 
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         Eq. 1 
 
     Eq. 2 
 
Stopped-flow traces were fit using the software KinetAsyst 3 (TgK-Scientific, Bradford-
on-Avon, U.K.) to eq 3, which defines a double-exponential process. A represents the absorbance 
at 461 nm at time t, B1 and B2 are the amplitudes of the decrease in absorbance, kobs1 and kobs2 
represent the observed rate constants for the change in absorbance, and C is an offset value 
accounting for the nonzero absorbance of the enzyme-bound reduced flavin at infinite time. For 
the stopped-flow traces that were triphasic, eq 4 was used, which is similar to eq 3, except an 
additional B3 amplitude and kobs3 are included for the third phase. Concentration dependence of 
the observed rate constants for flavin reduction was analyzed with eq 5, where S represents the 
concentration of substrate, kred is the rate constant for flavin reduction at saturating concentration 
of substrate, and Kd is the apparent dissociation constant for substrate binding. Viscosity effects 
on the kcat values were fit to eq 6; those on the kcat/Km values were fit to eq 7. In these equations 
(k)o and (k)η are the kinetic parameters in the absence and presence of viscosigen, respectively, Ѕ 
is the degree of viscosity dependence, ηrel is the relative viscosity of the aqueous buffered 
solution, and YH is the limiting value of the steady-state kinetic parameter of interest at high 
concentration of viscosigen. Sequence identities reported in the introduction were performed 
with ClustalOmega.28  
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A = B1– kobs1t + B2– kobs2t + C                                                     Eq. 3 
 
A = B1– kobs1t + B2– kobs2t + B3– kobs3t + C                             Eq. 4 
 
݇୭ୠୱ = ௞౨౛ౚௌ௄ౚାௌ                                             Eq. 5 
 
݇୭ୠୱ (௞)೚(௞)ಏ = Ѕ(η୰ୣ୪ − 1) + 1               Eq. 6 
    
݇୭ୠୱ (௞)೚(௞)ಏ = ଵଵା ೊಹ൫ಏ౨౛ౢషభ൯൫ಏ౨౛ౢషభ൯శ ೄ
             Eq. 7 
 
  
5.4 Results 
5.4.1 Reductive half-reaction at pH 8.0 
To evaluate the oxidation of NADH by PA1024, the reduction of the enzyme-bound 
FMN was followed by monitoring the decrease at 461 nm under anaerobic conditions at pH 8.0 
and 25 oC with the use of a stopped-flow spectrophotometer. The stopped-flow traces and 
concentration dependence of NADH for the observed rate constant of flavin reduction, kobs, are 
shown in Figure 5.1 as an example. The enzyme was fully reduced in a triphasic manner with 
the fast phase accounting for 93% of the amplitude change. The slow phases accounted for a 
combined 7 % of the total amplitude change and could be the result of a fraction of damaged 
enzyme. Stopped-flow traces were analyzed with eq 3, and the resulting parameters were fit to eq 
5, demonstrating the enzyme was fully saturated from 90-500 µM NADH, with a kred value of 38 
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± 1 s-1. The Kd value was not measurable because 90 µM was the lowest concentration of NADH 
possible without compromising pseudo-first order conditions; however, the fact that the enzyme 
was fully saturated with 90 µM suggests a Kd value equal to or less than 10 µM.   
 
Figure 5.1 Anaerobic reduction of PA1024 by NADH at pH 8.0. (A) Anaerobic reduction with 90-500 µM NADH of PA1024 at 8.0 and 25 oC. (B) Observed rate constants of flavin reduction as a function of NADH concentration Note the log time scale on the x axis. The dead time of the instrument was 2.2 ms. 20 mM sodium phosphate and 200 mM NaCl were the buffer conditions.  
5.4.2 Effect of pH on the reductive half-reaction 
The pH dependence of the rate constant of flavin reduction, kred, was determined to 
establish relevant ionizations involved in the reductive half-reaction (Figure 5.2). The kred values 
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were determined over a pH range of 6-11 on a stopped-flow spectrophotometer by measuring the 
decrease in FMN absorbance at 461 upon reduction by NADH. The concentration of NADH was 
varied from 90-500 µM at all pHs. Biphasic stopped-flow traces were analyzed with eq 3 and 
triphasic traces were analyzed with eq 4. The resulting parameters were fit to eq 5 to give a kred 
and Kd value. All pH values were biphasic or triphasic in nature with the fast phase accounting 
for more than 90% of the total amplitude change and the NADH Kd was below 90 uM for all pH 
values except pH 11, which gave a measureable Kd value of 140 ± 25 µM. An accurate y-
intercept of zero could be obtained for pH 11, indicating that flavin reduction is irreversible. The 
other pH values may be irreversible as well, but it is not possible to verify since accurate y-
intercepts could not be calculated. 
As shown in Figure 5.2, the kred values showed an offset at low pH and increased with 
increasing pH to a limiting value at high pH. The two catalytic regimes are modulated by a group 
with a pKa value of 6.3 ± 0.2, which is required to be deprotonated for maximal kred. The kred pH 
profile values are listed in the top of Table 1. At all concentrations of NADH in all pHs tested, 
there was no accumulation of a charge transfer band between 500-700 nm, the absence of which 
indicates no detectable formation of a Ered-NAD+ complex29 (data not shown). 
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Figure 5.2 Effect of pH on the kred and kcat of PA1024. (A and B - blue open circles) effect of pH on the kred and (A – solid black circles) effect of pH on the kcat of PA1024 with 1,4-benzoquinone and (B - solid black circles) effect of pH on the kcat with 5-hydroxy-1,4-naphthoquinone.  Assays were carried out in 20 mM sodium phosphate or sodium pyrophosphate (depending on the pH) and 200 mM sodium chloride at 25 oC. NADH was varied from 90 µM to 500 µM. Curves with open blue circles were fit to eq 1. Curves with solid black circles were fit to eq 2.  
5.4.3 Effect of pH on the steady-state kinetics 
The pH-dependences of the steady-state kinetic parameters kcat and kcat/Km were 
determined with 1,4-benzoquinone and 5-hydroxy-1,4-naphthoquinone as substrates to establish 
relevant ionizations of groups involved in the overall catalytic cycle. The kcat and kcat/Km values 
were obtained over a pH range of 5-11 by measuring the decrease in absorbance at 340 nm, 
indicating the oxidation of NADH to NAD+. NADH was held at a constant 100 µM and the 
quinone was varied for the pH range of 5-8.0. NADH was varied and the quinone was held at a 
saturating concentration for the pH range of 8.5-11 (See materials and methods for explanation). 
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All of the pKa values and limiting values for the steady-state kinetics are listed in the bottom of 
Table 5.1. As shown in Figure 5.2, the kcat pH-profile with 1,4-benzoquinone was different from 
the kred pH profile, in that it contained an additional group at high pH required to be protonated 
for maximal kcat. The two groups are distinct as the number of pH unit separation between the 
pair is greater than 2. The group at 6.4 is required to be deprotonated for maximal kcat, whereas 
the group at is 11.0 required to be protonated for maximal kcat, defining an optimal pH of 8.5 for 
the NADH:benzoquinone reductase activity.  
The kcat pH-profile with 5-hydroxy-1,4-naphthoquinone in Figure 5.2B demonstrated a 
bell-shape dependence with an offset at low pH, defining two separate pKas with an optimal pH 
of 8.4. The second pKa seen in both kcat profiles of the quinone substrates was absent in the kred 
pH profile, indicating the second pKa occurs in the oxidative half-reaction; however, the second 
pKa of 11 is not well defined since the highest pH tested was pH 11, thus we cannot definitively 
conclude this pKa is real and cannot elaborate further on the significance of this pKa. The kcat/Km 
pH profile for 5-hydroxy-1,4-NQ shown in Figure S2 of the supplemental information was 
qualitatively similar to the kcat pH profile but displayed large errors due to the barely 
measureable, low µM KM values for the quinone substrate. 4 µM was the lowest quinone 
concentration possible without violating the first requirement of steady-state kinetics, ie; [S] » 
[E]. The fact that the kcat and kcat/Km pH profiles have almost identical shapes establishes these 
two pKas are purely catalytic and not related to any binding event.  
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Table 5.1 pH effects on the kred and kcat of PA1024.           kred (s-1)   Substrate  pKac     (kred)La (kred)Hb NADH   7.3e  11f 44f         kcat (s-1)   Substrate* pKa1d pKa2d   (kcat)La   (kcat)H b 5-H-1,4-NQ  6.4e 11.0e 3f 25f  1,4-BQ  6.9e 11.0e 9f  31f   1,4-BQ: 1,4-benzoquinone; 5-H-1,4-NQ: 5-hydroxy-1,4-naphthoquinone a pH-independent limiting value at low pH b pH-independent limiting value at high pH c Determined by using eq 1 d Determined by using eq 2 e (± 0.1) f (± 1) *NADH was used as the reducing substrate  
5.4.4 Effect of viscosity on the steady-state kinetics 
The effect of viscosity on the kinetic parameters of PA1024 with 5-hydroxy-1,4-
napthoquinone at pH 8.5 was carried out to assess the presence or absence of diffusion-
controlled events during the catalytic cycle. The kcat and kcat/Km values were determined at 
different concentrations of viscosigen on a UV-Visible spectrophotometer by measuring the 
decrease in NADH absorbance at 340 nm. NADH was fixed at 100 µM and the quinone was 
varied. As shown in Figure 5.3A, the effect of glucose on kcat at pH 8.5 was linear with a slope 
of 34 ± 3 %, demonstrating the presence of a diffusion-controlled event in kcat. 
Because the Km for 5-hydroxy-1,4-naphthoquinone was not measurable at pH 8.5 at 
increased relative viscosities, accurate kcat/Km values could not be obtained at different relative 
viscosities for pH 8.5. Thus, the pH was lowered to 6.0 and the effect of glucose was performed. 
For the kcat value, glucose gave a value of 20 ± 2 % (Figure 5.3B). For the kcat/Km value, glucose 
(Figure 5.3C) gave an inverse solvent effect of 77 ± 11 %. The effect of viscosity at pH 11 could 
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not be measured due to an apparent side reaction between glucose with the quinone substrate that 
prevented accurate determination of initial rates. 
 
Figure 5.3 Effect of viscosity on kcat and kcat/Km of PA1024. (A) Effect of viscosity on the kcat of PA1024 at pH 8.5 and 25 oC.  (B) Effect of viscosity on the kcat of PA1024 at pH 6.0 and 25 oC. Panel C. Effect of viscosity on the kcat/Km of PA1024 at pH 6.0 and 25 oC. PA1024 activity was measured at varying concentrations of 5-hydroxy-1,4-naphthoquinone and 100 µM NADH at different concentrations of glucose. The buffer consisted of 20 mM sodium phosphate and 200 mM NaCl. The normalized kcat or kcat/Km values are shown as a function of relative viscosity. Panels A and B were fit to eq 6. Panel C was fit to eq 7. The dashed line with a 
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slope of 1 represents the theoretical limit for a fully diffusion controlled process, whereas the dashed line with a slope of 0 represents a process that lacks diffusion control.  
5.5 Discussion 
The present study aimed to examine to the effect of pH and viscosity on the kinetic 
parameters of PA1024 to gain mechanistic insights on the catalytic cycle. The results indicate 
there are two active states of the enzyme, a slow regime at low pH and a fast regime at high pH, 
which are controlled by the depronation of an enzymatic group with pKa ~7.   The two regimes 
could have implications in the P. aeruginosa pH-influenced stress response. An additional group 
with pKa ~11 is required to be protonated, indicating the oxidative half-reaction concludes with 
protonation of the hydroquinolate, which has been proposed for the prototypical eukaryotic 
NQO1.30 Viscosity effects on the kinetics of PA1024 have been employed to gain additional 
mechanistic clues. The details are discussed below.  
5.5.1 PA1024 possesses two competent pH regimes of catalytic activity 
PA1024 operates over a broad pH range with two catalytic regimes of activity that are 
modulated by the deprotonation of an enzymatic group (Figure 5.2). Evidence of this conclusion 
stems from the effect of pH on the kred and kcat values. The fast regime at basic pH is four fold 
faster than the slow regime at acidic pH. Although this may seem like a small fold increase, even 
small fluctuations in the [NADH]/[NAD+] ratio can have significant effects on various metabolic 
processes.31, 32  
The pH-driven change in the catalytic rate of PA0124 may have implications in P. 
aeruginosa antibiotic resistance and metabolic versatility.  The airway surface liquid (ASL) of 
the lungs have been shown to be acidified in cystic fibrosis (CF) patients, which is a disease that 
primarily afflicts the lungs and dramatically increases susceptibility of P. aeruginosa infection.33, 
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34 The acidification of the ASL results from the impairment of bicarbonate ion transport in CF 
patients.35 Studies have demonstrated that the antimicrobial compounds present in the ASL, 
which are critical components of the host defense mechanism, and various commercial 
antibiotics are rendered ineffective at acidic pH, allowing P. aeruginosa to thrive in acidic 
environments.36-38 Another study demonstrated that biofilm production is enhanced at high pH, 
representing yet another important pH-influenced mechanism by which the bacterium increases 
survival chances.39  We speculate that perhaps at acidic pHs, PA1024 and the bacterium are in a 
resting state, therefore only the slow catalytic regime is required to maintain the 
[NADH]/[NAD+] balance. But as the pH increases to neutral or slightly higher than neutral pHs, 
the bacterium faces more metabolic stress, therefore the fast catalytic regime is employed to 
quickly produce NAD+ in order to upregulate β-oxidation pathways for increased virulence and 
survival.  
5.5.2 Rate-limiting contributions are altered as pH changes 
Comparison of the rate of flavin reduction to the kcat value (Figure 2) indicates flavin 
reduction is the principal rate-limiting step for the overall turnover from pHs 6-7. (Ref lot6p 
paper for comparison) After the deprotonation of group with pKa ~7.3, another step becomes rate 
limiting based on the comparison of kcat and kred values in Figure 5.2. The results of the viscosity 
effects on kcat are consistent with a partially rate-limiting unimolecular step contributing to 
overall turnover, such as the release of the hydroquinone or NAD+. Evidence of this conclusion 
comes from the effect of solvent viscosity on kcat at pH 6.0 and 8.5, which are 20% and 35% 
diffusion controlled, respectively, based on the slopes of the linear plots (Figure 3). However, a 
slow release of the NAD+ is a less likely possibility because there was no accumulation of the 
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Ered-NAD+ complex over 60 secs with excess of NADH, which typically generates a charge 
transfer band in the 500-700 nm region of the visible spectrum.29  
5.5.3 A conformational change may be required to bind the quinone 
A conformational change of the reduced PA1024 may be required to efficiently bind the 
quinone. This conclusion was drawn based on the observation of inverse viscosity effects on the 
kcat/Km values with 5-hydroxy-1,4-naphthoquinone (Figure 5.3C). Inverse viscosity effects have 
been reported for the NAD-malic enzyme, which were accredited to an enzyme conformational 
change that may involve small motions or rotations.40  In the case of choline oxidase, the inverse 
viscosity effects observed were attributed to the movement of a phenylalanine residue acting as 
an oxygen gate. 41 The inverse effect reported here could be the result of a minor conformational 
change to a configuration that favors quinone binding.  
5.5.4 Conclusions 
To summarize, we have employed pH and viscosity effects to elucidate key features of 
the overall catalytic mechanism of PA1024. The overall turnover is principally limited by flavin 
reduction and, to a lesser extent, the release of the hydroquinone product for pHs 5-9, however at 
higher pHs 10-11, presumably the release of the hydroquinone product becomes more rate 
limiting based on the comparison of the reductive half-reaction and steady-state kinetics. The 
enzyme functions with two catalytic regimes that are dictated by the deprotonation of a group on 
the enzyme with pKa ~6 that elicits the fast regime.  
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6 STERIC HINDRANCE CONTROLS THE PYRIDINE NUCLEOTIDE SPECIFICTY 
OF A FLAVIN-DEPENDENT NADH:QUINONE OXIDOREDUCTASE 
6.1 Abstract 
The crystal structure of the NADH:quinone oxidoreductase PA1024 has been solved in complex 
with the reaction product NAD+. The nicotinamide C4 is located 3.6 Å from the FMN N5 atom, 
representing a suitable separation and conformation for hydride transfer. NAD+ is bound at the 
interface of the TIM-barrel domain and the extended domain of the enzyme in a folded 
conformation, with the two ribose groups close to each other. The steric hindrance of the ribose 
of NAD+ and a nearby P78 controls the strict coenzyme specificity for NADH in PA1024. The 
comparison of the structure with that of the ligand-free enzyme revealed a different conformation 
of a short loop (75-86) that retains the NAD+ bound and an unusual interrupted helix that binds 
the pyrophosphate moiety of NAD+. The structure of the PA1024-NAD+ complex contributes to 
ongoing efforts to understand pyridine nucleotide specificity, NAD+ conformational diversity, 
and enzyme active site gates. 
6.2 Statement of importance 
Understanding the coenzyme specificity of nicotinamide-dependent enzymes is crucial to 
the advancement of protein engineering efforts. NADH is a far less expensive than NADPH, and 
many efforts by various research groups are currently underway to alter coenzyme specificity 
towards NADH. The coenzyme specificity in enzymes commonly relies on electrostatics, but 
rarely on steric hindrance as we have reported here for the NAD+-PA1024 complex. The steric 
hindrance of the ribose groups of NAD+ and a nearby P78 in the putative 2’phosphate-binding 
region of NADP+ in the model controls the strict substrate specificity for NADH in PA1024. 
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6.3 Introduction 
Pyridine nucleotides are ubiquitous and important biological molecules that are vital to 
the function of living cells.1 The two primary forms, reduced nicotinamide adenine dinucleotide 
(NADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH), along with their 
oxidized counterparts NAD+ and NADP+, participate in numerous biological processes, 
including among others cellular energy production, mitochondrial functions, calcium regulation, 
oxidative stress, gene expression, immune functions, the aging process, and cell death.2 The 
chemical structures of NADH and NADPH differ only by the presence of an extra phosphate 
group on the 2’hydroxyl of the adenine ribose moiety. NADH is commonly involved in catabolic 
pathways, whereas NADPH serves in anabolic pathways.3 The small structural difference 
between the two molecules of a phosphate versus a hydroxyl group is responsible for eliciting 
different roles for each molecule and the enzymes that catalyze these reactions.  
 A plethora of enzymes with varying functions employ pyridine nucleotides as substrates 
or, more seldom, cofactors. Major classes include, but are not limited to, oxidoreductases, such 
as NAD(P)H quinone oxidoreductases4 (NQOs) and azoreductases;5 reductases, such as 
cytochrome P450 reductases6 and glutathione reductase;7 and dehydrogenases, such as lactate 
dehydrogenase8 and glutamate dehydrogenase.9 These enzymes often show a preference for 
NADH or NADPH; however, among the NQOs, lot6p and NQO1 can utilize both NADH and 
NADPH.10, 11 YhdA from Bacillus subtilis and PA1225 from Pseudomonas aeruginosa are 
NQOs specific for NADPH,12, 13 while AzoA from Enterococcus faecalis and tryptophan 
repressor binding protein (WrbA) are specific for NADH.14, 15 
The most common fold that binds pyridine nucleotides is the βαβαβ motif, also known as 
the Rossmann fold,16, 17 yet other folds have been discovered to bind NAD(P)H, such as the 
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TIM-barrel fold18 and the flavodoxin-like fold.4 The pyridine nucleotide is usually bound to the 
protein in an extended conformation.16 The adenine portion of NAD(P)H typically binds a 
mostly hydrophobic pocket, whereas the pyrophosphate portion binds to the backbone amide 
groups of glycine residues positioned on α-helices or loops. NADPH-specific enzymes 
frequently have insertions of basic residues within the nicotinamide-binding region to bind the 
extra phosphate group, while NADH-specific enzymes have acidic residues positioned to repel 
the additional phosphate on NADPH. Numerous reports describe alteration or switching of the 
specificity of NADPH- and NADH-dependent enzymes through site-directed mutagenesis.19-25 
Despite the wealth of knowledge accumulated, the structural rules governing pyridine 
nucleotides specificity have yet to be fully elucidated. 
PA1024 is a recently characterized FMN-dependent NADH:quinone oxidoreductase that 
demonstrates a strict specificity for NADH.26 The rate of flavin reduction at pH 7.0 with 500 µM 
NADH is 22 s-1, whereas the reaction with an equivalent concentration of NADPH is 3,500 times 
slower.26 A previous study determined the ligand-free structure of PA1024, indicating the overall 
fold of the enzyme is a TIM-barrel fold.27 In the present study, we have solved the crystal 
structure to 2.2 Å resolution of PA1024 in complex with the reaction product NAD+ at pH 7.0. 
The complex reveals the structural basis for the strict NADH specificity of the enzyme and its 
lack of reactivity with NADPH. The results also reveal an active site gate that assumes a 
different conformation in the PA1024-NAD+ complex as compared to the ligand-free enzyme 
structure and an unusual “interrupted helix” that binds the pyrophosphate moiety of NAD+. The 
findings of this study contribute to the overall understanding of nicotinamide coenzyme 
specificity and aid in protein engineering efforts with related enzymes. 
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6.4 Results and Discussion 
6.4.1 Overall structure of the PA1024-NAD+ complex 
PA1024 was co-crystallized with NAD+. The structure was solved in the trigonal space 
group P3121 with one molecule per asymmetric unit by molecular replacement using the 
coordinates of the ligand-free form of PA1024 as the initial search model. The structure was 
refined to Rwork and Rfree values of 15.6% and 20.3%, respectively, to 2.2 Å resolution. The 
resolution cutoff was determined by combining several criteria including CC1/2, 〈I/σ(I)〉, and 
completeness, but not the Rmerge values because they are poorly suited for determining high-
resolution limits.28 The crystallographic data and refinement statistics are summarized in Table 
6.1. The final model of PA1024 in complex with NAD+ (Protein Data Bank - PDB code 6E2A) 
accounts for one polypeptide chain containing 326 residues from G2 to G327, 150 solvent sites 
treated as water oxygens, one FMN molecule, one NAD+ molecule and two glycerol molecules 
in the asymmetric unit. The N-terminal residue M1 and the C-terminal residue V328, as well as the 
C-terminal polyhistidine-tag, were excluded from the final structure due to lack of observable 
electron density. 
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Table 6.1 X-ray diffraction data collection and refinement statistics. Data collection  Space group P3121 a, b, c (Å)  93.38, 93.38, 80.76 α, β, γ (°)  90, 90, 120 Mosaicity (°)   0.64 Resolution range (Å) 80.76 – 2.20 (2.27-2.20) Total No. of observed reflections 133527 (11413) No. of unique reflections 21045 (1789) Completeness (%) 99.9 (100) Redundancy 6.3 (6.4) CC1/2 0.995 (0.684) 〈 I/σ(I)〉  9.6 (2.3) Rmerge  0.137 (0.952) Overall B factor from Wilson plot (Å2)  24.1 Refinement   Refinement resolution range (Å) 40.44 – 2.20 (2.27-2.20) Rwork  0.156  Rfree  0.203  RMS deviations from ideality     Bonds lengths (Å) 0.007 Angles (°) 0.830 Number of atoms Protein  2427 Water 150 FMN 31 NAD+ 44 Glycerol 12 Average B factors (Å2)   Protein 33.7 Water 38.4 FMN 26.3 NAD 55.2 Glycerol 46.1 Ramachandran analyses    Most favoured (%) 97 Allowed (%) 3  Values for the outer shell are given in parentheses.  
 
The monomeric enzyme consists of two domains, a TIM-barrel domain and an inserted 
domain, which are connected by two loops. The TIM-barrel domain (M1 – P211 and E299 – V328) 
consists of eight α-helices and eight parallel β-strands, with the FMN and substrate binding sites 
capping the barrel. In the PA1024
to the ligand-free structure of the enzyme previously reported. The overall structure of PA1024 
in complex with NAD+ is highly similar to the lig
an RMSD value of 0.13 Å on 326 equivalent C
Figure 6.1 Superimposition of the ligandThe overall structure of the ligandPA1024- NAD+ complex (PDB ID: 6E2A) is in grey. The loop residues 75red (ligand-free form) and green (PA1024sticks and the NAD+ carbons are in cyan. The dashed line represents the distance between the position of the C atom of Q80 in the ligand 
Comparison of the structure of the PA1024
PA1024 indicates a conformational change occurs at a loop comprised of residues 75
6.1). The loop residues P78, P82, and P84,
share high identity and similarity 
to the loop. Q80 on the loop shows the greatest variability from the ligand
it moves 5.5 Å to form a hydrogen bond with the side chain of Y261 (2.9 Å) and l
-NAD+ complex, the FMN-binding site is practically identical 
and-free structure determined by Ha et al. with 
α atoms (Figure 6.1).27 
-free and NAD+-complex structures of PA1024.-free form of PA1024 (PDB ID: 2GJL) is in blue and the -86 are highlighted in -NAD+ complex). The FMN carbons are in yellow 
-free and NAD+-complex structures. 
-NAD+ complex to the ligand
 which are fully conserved in over 500
with PA1024, are likely necessary to provide internal rigidity 
-free conformation, as 
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-free structure of 
-86 (Figure 
 sequences that 
atches an 
apparent active site “gate” to secure
isoleucine or leucine occurs at this 
required to physically block the active site entrance and 
“lids” at the entrance of the active site have also been observed in D
pig kidney29 and human30, Pseudomonas aeruginosa
oxidase,32 dihydrofolate reductase,
Figure 6.2 Surface depiction of ligandstructure (right). The TIM-barrel domain is in grey surface and the inserted domain is in blue surface. Q80 is in green surface and Y261 is in orange surface. The NADcarbons are in yellow sticks.    
 The NAD+ molecule is bound to the 
instead is buried in the protein environment, making it impossible for the NAD
NQO1 and NQO2 are similar to PA1024 in this regard, as the 
proteins and the pyridine nucleotide substrate binds to the 
 the NAD+ (Figure 6.2). Q80 is highly conserved, but 
position in some cases, suggesting that a long side
contain the NADH. Active site gates or 
-amino acid oxidase from 
 D-arginine dehydrogenase,
33 RNA polymerase,34 and many more enzymes.
-free structure (left) and the PA1024-NAD+ complex 
+ carbons are in cyan sticks and the FMN 
si-face of the FMN. The re-face of the cofactor 
re-face of FAD is buried in these 
si-face.36, 37 In contrast to PA1024, 
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-chain is 
31 choline 
35 
 
+ to access. 
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which is FMN-dependent and has TIM-barrel fold, NQO1 and NQO1 utilize FAD as a cofactor 
and adopt a flavodoxin-like fold. 
 
6.4.2 “Folded” conformation of NAD+ bound to PA1024 
The electron density of the NAD+ bound to PA1024 is well defined (Figure 6.3) and the 
occupancy is ~80%. The average B-factor for 44 NAD+ atoms is 55 Å2, which is higher than the 
average value for the protein atoms, 34 Å2, and the protein residues in the NAD+-binding site, 40 
Å2. The high B-factor suggests some degree of flexibility of the NAD+, which agrees well with 
the observation that the NAD+-binding site is between the TIM-barrel domain and the inserted 
domain and includes a mobile loop (Figure 6.1). NAD+ is bound to the enzyme in a “folded” 
fashion (Figure 6.4), rather than in an extended conformation. The nicotinamide ring binds close 
to the FMN, whereas the adenine ring resides close to the enzyme surface (Fig. 2). Variations of 
the folded binding mode of NAD+ have been observed in other FMN-dependent enzymes, such 
as the NADH:quinone oxidoreductase WrbA38 and flavin reductase P.39 It is worth noting that 
NAD+ is an inhibitor of flavin reductase P and that the conformation of NAD+ in WrbA does not 
appear to be catalytically relevant because the nicotinamide C4 atom is located away from the 
flavin. A folded binding mode has also been observed in both the NAD+ and NADP+ complex 
with the short-chain flavin reductase HpaC from Sulfolobus tokodaii strain 740 and the NADP+ 
complex with catalase from beef liver.41 In contrast, FMN-dependent enzymes that have been co-
crystallized with NAD+/NADH in the extended conformation include pentaerythritol tetranitrate 
reductase,42 PfaD from Shewanella oneidensis, and the hydrophilic domain of respiratory 
complex I from Thermus thermophilus.43 
  
 Figure 6.3 Binding mode of NADσA-weighted 2Fo-Fc electron density map countered at 1value of the electron density) is shownsticks and the FMN carbons are in yellow sticks. The dashed line indicates the distance between the C4 atom of the nicotinamide and the N5 atom of the FMN and the angle between the N10 and N5 atoms of the FMN and C4 atom of the nicotin 
+ to PA1024.  σ level (where σ is the root mean square  for FMN and NAD+. The NAD+ carbons are in cyan 
amide.  
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Figure 6.4 Interactions of PA1024 residues with NADA) Residues that participate in the binding of NAD. FMN carbons are in yellow sticks, NADcarbons are in cyan sticks, and PA1024 residue carbons are in grey. B) Schematic representation of the interactions of NAD+ with PA1024. The dashed lines represent distances between the heavy atoms of the protein and the FMN cofactor.  
6.4.3 Interactions of NAD+ with PA1024
Nicotinamide moiety 
The nicotinamide NH2 moiety of NAD
FMN (3.4 Å) and the side-chain hydroxyl of S288 (3.3 Å) (
contacts are made by the β- and γ
3.7 Å, respectively). As shown in 
of FMN with a donor/acceptor angle of 110.6° for the atoms involved in the hydride transfer 
reaction. Thus, the combination 
the PA1024-NAD+ complex represent a binding mode relevant for facile hydride transfer from 
the nicotinamide of the NAD+ to the N5 atom of the FMN. The nicotinamide ring of the NAD
does not appear to directly π-π stack with the pyrazine ring of FMN. A conformation similar to 
that seen here was described in the c
complex with NAD+ (PDB ID: 
+. 
 
 
+ forms hydrogen bonds with the N10 atom of 
Figure 6.4). Two van der Waals 
-carbons of Q24 with the nicotinamide ring of NAD
Figure 3, the nicotinamide C4 of NAD+ is 3.6 Å from the N5 
of the proximity and appropriate angle seen in the structure of 
rystal structure of PfaD from Shewanella oneidensis
4Z9R). In contrast, complexes of 1,4,5,6-tetrahydro
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+ 
+ (3.4 and 
+ 
 in 
-NADH in 
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pentaerythritol tetranitrate reductase and NADH in the hydrophilic domain of respiratory 
complex I from Thermus thermophilus showed the nicotinamide ring π-π stacked with the 
pyrazine of FMN, but the carboxamide portion of the nicotinamide ring is tilted and aligns with 
the O4 and N3 atoms on the pyrimidine ring of FMN.42, 43 
 
Ribose moieties 
 The 2’hydroxyl of the adenine ribose establishes a hydrogen bond with the backbone 
C=O of P78 (3.1 Å). The 3’hydroxyl of the adenine ribose forms a hydrogen bond with the side 
chain of H152 (3.5 Å). The ring O atom of the adenine ribose engages in a hydrogen bond with 
the side-chain hydroxyl of Y261 (3.1 Å) (Figure 6.4). The nicotinamide ribose instead is not 
well defined in the electron density map (Figure 6.3), thereby preventing a clear depiction of its 
interactions with the protein. 
 
Pyrophosphate moiety 
The O5 phosphate atom of the pyrophosphate moiety of NAD+ is close to the NH group 
on the side-chain of Q24 (3.7 Å) (Figure 6.4). The O1 and O2 atoms of the adenine phosphate 
form hydrogen bonds with the backbone amides of G270 (3.1 Å) and Q80 (3.4 Å). G270 resides 
on a short loop (268VSG270) that is connected to two α-helices in what can be described as an 
interrupted helix (Figure 6.5). The interrupted helix is part of the inserted domain of PA1024 
and appears to be a single helix that has been slightly unwound. Y261 anchors the helix by 
stacking on the adenine of NAD+ and Q80 interacts with Y261. G270 is fully conserved in the 
500 sequences that share high identity with PA1024; therefore, G270 is likely essential to 
provide the necessary space to bind the pyrophosphat
likely required to have unbulky side
 
Figure 6.5 Pyrophosphate binding pocket of NADThe two α-helices in green are connected by a short loop composed of V268, S269, and G270 that form an “interrupted helix”. The NADin yellow sticks. The dashed lines represent distances. 
Adenine ring moiety 
The N3 atom of the adenine moiety of NAD
C=O of N237 (3.1 Å). The adenine moiety of NAD
Comparison of 500 proteins sharing similar amino acid sequences 
highly conserved as either a tyrosine or phenylalanine, and in a few cases (<5%), an isoleucine. 
The important structural feature at position 261 for binding the pyridine nucleotide appears to be 
e of NAD+. Residues S271 and V272 are 
-chains to accommodate the pyrophosphate of NAD
+ in PA1024. 
+ carbons are in cyan sticks and the FMN carbons are  
+ forms a hydrogen bond with the side chain 
+ appears to π-π stack with Y261 (
to PA1024 indicates Y261 is 
176 
+.  
 
Fig. 5). 
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an aromatic residue capable of π-π stacking interactions with the adenine moiety. A similar π-π 
stacking interaction with the adenine of ADP is well established in the aminoglycoside 
phosphotransferase class of enzymes.44 In contrast, intramolecular π-π stacking of the adenine 
and nicotinamide has been observed in complexes with both NAD+ and NADP+ in the short-
chain flavin reductase HpaC from Sulfolobus tokodaii strain 7.40 
 
6.4.4 Structural features responsible for coenzyme specificity 
The folded binding mode of the pyridine nucleotide would position the 2’phosphate on 
the adenine ribose of NADP+ ~2 Å from the 2’hydroxyl on the nicotinamide ribose of NADP+, 
creating a steric clash that likely prevents NADP+ from binding to the enzyme (Figure 6.6). The 
2’phosphate of the adenine ribose of NADP+ also would likely clash with P78 of PA1024 at a 
distance of 1.9 Å (Figure 6.6). We propose that the steric constraint imposed by the folded 
conformation of the NAD+ and P78 confer the strict specificity for NADH to PA1024. 
Intriguingly, charged residues do not appear to play a role in the coenzyme specificity of 
PA1024. 
  
Figure 6.6 Model of the PA1024Different conformations of the phosphate group in the NADPcarbons are in green, cyan and pink sticks,PA1024 are in grey. The red circles represent steric clashes. 
The majority of the structure
nucleotides attributes their specificity to electrostatic
2’phosphate-binding region has commonly been shown to discriminate between NADH
in NADH-specific enzymes. Examples include D175 in 
dehydrogenase, D53 in Bacillus 
alcohol dehydrogenase.45 A recent study describes a variant of 
D-lactate dehydrogenase with three point mutations (D176S/I177R/F178T) that displ
significantly improved catalytic activity on both NADH and NADPH.
-NADP+ complex. + were modeled. The NADP and the P78 and Q80 carbons and nearby loops of  
-function investigations on enzymes that utilize pyridine 
s. An aspartate residue located in the 
Lactobacillus bulgarius
stearothermophilus L-lactate dehydrogenase, and D223 in yeast 
Lactibacillus delbrueckii 
21 In Type II NADH 
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dehydrogenase, a relatively NADH-specific enzyme, a variant of E203Q granted the enzyme the 
ability to oxidize NADH and NADPH with similar efficiency.46  
The presence of arginine or lysine is typically observed in the 2’phosphate-binding region 
of NADP+-specific enzymes. 4-hydroxyacetophenone monooxygenase exhibits a 700-fold 
preference for NADPH over NADH, and makes use of three basic residues (R339, K439, and 
R440) to dictate coenzyme specificity.47 Crystallographic studies on 6-phosphogluconate 
dehydrogenase attribute the NADP+ specificity to an interaction between the 2’-phosphate of 
NADP+ and R33, since without that interaction there is no cleft for binding the adenine of 
NADH.48 In the crystal structure of NADP+ bound to NQO1, which can oxidize both NADH and 
NADPH, the backbone amide N atom of F232 interacts with one of the O atoms of the phosphate 
group on the adenine ribose of NADP+.36 This additional hydrogen bond is not present with 
NADH as substrate and may explain the differences in affinity between NADH and NADPH in 
NQO1, but the absence of fully charged side-chains interacting with the extra phosphate on the 
adenine ribose may grant NQO1 its dual specificity.  
Only a few studies have described a steric factor as controlling specificity in pyridine 
nucleotide-dependent enzymes, as in the case reported here for PA1024. Homology modeling 
and docking analysis with NADPH of the bifunctional alcohol/aldehyde dehydrogenase from 
Clostridium thermocellum suggested the extra phosphate of NADPH would encounter 
electrostatic repulsion and steric hindrance with D494.49 A variant of the enzyme with the 
mutation D494G increased the specificity with NADPH in C. thermocellum bifunctional 
alcohol/aldehyde dehydrogenase. A study on cytochrome P450 nitric oxide reductase, which 
prefers NADH but can oxidize NADPH at 20% the relative activity of NADH, attributed the 
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preference for NADH to steric clash of a serine residue (S75) with the 2’-phosphate moiety of 
NADPH.50  
6.5 Conclusions 
We have determined the crystal structure of the FMN-dependent NADH:quinone 
oxidoreductase PA1024 in complex with the reaction product NAD+. The results have uncovered 
a different conformation of a short loop composed of residues 75-86 covering the nicotinamide-
binding site in the structure of the PA1024-NAD+ complex as compared to the ligand-free 
enzyme. P78, P82, and P84 provide internal rigidity to the loop. Q80 serves as an active site 
latch that secures the NAD+ within the binding pocket. An interrupted helix that consists of two 
α-helices connected by a small three-residue loop serves to bind the pyrophosphate of NAD+. 
Furthermore, the structural factors governing the strict coenzyme specificity of PA1204 for 
NADH have been determined. The NADP+ likely cannot bind due to a steric clash of its 
2’phosphate with P78. The availability of the structure of the PA1024-NAD+ complex provides a 
firm framework for future structure-function studies aimed at the characterization of the FMN-
dependent NADH:quinone oxidoreductase PA1024. 
6.6 Materials and Methods 
6.6.1 Protein production and crystallization 
Recombinant PA1024 from P. aeruginosa was obtained through expression and 
purification methods previously described.26 The recombinant PA1024 was dialyzed against 20 
mM Tris-Cl, pH 8 (25°C), 200 mM NaCl and 10% glycerol. The purified enzyme was 
concentrated to 5 mg mL-1, mixed with 2 mM NAD+ (oxidized form of nicotinamide adenine 
dinucleotide) and incubated for 30 minutes at 4° C. The enzyme concentration was estimated 
based on the molar extinction coefficient of enzyme-bound FMN.26 Crystallization was 
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performed by the hanging drop vapor diffusion method at room temperature in 4 µL drops of a 
1:1 ratio of protein previously incubated with NAD+ and the reservoir solution. Yellow crystals 
were obtained within a day in presence of 0.1 M HEPES at pH 7.0, 4% (v/v) tacsimate at pH 7.0, 
and 15% (w/v) poly-ethylene glycol methyl ether 5000 as previously described.27 Prior to 
crystallization, PA1024 activity was determined by monitoring the NADH consumption in the 
presence of different quinones.26 
6.6.2 Data collection and processing 
The crystals were cryo-cooled in the mother liquor with 25% (v/v) glycerol and flash 
frozen immediately in liquid nitrogen. X-ray diffraction data were collected at 100 K on 
beamline 22-ID with detector Eiger 16M of the Southeast Regional Collaborative Access Team 
(SER-CAT) at the Advanced Photon Source, Argonne National Laboratory. 180 images of 1° 
oscillation per frame were collected with a 200 mm crystal-to-detector distance and an exposure 
time of 1 s per image. Data integration and analysis were carried out using iMOSFLM51 and 
AIMLESS52 in the CCP4 suite.53 The resolution cutoff was determined by combining several 
criteria including CC1/2 of > 0.5 for the highest resolution shell, 〈I/σ(I)〉 > 2 and completeness.  
The data collection and processing statistics are summarized in Table 1. 
6.6.3 Structure determination 
The structure of the complex PA1024 with NAD+ was solved by molecular replacement 
performed using the coordinates of the holo-form of PA1024 as the initial search model (PDB 
ID: 2GJL) (REF 2GJL). A unique solution was found by PhaserMR54, 55 in the trigonal space 
group P3121 with unit cell dimensions of a = 93.38, b = 93.38, c = 80.76 Å. The Matthews 
coefficient calculated with the CCP4i suite53 suggested one monomer in the asymmetric unit. 
The model was subjected to several rounds of refinement using Phenix.refine.56 Electron density 
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and difference map were inspected, and modifications to the model were made with COOT.57 
The refinement ended when inspection of the maps suggested no more changes were justified, 
and no significant changes in the Rfree and Rwork were observed. Solvent molecules were inserted 
at stereochemically reasonable positions in peaks of 2Fo-Fc and Fo-Fc maps contoured at 1 and 3 
sigma (σ) levels, respectively. Ligand restraint files were generated with phenix.elbow.58 The 
final Rwork and Rfree values were 15.6% and 20.3% for the refined structure. The quality of the 
model was regularly checked for steric clashes, incorrect stereochemistry and rotamer outliers 
using MolProbity.59 All structural figures were produced using PyMol (www.pymol.org). 
Refined atomic coordinates and experimental structure factors have been deposited in the Protein 
Data Bank (PDB entry 6E2A). Refinement statistics are given in Table 1. 
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7 GENERAL DISCUSSION AND CONCLUSIONS 
PaDADH has been studied in this dissertation by a combined approach of mutagenesis and 
pH kinetic effects. The mutagenesis was initially carried out in hopes of identifying the catalytic 
base that deprotonates the substrate α-amino group. However, the pH profiles of variants 
targeting H48, E87, Y53 and Y254 indicated the deprotonation was still occurring in the 
mechanism. This finding was taken as evidence that there is no catalytic base functioning in the 
mechanism, since all the potential bases were ruled out by mutagenesis, and consequently it was 
proposed that the pKa belongs to the substrate α-amine that loses its proton to solvent possibly 
with the aid of enzymatic residues. H48 may be involving in transferring the proton to the bulk 
solvent, suggested by the hollowed pH profiles of the H48F variant. Hollowed pH profiles are 
indicative of a disruption in the fast equilibration of the proton on the ES complex.  
Comparison of the the pH profiles of the E87L variant to the wild-type demonstrated the 
requirement of E87 to be depronated for tight binding of cationic substrates, as the binding pKa 
seen in the kcat/Km pH profiles disappeared in the E87L variant. D-arginine and D-lysine most 
likely form strong electrostatic interactions with E87, and this residue is the principle factor 
controlling substrate specificity in PaDADH.  
In the second part of this dissertation, we demonstrated that PA1024 is not a nitronate 
monooxygenase, as it was annotated in the databanks. Instead, the enzyme exhibits an 
NADH:quinone reductase activity with a strict preference for NADH. The NADH specificity 
could have major implications in the physiological function of the enzyme, as NADH and 
NADPH often play very distinct roles within metabolic pathways. The biochemical 
characterization and bioinformatics anaylsis carried out established PA1024 as the founding 
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member of a new class of FMN-dependent NQRs with a TIM-barrel fold. All of the NQRs 
identified to date are a flavodoxin-like fold, making this the first TIM-barrel fold enzyme with 
demonstrated NQO activity.  
The kinetic characterization in combination with the structural analysis led to the 
identification of structural motfis unique to the catalytic function of this class of NQRs. These 
motifs were then used in a PHI-BLAST to identify close to 500 hypothetical proteins that belong 
to this class of NQRs. The method utilized in this study of implementing both experimental and 
computational approaches to identify structural motifs that define the catalytic function could be 
used to enhance gene function prediction of hypothetical proteins from other enzyme familes, 
instead of the current annotation method which relies solely on overall amino acid sequence 
similarity. Key hypothetical proteins could be selected and characterized, and PHI-BLAST could 
be used to identify other enzymes with similar function.  
The enzyme has a strict preference for NADH over NADPH. The structure of the enzyme 
in complex with NAD+ has been solved, leading to the structural basis for the strict NADH 
specificity. P78 and Q80 are positioned in the NAD+-complex to sterically clash with putative 
binding spot of the 2’-phosphate of NADP+. In addition, Q80 assumes two distinct 
conformations in the ligand-free and NAD+-complex structures, revealing a conformational 
gating mechanism of Q80 to secure the NAD+ within the binding pocket. Lastly, an unusual 
interrupted helix that consists of (268VSG270) serves to bind the pyrophosphate of NAD+ is 
observed in the structure of the NAD+-complex. This interrupted helix could potentially be a 
novel structural motif to bind the pyrophosphate moieties in TIM-barrel enzymes.   
The rate-limiting contributions of PA1024 are shifted as the pH increases. Product release 
becomes progressively more rate-limiting at high pH, whereas flavin reduction is principal rate 
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liming step at low pH. Kinetic solvent viscosity effects (KSVE) provided further evidence in 
favor of product release being partially rate-liming in the reaction catalyzed by PA1024. KSVE 
on the kcat/Km values with PA1024 suggested a conformational change may be required to bind 
the quinone. However, whether the release of the NAD+ or hydroquinone or a combination of 
both product release is responsible for the observed KSVE requires additional experiments.   
The in vivo deletion mutant of PA1024 could provide the necessary information to better 
determine to physiological role of the enzyme. The enzyme almost certainly oxidizes NADH to 
NAD+ in vivo, but if quinones are the true physiological electron acceptors is still debatable. But 
given their high kcat/Km values and widespread occurrence in nature, it is conceivable they could 
possibly be the natural substrates of the enzyme. The operon to which PA1024 belongs to 
consists of enzymes typically involved the β-oxidation of fatty acids. This operon could 
potentially be a novel β-oxidation pathway yet to be characterized in P. aeruginosa. Another 
study on Syntropos wolfei provided evidence that an NADH:acceptor reductase was the possible 
physiological partner of a butyrl-Coa reductase, as the NADH:acceptor reductase was copurified 
with the butyrl-Coa reductase. That same study also demonstrated that known NQO1 inhibitors 
decreased the rate of β-oxidation, consistent with a biochemical link between NADH:quinone 
reductases and β-oxidation. We propose that PA1024 plays a pivotal role in the maintenance of 
the [NADH]/[NAD+] ratio in the cell, and consequently the ability of P. aeruginosa to perform 
the β-oxidation of fatty acids through this hypothetical pathway. In order to verify this proposal, 
in vivo experiments targeting PA1024 and this operon would be necessary.  
